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ABSTRACT 
 
Abstract of thesis submitted by Alexander Euan Hamilton for the degree of Doctor of Medicine (MD) to the 
University of Manchester and entitled Non-Invasive Imaging Techniques and Evaluation of Sensory 
Neuronal Protection by N-acetylcysteine, September 2010. 
 
Background & Objectives 
The potential benefits of adjuvant pharmacotherapy with N-acetylcysteine and acetyl-L-carnitine to reduce 
the amount of primary sensory neurons in the dorsal root ganglion (DRG) which die by apoptosis after 
peripheral nerve injury has been previously established.   However, the duration of NAC therapy sufficient to 
achieve neuroprotection is unknown.   Establishment of clinical trials of NAC/ALCAR therapy is hindered 
by relatively poor existing methods of assessment of neuronal populations and nerve regeneration in human 
subjects.  Magnetic Resonance Imaging (MRI), a non-invasive modality, has been demonstrated in a pilot 
study to provide volumetric analysis of rat L4 DRG after sciatic nerve transection; detecting DRG volume 
reductions which reflect neuronal loss.   Further, MRI has been reported to detect changes occurring in 
peripheral nerves distal to the site of injury, corresponding to axonal degeneration and subsequent 
regeneration.    High Frequency Ultrasound (HFUS) is a new, high resolution imaging modality, not 
previously applied to the study of animal or human peripheral nervous system.  
 
Experiments were designed to test the duration of NAC treatment needed to achieve a neuroprotectant effect; 
to further evaluate the MRI DRG imaging protocol under interventional experimental conditions and in vivo;  
to investigate the ability of MRI and HFUS to visualise murine sciatic nerve and its response to injury and  to 
assess the ability of HFUS to visualise human digital nerves in the hand.   Further, a pilot study investigating 
the effect of NAC and ALCAR on primary sensory neurons in tissue culture was carried out to assess the 
neurotrophic effect of these agents in vitro.        
      
Methods 
1. Groups of rats underwent sciatic nerve transection, and NAC treatment for 7, 14, 30 or 60 days.   At 60 
days post injury neuron counts from L4 and L5 DRG were assessed histologically using a stereological 
optical fractionator analysis, and compared to the contralateral noN-axotomised DRG.  
2. Animals from treatment groups were MRI scanned after two months to measure the L4 DRG volume 
bilaterally.   A single animal was also scanned under anæsthesia and after death. 
3. Numerous MRI techniques were used to scan rats after sciatic nerve crush, division and intraneural 
injection of contrast, attempting to identify the nerve and its response to injury. 
4. Normal and injured rat sciatic nerve and intact human digital nerve were assessed by HFUS. 
5. Cultured DRG neurons were exposed to a range of ALCAR/NAC doses or NGF, with assessment of cell 
survival and neurite formation at 24h.  
 
Results 
1. Neuronal death was related to duration of NAC treatment; with losses of 20%, 9%, 4% & 0% after 
treatment for 7, 14, 30 and 60 days respectively.    
2. MR measured L4 DRG volume reduction correlated well with neuron loss.   In vivo MRI scanning is 
feasible; however images are subject to motion artefact distortion, precluding accurate quantification. 
3. The rat sciatic nerve could not reliably and consistently be identified by MRI in this model. 
4. High frequency ultrasound can image sciatic nerve and its branches and human digital nerve with good 
resolution and can detect neurotmesis and axonotmesis grade injurys. 
5. Non-toxic in vitro NAC/ALCAR dosage regimens have been defined, but do not affect neuron survival or 
neuritogenesis in the absence of NGF. 
 
Conclusions 
1. One month treatment with NAC post neurotomy prevents death of the majority of axotomised neurons.   
Apoptosis is prevented rather than delayed for some neuronal populations by NAC treatment. 
2. MRI is a valuable objective tool, and DRG volume serves as a proxy measure of neuronal loss, fit for 
translation to human studies.       
3. In vivo MRI DRG imaging requires motion compensation techniques such as respiratory gaiting. 
4. Further investigation is needed to facilitate murine sciatic nerve imaging with MRI in this model, but 
HFUS easily demonstrates two grades of peripheral nerve injury, and is proposed for investigation of 
human digital nerve trauma. 
5. The neuroprotective and regenerative effects of NAC/ALCAR on primary sensory neurons in vivo can 
not be replicated by direct treatment of isolated neurons in culture. 
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1.1 INTRODUCTION 
Over recent years the novel paradigm of pharmacotherapy to reduce the number of neurons 
that die as a result of nerve division has been internationally recognised as having the 
possibility to improve patient outcome after nerve injury (Hart et al., 2008).    However, 
before any human studies could be performed with any scientific rigour an objective 
method of assessing nerve cell death, regeneration and neuroprotection in live subjects 
must be established, as current clinical assessment is suboptimal (Jerosch-Herold, 2005).    
 
It has been proposed that magnetic resonance imaging (MRI) could act as a painless, non-
invasive, non-irradiating technique (International Commission on Non-Ionizing Radiation 
Protection 2004) of assessing events within the sensory dorsal root ganglion (DRG) and in 
degenerating or regenerating nerve fibres, and could lead to a clinically useful, objective 
means of surveillance of the response to neuroprotective agents, nerve regeneration and 
target organ reinervation. 
 
Initially this review will discuss nerve injury both as a clinical entity and a neurobiological 
phenomenon, nerve cell death post-axotomy, the evidence for neuroprotective agents and 
some of the proposed mechanisms of their actions.   Secondly, the role of MRI 
neurography, and its potential use in the next part of the neuroprotection story will be 
considered.    
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1.2 NERVE INJURY, NEURON DEATH AND 
NEUROPROTECTION 
1.2.1 NERVE INJURY 
Peripheral nerve trauma is common, with an incidence of 1:1000, or 300,000 cases per 
year in Europe.   At present, despite the techniques of microneural repair being perfected 
over the last thirty years, such injuries still do not have an encouraging outcome (Lundborg 
2000; Kline, 2000).   Recovery of sensory function is always impaired (Glickman & 
Mackinnon, 1990) reflecting reduced cutaneous innervation (Weiberg et al., 2003).   
Although restoration of gross motor function is more encouraging (Hoang, 2006), fine 
movement such as the precision grip and manipulative work is impaired, possibly due to 
lack of sensory feedback and proprioception (Westling & Johansson, 1984; Schenker et al., 
2006).  
 
The prolonged, often painful, unpredictable and frustrating path towards only partial 
sensorimotor restitution has a profound impact on the quality of life of patients (Dagnum 
1998), but also a significant socioeconomic impact for society as the estimated healthcare 
cost to treat and rehabilitate a patient with a median nerve injury is around £47,000 – 
regardless of the eventual outcome (Rosberg et al., 2005).    Further, many people involved 
in upper limb trauma are young workers in industry or agriculture and 50% of patients who 
sustain a major upper limb injury never return to work (Jaquet et al., 2001).  
 
The current bleak prognosis for functional sensory-motor recovery is multifactorial, and 
reflects the fact that axonal injury not only directly damages the involved neurons but 
initiates a profound pathophysiological cascade involving all parts of the CNS/PNS/target 
organ axis (Lundborg, 2000).   Amongst the implicated issues are the slow rate of 
      Chapter 1 
 
Alex. E. Hamilton: MD Thesis, 2011. 19 
 
neurite/axonal regeneration; the particularly difficult hurdle for tens of thousands of 
neurites crossing the site of injury/repair and ongoing re-growth; entry into the correct 
endoneural tubes to reach appropriate targets (skeletal muscle or skin sensory organs) and 
the response of these target organs to prolonged denervation, such as muscle atrophy 
(Gordon et al., 2003).   Further, the brain‟s dynamic and adaptive somatotopic mapping of 
the motor and sensory areas in the pre-, and post-central gyri as well as sub-cortical areas 
may hinder functional recovery if the delay before re-innervation is substantial  (Lundborg 
& Richard,  2003). 
 
Finally, and of significant interest to this study, only neurons that survive the initial injury 
and subsequent repair/regeneration events are able to participate in functional re-
innervation (Fu & Gordon, 1997).   Important in sensory perception is the number of 
innervating neurons and the size and overlap of their receptive field – so called innervation 
density (Kelly et al., 2005).   Therefore reduction in the surviving pool of damaged nerve 
cells is likely to be a major contributing factor to poor recovery.   Experimental models of 
peripheral nerve injury demonstrate death of up to 50% of primary sensory neurons in the 
dorsal root ganglion (DRG) depending on the experimental model (Arvidsson et al., 1986; 
Cheema et al., 1994a & b; Degn et al., 1999; Ekstrom, 1995; Groves et al., 1997; Himes & 
Tessler, 1989; Liss et al., 1994; Liss et al., 1996; Ljungberg et al., 1999; McKay Hart et 
al., 2002a; Ranson 1909; Rich et al., 1987; Rich et al., 1989; Tandrup et al., 2000; Ygge 
1989), and ≈60% of motor neuron cell bodies in the ventral horn of the spinal cord after 
spinal root injury (Koliastos et al., 1994; Novikov et al., 1997).   Similar magnitude of 
sensory neuronal loss was seen in one of few post-mortem human studies of amputees 
(Suzuki et al., 1993). 
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Critically, neuronal cells do not die as a result of traumatic necrosis at the time of injury, 
but in a controlled fashion by apoptosis over a two-month period (Ma et al., 2001; McKay 
Hart et al., 2002a).   There exists clearly, an opportunity to improve functional outcome of 
nerve injury if this controlled cell death can be prevented by the neuroprotective agents.  
 
1.2.2 NEUROBIOLOGY OF NERVE INJURY AND REGENERATION 
To understand some of the MRI signal changes that occur after nerve injury, it is necessary 
to review briefly the cellular events that occur after axotomy of peripheral nerves.   These 
processes can be artificially segregated into events at the neuron cell body and proximal 
nerve stump; events at the distal nerve stump, representing Wallerian Degeneration (WD) 
and Schwann cell and immune cell activity; and the process of regeneration of surviving 
neurons. 
 
1.2.2.1 Proximal stump 
Axotomy induces a phenotypic change in peripheral neurons, differentiated functions 
being sacrificed as the cell enters a „growth mode‟, and an axon regeneration program is 
entered (Snider et al., 2002; Skein, 1989).   Early signalling events initiating this process 
include antedromal electrical activity stimulated by the contact of extruding axoplasm with 
the extracellular milieu (Ambron & Walters, 1996).   Retrograde transport of some 
signalling factor occurs by the „importin‟ system (Blesch & Tuszynski, 2004), this is 
subsequently re-enforced by neurotoxic cytokines (e.g. TNF-α) produced by macrophages 
(Stoll et al., 1989), and LIF from Schwann cells (Curtis et al., 1994; Murphy et al., 1997) 
as part of the neuroinflammatory reaction.   Neurolemmal disruption is repaired in a Ca
2+
 
and calpain dependant process of cytoskeletal rearrangement, which is faster in small 
fibres (Howard et al., 1999).   The axon then degenerates proximally until the first node of 
Ranvier, creating a small area of WD in the proximal stump (Terenghi, 1999).  
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Axonal transport is both disrupted and modified as a result of injury, with up-regulation of 
axoplasmic transport motor element expression (kinesin light chain and dynein) (Tonra et 
al., 1998).   Neurotrophic factors produced by Schwann cell in the distal stump diffuse 
across the injury site and are subsequently retrogradely transported in proximal axons, and 
NGF, GDNF, NT3, BDNF, LIF and CNTF are distributed differentially to fibres of 
differing diameters (Terenghi, 1999).  
 
Cell bodies of axotomised neurons undergo changes of chromatolysis, involving somatic 
and nuclear shrinking, Nissl body displacement, nuclear peripheralisation, central process 
retraction and accumulation of active mitochondria within the perikaryon.   Notably, a 
small population of cells do not adopt this morphology, but become enlarged and 
vacuolated (Groves et al., 1997).   These cells had been attributed a regenerative role; 
however they have more recently been demonstrated to die (McKay Hart et al., 2002a).   
 
1.2.2.2 Distal stump after acute injury 
The purpose of the events in the distal nerve stump are to remove injured tissue, and axon 
growth inhibiting myelin (Küry et al., 2001).   After nerve division there is bleeding into 
the transaction site from the vasa nervosa and accompanied surrounding tissue injury.   
The elastic neural tissue retracts and axoplasm pouts from the cut ends.   A complex 
neuroinflammatory reaction ensues, synchronous with the events of WD (Stoll et al., 
2002).    
 
The axons in the distal stump detach from their myelin sheath, and degenerate by Ca
2+
 and 
axonal protease dependant mechanism (George et al., 1995), which is complete by 24-48 
hours post injury dependant on axon diameter (Stoll et al., 1989).   T-cells and 
macrophages infiltrate the lesion site at around day 2, spread to the whole distal stump by 
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day 4, (Stoll et al., 1989a; Stoll & Jander, 1999) and peak at day 5 (Lazar et al., 1999).   
The axonal debris and myelin sheaths are degenerated and phagocytosed by macrophages 
and activated Schwann cells (Renolds et al., 1993; Terenghi, 1999).   This macrophage led 
clearance of myelin debris is a prerequisite for neurite ingrowth, because myelin associated 
glycoprotein and other myelin degradation products (MDPs) factors will inhibit this 
process.   Clearance of all MDPs takes about one month (You et al., 1997).  
 
Schwann cells de-differentiate and proliferate under control of macrophage signalling and 
MDPs (Terenghi, 1999) and loss of contact with axons (Renolds & Woolf 1993).   These 
cells detach from the endoneural sheath, dowN-regulate protein synthesis, fragment their 
myelin sheath and divide to form the bands of Büngner; solid columns within basal lamina 
tubes which act as guidance cues for ingressing neurites (Stoll et al., 1989a; Liu et al., 
1995; Terenghi, 1999).  
 
1.2.2.3 Distal stump and chronic denervation 
The events of WD are to promote nerve regeneration, but if this is prevented or not 
possible, more chronic changes occur in the distal stump.   Schwann cells loose their 
responsiveness to Glial Growth Factor 2-6 months after denervation, although they are still 
able to myelinate axons during this time, cease to express p75 receptor at 3 months, 
progressively loose expression of the erb-receptor for neuregulin and finally will atrophy 
and die by apoptosis if denervation is prolonged (Li et al., 1997; Terenghi, 1999; Gordon 
et al., 2003).   Beginning with the neuroinflammatory response fibrin deposition and 
scarring occur, endoneural tubes fibrosis begins at 28-35 days post injury, narrowing these 
tubes until they have only 1% of their original diameter by 2 years in man. 
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Sensory organs atrophy after prolonged denervation, Merkel‟s discs disappear by 35 days 
in cats (Liss et al., 1994), Meissners corpuscles after 6 months  and Panacinian corpuscles 
survive for 10 months in the rat (Zelena, 1982).   After muscled de-afferentation 
irreversible loss of muscle mass and destruction of motor end plates occurs by 1m post 
injury, and is associated with muscle fibre expression of apoptotic genes (Kobayashi et al., 
1997; Tews et al., 1997; Lee et al., 2000).   More recently however, the reason for this loss 
of mass has been demonstrated to be partly due to the reduced number of regenerating 
axons available for reinervation, and depletion of intramuscular satellite cells, which limits 
the potential for hypertrophy (Gordon et al., 2003).  
 
1.2.2.4 Nerve regeneration and the role of growth factors in axonal outgrowth.  
If divided nerve stumps are brought together by nerve repair, grafting or conduit axons will 
begin a regenerative program 3-14 days after injury (Fu & Gordon, 1997; Terenghi, 1999).    
Axonal progression through the injury site and into the distal stump is slow, corresponding 
to the rate of slow axonal transport (Fu & Gordon, 1997), and averages ≈1mm/d, being 
0.25mm/d to cross the gap, and progressing at 1-8.5mm/d distally, with the rate being 
inversely proportional to distance from the soma (Green, 1998).   It is estimated that this 
would represent 800 days (over two years) for a brachial plexus lesion in an adult (Gordon 
et al., 2003).   Axon survival and progression is dependent on contact guidance (Tonge et 
al., 1996; Tonge et al., 1997) mediated by integrin coupling (Schoenwaelder & Burwidge, 
1999) and NTFs (Terenghi, 1999; Lundborg, 2000), both of which are supplied by 
activated Schwann cells. 
 
NTF signalling from Schwann cells and target organs to ingrowing axons has been 
extensively studied. Members of the neurotrophin family have a two receptor system 
(Sutter et al., 1979; Bothwell, 1991; Kaplan & Miller, 2000) which includes a high-affinity 
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specific tyrosine kinase receptors (Trk receptor) specific for each neurotrophin, and a 
second neurotrophin receptor (p75
NRT
) a member of the TNF receptor family which binds 
neurotrophic factors with lower affinity than Trk receptors but which has the same 
specificity for all members of the neurotrophin family (Kaplan & Miller, 1997).   The 
complexity of NTF-receptor interaction is in part due to affinity of differing neurotrophins 
for the high affinity tyrosine kinase receptor (Trk) subclasses expressed by populations of 
neurons. 
 
Control of axonal development and regrowth is complex, being regulated by specific 
neuronal growth factors and guided by interplay between the microtubule and 
microfilament systems of the ingressing growth cone and the target extracellular matrix 
and numerous cell surface molecules (Gordon-Weeks, 2004; Calabrese, 2008).   In a recent 
review of signalling and pharmacological control and regulation of axonal formation 
Calabrese (2008) records over 25 different agents which enhance neurite formation in a 
variety of culture systems.  
 
1.2.3 QUANTIFICATION OF NEURONAL CELL LOSS 
The fact that sensory and motor nerve cells are lost after neurotomy has been known for 
almost exactly a century, since the silver staining experiments of the early pioneers of 
neurobiological research such as Ranson and Cajal (Ranson, 1906 & 1909; McKay Hart et 
al., 2002a). 
 
More recently however, the phenomenon has been reinvestigated by using a variety of 
animal models of peripheral nerve injury and neuronal counting techniques including the 
cat (Risling et al., 1983; Liss et al., 1994), rat (Rich et al., 1989; Himes & Tesler 1989; 
Ygge 1989; Vestergaard et al., 1997) monkey (Liss et al., 1996).   These groups 
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documented a range of magnitude of this cell death of between 7-50% of the DRG 
neuronal population.   The wide variation in these observations has been partly attributed 
to differences in experimental models, cell-labelling methodology, time points chosen and, 
particularly, the quantification method of cell counting (Tandrup, 2004).   Most of these 
studies used an assumption-based model of cell number estimation, such as counting 
nucleoli in every tenth section after toluidine blue or cresyl violet staining; this 
methodology that has been shown to be biased, with the mean of all possible estimated 
tending away from the true value (West, 1993; West, 1999). 
 . 
More accurate neuronal quantification was achieved by theoretical and technological 
advances in the techniques of assumption free stereology.   Based on the principles of 
Sterio, the Optical Fractionator method was developed by combining a three-dimensional 
counting probe, the Optical Dissector, with a systemic uniform counting scheme, the 
Fractionator (West, 1993; West, 1999; Hart & Terenghi, 2004; Tandrup, 2004).  
 
Further quantification of the time scale and extent of sensory neuronal loss was carried out 
using such optical dissection, immunocytochemical morphological histology, and TUNEL 
analysis (terminal deoxyribonucleotidyl transferase uptake nick-end labelling) (McKay 
Hart et al., 2002a).   TUNEL positive „dying‟ neurons were detected as early as 24 hours 
post injury, and the rate of death escalated to a peak at 2 weeks, reaching a plateau by 2 
months, but with some neuronal loss continuing for up to 6 months.   TUNEL positive 
neurons displayed morphological features of apoptosis such as cytoplasmic granulation, 
vacuolation, and membrane abnormalities.   Healthy L4/5 ganglia pairs were found to 
contain ≈30,000 neurons.   Stereologically detectable and significant loss of neuron 
numbers was evident at 1 week, and continued until reaching a steady state at 2 months, 
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when a total of 39.2% of all L4/5 DRG neurons was lost; this was estimated to represent 
≈70% of all axotomised cells. 
 
Importantly for future work, these authors used the Cavalieri principle (Gundersen et al., 
1988) to calculate the volume of the DRG, by multiplication of the mean section thickness, 
measured by the microcator on the stereology microscope stage, by the mean cross 
sectional area of a subset of histological sections, measured by image analysis software.   
The volume of the DRG, corrected for the age related change in size as the animals grow, 
was found to vary in proportion to neuronal numbers, and that DRG volume reduction is a 
statistically robust proxy measurement of neuronal death. 
 
Active neuroprotection was also demonstrated with less TUNEL positive cells and less 
neuronal loss occurring after nerve repair, with the protective effect being more 
pronounced by immediate or early repair and compromised as the injury to repair delay 
was increased.    This suggested that for pharmacotherapeutic neuroprotective agents to be 
effective a window of opportunity existed in the first week after injury. 
 
1.2.4 CELL DEATH AND THE NEUROPROTECTIVE AGENTS 
The concept of post-injury neuroprotection and the possibility of supplying exogenous 
pharmacotherapy systemically or directly to the site of injury has been a recognised goal 
for several years. 
 
1.2.4.1 Neurotrophin starvation as a mechanism for triggering apoptosis. 
The stimulus for cell death has long been presumed to be deprivation of neuronal somata 
of retrograde transport of target derived NTFs and many experimental trials using 
neurotrophins to support cell survival and promote regeneration have been tested in vitro, 
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and by a number of delivery systems in animal models (Pitts et al., 2006; Terenghi 1999; 
Yin et al., 1998).  However, despite an extensive body of work since the discovery of NGF 
in the 1940s (Levi-Montalchini, 1998), none of these strategies has led to a clinically 
acceptable treatment for nerve injury for several reasons, including the complexity of the 
effects and interactions of different NTFs on fibre subpopulations, unpredictable responses, 
problematic delivery through the blood-nerve barrier and concerns over potential toxicity 
and carcinogenicity (Lundborg, 2000; Terenghi, 1999).   
 
Starvation of neurotrophic support is regarded as the most important contributing factor to 
cell death post axotomy (Fu & Gordon, 1997; Ambron & Walters, 1996).   However, the 
situation may be more complicated (Chan et al., 2003), and possibly reflects the influence 
of neurotoxic cytokines produced as part of the neuroinflammatory response of WD (Stoll 
et al., 2002), or abortive entry of terminally differentiated mature cells into the mitotic 
cycle (El Shamy et al., 1998).   DRG neurons die in the S-phase, after having overridden 
the G1 restriction point of the cell cycle (Friedlander et al., 1996; Borner, 1996).   It is 
interesting to speculate if this may represent a pathophysiological extension of the 
axotomised nerve cell‟s phenotypic shift towards regeneration and repair. 
 
When discussing neurotrophin withdrawal, obviously axotomy will disrupt transport of all 
NT factors to which each specific neuron is sensitive; NGF is the best studied survival 
promoting factor.   Much of the current understanding of NFG receptor interaction and 
resultant downstream signalling with regard to neuronal survival and apoptosis has come 
from examining peripheral sympathetic neuron development in the mouse, and the 
apoptotic attrition of initially overabundant neuronal populations that exist in this 
ontogenic process (Green & Kaplan, 1995; Kaplan & Miller, 1997, 2000; Kaplan & 
Stephens, 1994; Miller & Kaplan, 2001a, 2001b, 2003, 2007).   As with peripheral sensory 
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neuronal apoptosis post-axotomy, this cell death is related to nuclear starvation of 
neurotrophic factors (Fu & Gordon, 1997; Kaplan & Miller, 2000). 
 
NGF mediated activities of TrkA and p75
NTR 
during development of peripheral 
sympathetic neurons are complex, they seem to act antagonistically to determine the 
cellular response to neurotrophin concentration in the environment on the in-growing 
axons.     In developing peripheral sympathetic neurons p75
NTR
 has a constitutively active 
non-ligand dependent pro-apoptotic role (Bredesen & Rabizadeh, 1997; Barker, 2004), 
which is counteracted by TrkA mediated apoptosis suppression (Majdan & Miller, 1999).   
This antagonism constructs a system whereby if a neuron does not encounter and sequester 
a sufficient quantity of an appropriate TrkA activating neurotrophin, in the case of 
sympathetic fibres NGF, the default p75NTR pro-apoptotic pathway will prevail and 
destroy the cell through p53 (Mazzoni et al., 1999) mediated pruning of neurons which fail 
to innervate the correct target organ or neural circuit (Majdan et al., 2001). 
 
Trk signalling in the cell soma, located at a topographically distinct point from the axon is 
required for cell survival determination decisions and alteration of gene expression.   This 
distant Trk activity requires retrograde transport of vesicle-contained, activated Trk dimers, 
possibly binding NGF itself (Miller & Kaplan, 2001b), to the cell body. 
 
Post axotomy apoptosis induction is via the „intrinsic‟ or „mitochondrial‟ pathway (Benn & 
Woolf, 2004; Polster & Fiskum, 2004), mediated by NTF withdrawal, possibly via the 
p75
NTR
, expression of which is up-regulated in peripheral neurons post injury, and 
blockade of which is neuroprotective in vivo (Cheema et al., 2006).   Intracellular 
transduction of such signals forms a dynamic balance of flux through different kinase 
cassettes; specifically the relative activity of growth factor activated ERK, versus stress 
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responsive JNK and p38 MAPK may dictate cell fate (Xia et al., 1995; Ham et al., 1995; 
Ambron & Walters, 1996; Nunez, 1998). 
 
1.2.4.2 Mechanism of Apoptosis 
The key stages of commitment and execution of the death program begin at the 
mitochondrial level (Polster & Fiskum, 2004), with the „point-of-no-return‟ and the rate 
limiting step being collapse of the mitochondrial inner transmembrane potential (ΔΨm), 
which allows mitochondrial membrane permeabilisation (MMP) (Kroemer, 2003).   It is 
noted that mitochondrial accumulate in neuronal perikarya after axotomy (Al Abdula & 
Martin, 1998).   Regulation of the MMP is controlled by members of the B-Cell 
Lymphoma-2 (BCL-2) family of proteins, which have anti-apoptotic (BCL-2, BCL-Xc, 
BCL-W) or pro-apoptotic (BAX, BAK, BOK, BCL-Xs) activity and differing subcellular 
and mitochondrial localisation (Mohamad et al., 2005).   Members of this family act as 
„sensors‟ for apoptosis encouraging receptor signalling (Li et al., 1998), growth factor 
withdrawal (Zha et al., 1996) and cytoskeletal integrity (Puthalakath et al., 1999).   The c-
Jun activation after NTF withdrawal induces expression and phosphorylation of pro-
apoptotic BCL-2 family members (Putcha & Johnston, 2004).  
 
The effector mechanism of MMP is translocation of BAX from the cytosol to the outer 
mitochondrial membrane (OMM) where, possibly by associating with the voltage-
dependent ion channel, it forms breaches or pores in the phospholipid bilayer allowing 
escape of apoptotic factors in the cytoplasm (Shimizu et al., 2001).   The interaction of 
BAX with the OMM is inhibited by BCL-2 and the other anti-apoptotic family members; 
the intraneuronal ratio of BCL-2:BAX is predictive of irreversible apoptosis commitment 
(Gillardon et al., 1996; Middleton et al., 1996).   MMP triggers cell death by allowing 
efflux of molecules that begin the apoptosis execution program (Polster & Fiskum, 2004) 
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notably cytochrome C (CyC) (Zou et al. 1997),  which activates the Ca
2+
 dependent 
Cysteine protease (caspase) cascade at caspase-9 by the interaction of cytosolic CyC and 
APAF to form the apoptosome complex (Mohamad et al. 2005).   This construct catalyses 
cleavage of  a proenzyme  producing a further regulator protease (caspase-3) which 
initiated a positive feedback cascade of activation of the downstream effector caspases  
which cleave essential cellular substrates and further activate proteases such as DNAse-1 
thus destroying the cell (Nagata, 2000).    
 
The mechanism of neuronal cell death is therefore dependent on caspase-3 (Kouroki et al., 
1998; Cregan et al., 1999) and caspase-9 (Krajewski et al., 1996; Yakovlev et al., 1997) 
activity, and can be prevented by pan-caspase inhibition (Chan et al., 2003).   Such 
involvement of the caspase cascade allows the neuronal death to be designated as apoptosis 
in the „death-style‟ classification of Assuncao Guimaraes & Linden (2004). 
 
Mitochondria are also implicated in the role of oxidative stress in free radical generation in 
apoptosis of axotomized neurons.   Free radical (FR
●
) mediated DNA damage can be 
detected within dying neurons (Martin et al., 1999), and may be mediated by increased 
nitric oxide synthase (NOS) activity (Novikov et al., 1995; He et al., 2000) and increased 
mitochondrial Nitric oxide (NO
●
) (Brorson et al., 1998; Esteves et al., 1998; Brown & 
Borutaite, 2001).   Supraphysiological NO
●
 accumulation permanently inhibits the electron 
transport chain at CyC and allows generation of reactive oxygen species (ROS), notably 
the superoxide ion (O2
-●
), which reacts with NO
●
 to form peroxynitrate (ONOO
-
) (Beal, 
2000; Keller et al., 1998; Nicholls & Budd, 2000).   
 
Failure of oxidative phosphorylation and ATP depletion eventually caused Ca
2+
 
disregulation (Nicholls & Budd, 2000) and can even trigger the MMP (Keller et al., 1998).   
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Oxidative stress could potentially trigger apoptosis via MMP; however direct evidence of 
oxidative stress in axotomized peripheral nerves includes the detection of ONOO- and 
hydroxyl radical mediated DNA damage in apoptotic spinal motor neurons (Martin et al., 
1999), increased activity of NOS in neurotomised DRG and the finding of a 30% up-
regulation of DRG MN-superoxide dismutase activity (Rosenfeld et al., 1997).   This last 
point may represent a homeostatic response to ROS as this enzyme will deactivate O2
-●
 
and ONOO
-
 by forming the less harmful hydrogen peroxide (H2O2).   
 
1.2.4.3 Neuroprotective Agents 
The presumed importance of oxidative metabolic disruption and implication of ROS in 
apoptosis induction led to the proposition of antioxidants as putative neuroprotective 
agents.   Two such molecules, N-acetylcysteine (NAC) and acetyl-L-carnitine (ALCAR) 
have been previously studied in the context of murine sciatic nerve neuronal pool apoptosis 
(McKay Hart et al., 2002b; Wilson et al., 2003; Hart et al., 2004a; Zhang et al., 2005; 
West et al., 2007a; Wilson et al., 2007; Reid et al., 2009). 
 
1.2.4.3.1 N-acetylcysteine 
NAC is a sulfhydryl group (thiol) containing, free radical scavenging antioxidant molecule 
with a long history of clinical use as treatment for hepatocyte toxicity in paracetamol 
overdose, and as a mucolytic (Prescott et al., 1979; 1989) (Figure 1.1). 
Figure 1.1: Molecular structure of N-acetylcysteine. 
(www.sigma-aldrich.com) 
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The biological effects of NAC administration to neuronal type cells has been studied in 
vitro, particularly using PC12 phæochromocytoma derived cell lines and sympathetic 
neuron cultures although to date there is little work studying the response of primary 
sensory neurons.    NAC has direct reductant activity (Kamata et al. 1996; Yan et al. 
1995), interacts with ROS via its sulfhydryl groups (Aruoma et al. 1989) and blocks lipid 
peroxidation by peroxynitrate (Han et al., 1997).   NAC blocks the surge on ROS that 
occurs after occurs after withdrawal of trophic support to sympathetic neurons, inhibiting 
mitochondrial CyC release (Kirkland & Franklin, 2001); the molecule therefore 
counteracts several noxious stimuli implicated in the apoptosis induction.    
 
 NAC also supplements intracellular levels of glutathione by acting as a cysteine donor 
(Yan et al. 1995; Kamata et al. 1996), which is a major neuronal free radical scavenger 
(Heales et al., 1999), depletion of which causes oxidative stress and neuronal death (Ratan 
et al., 1994; Wullner et al., 1999).    Promotion of glutathione biosynthesis is believed to 
be the mechanism by which NAC is hepatoprotective against paracetamol (Corcoran & 
Wong, 1986).   However, glutathione up regulation cannot solely explain the 
neuroprotective effect of NAC, as trophic factor deprived PC12 cells still derive a survival 
benefit from NAC therapy when glutathione metabolism is inhibited (Yan et al., 1995), 
and by administration of the L-stereoisomer of NAC which does not influence glutathione 
levels (Ferrari et al., 1995). 
 
NAC alters cell proliferation and DNA synthesis, blocking cells in the G1 phase of the cell 
cycle (Ferrari et al., 1995; Yan et al., 1995; Sekharam et al., 1998).   As attempted mitosis 
of terminally differentiated neurons in response to trophic factor withdrawal has been 
proposed as explanation for neuronal death, this is an additional mechanism by which 
NAC may offer neuroprotection post axotomy.    
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 NAC modifies intracellular signalling and transcription.    In PC12 cells NAC activates the 
anti apoptotic ERK-1 kinase pathway (Xia et al., 1995; Yan & Greene, 1998).   Further, 
NAC up regulates p21Ras signalling, a pathway implicated in the trophic effect of several 
growth factors including NGF (Nobes & Tolkovsky, 1995; Miller & Kaplan, 2001a, 
2001b, 2003, 2007).   NAC up regulation of Ras is essential for the neuroprotective effect 
of NAC in growth factor depleted PC12 cells (Yan & Greene, 1998).   In the same model, 
NAC was demonstrated to inhibit induction the pro-apoptotic kinase JNK (Park et al. 
1996), therefore NAC would seem to modify both pro-, and anti-apoptotic signalling 
cassettes to favour survival.   Neuroprotection of PC12 cells by NAC is transcription 
dependent (Yan et al., 1995), as critical Cysteine groups have been identified on some 
transcription factors, such as NF-kB and AP1 which need to be in a reduced state to allow 
DNA binding, alteration of transcription via its innate redox activity has been proposed as 
a further mechanism by which the neuroprotective ability of NAC (Abate
 
et al., 1990; 
Meyer et al., 1993). 
 
1.2.4.3.2 Acetyl-L-carnitine 
ALCAR is a vitamin-like compound synthesized in the liver, kidney and brain from the 
essential amino acids, lysine and methionine (Calabrese et al., 2006) and is quantitatively 
and functionally the most significant acylcarnitine ester in the carnitine pool of mammalian 
tissues, and has several metabolic activities (Rebouche, 2004) (Figure 1.2). 
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It is involved in transporting long-chain free fatty acids across the mitochondrial 
membrane as part of lipid β-oxidation and facilitating removal of excess short- and 
medium-chain fatty acids that accumulate during lipid metabolism (Ames 2004).   Further, 
it increases cellular oxygen consumption, stabilizes the inner mitochondrial membrane 
(Ames 2004).   By acting as a reservoir for activated acetyl units, carnitine buffers 
potentially toxic acyl-CoA metabolites and modulates the ratio of acyl-CoA/CoA ratio 
(Calabrese et al., 2006; Bremner, 1990).   It has been proposed that by acting as a feeding 
source of free CoA into the tricarboxylic acid cycle can provide “energy properties...in 
situations of energy crisis” (Jeulin et al., 1996).   Like NAC, ALCAR has antioxidant 
properties (Dhitavat et al., 2002; Hagen et al., 2002). 
 
In vitro ALCAR is neuroprotective, possibly by preventing the mitochondrial uncoupling 
stage of apoptosis (Virmani et al., 1995) and up regulating NGF receptor activity 
(Taglialatela et al., 1991).   Rat sciatic nerve transaction studies have suggested that 
ALCAR increases neuronal regeneration (McKay Hart et al., 2002b) and human clinical 
trials had shown improved target organ re-innervation in HIV neuropathy (Hart et al., 
2004b).   Further, human dietary supplementation studies have suggested that acetyl-L-
carnitine may slow or reverse mild cognitive impairment and progression of dementia in 
Figure 1.2: Molecular structure of acetyl-L-carnitine. 
(www.sigma-aldrich.com) 
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Alzheimer‟s disease (Rebouche 2004).   ALCAR is neuroprotective for CNS neurons after 
ischæmic trauma during cardiac arrest and resuscitation by preventing neuronal shift to 
anærobic metabolism (Zanelli et al., 2005).   
 
In recent years a series of experiments were designed to demonstrate that: 
1. ALCAR and NAC act as neuroprotective agents for sensory neurons after rat sciatic 
nerve division, and have a dose response (Hart et al., 2002b; Wilson et al., 2003; 
Hart et al., 2004a; West et al., 2007a). 
2. NAC is neuroprotective for motor neurons in the ventral horn after rat ventral root 
injury (Zhang et al., 2005). 
3. The effect of NAC neuroprotection is mediated by mitochondrial preservation 
(Wilson et al., 2003; Hart et al., 2004a). 
4. ALCAR promotes sensory neuron regeneration independent of its neuroprotective 
effect (McKay Hart et al., 2002b; Wilson et al., 2010). 
5. Delay in ALCAR treatment for up to 24h post injury does not negatively affect its 
neuroprotective potential (Wilson et al., 2007). 
6. NAC therapy will up-regulate anti-apoptotic genes and down regulate pro-apoptotic 
genes in cutaneous sensory neuronal populations (Reid et al., 2009). 
 
1.2.4.3.3 ALCAR and NAC are neuroprotective for sensory neurons 
In experiments devised to investigate the effect of these neuroprotectants on sensory 
neurons of the DRG apoptosis was detected by TUNEL staining, while L4/5 ganglia 
neuronal counts were determined either by optical dissector stereology with the total 
ganglion neuronal population estimation made by extrapolation of cell density using the 
Cavalieri principal (McKay Hart et al., 2002b; Wilson et al., 2003; Hart et al., 2004a), or 
by use of the optical fractionator technique (West et al., 2007a). 
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DRG morphology in the no-treatment, and sham groups showed many neurons 
demonstrating features of apoptosis, and this was subjectively improved by low-dose 
neuroprotectant treatment, and nearly normalised with high dose ALCAR or NAC.   In the 
treatment groups with both ALCAR and NAC there was substantial, statistically significant 
reduction in the quantity of TUNEL positive cells at two weeks and two months; 
suggesting that treatment with the neuroprotectants reduced the rate of sensory neuronal 
apoptosis after nerve injury (McKay Hart et al., 2002b; Hart et al., 2004a). 
 
A protective effect was also seen when assessing total neuronal number, in both studies no-
treatment and sham groups lost 21% of sensory cells at two weeks and 35% at 2 months 
in the operated side ganglia.   Cell death was significantly reduced with ALCAR/NAC 
treatment, representing rescue of 5,500-6,000 neurons at 2 weeks and over 10,000 cells at 2 
months; there was also some evidence for a dose response in both cell morphological 
assessment and TUNEL positivity at two weeks for both ALCAR and NAC (McKay Hart 
et al., 2002b; Hart et al., 2004a).   Further investigation of the dose response relationship 
of ALCAR showed that 50mg/kg/day was the optimum dose of this agent, and that the 
DRG volume is a statistically significant proxy measure of neuroprotection in action 
(Wilson et al., 2003). 
 
A dose response study for NAC demonstrated a cumulative neuroprotective effect of NAC 
over a dose range of 1-150mg/kg, with the highest dose providing complete abolition of 
neuron loss (West et al 2007a).   Interestingly this dose is identical to that used in the first 
steps of treatment with NAC for paracetamol intoxication (British National Formulary, 
2010). 
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1.2.4.3.4 NAC in neuroprotective for motoneurons 
Motoneurons in the ventral horn of the spinal cord typically undergo less apoptosis after 
peripheral nerve injury that their sensory counterparts (Ma et al., 2001; Hu & McLachlan, 
2003).   However, the amount of cell attrition appears to relate to the distance of the 
peripheral lesion from the somata (Li et al., 1994; Mattsson et al., 1999), and indeed 
massive ventral horn motor neuron death is seen after proximal axonal damage at the level 
of the ventral root, such as occurs in perinatal or high impact brachial plexus injury; as 
many as 80-90% of motor neurons die after ventral root avulsion (Koliastos et al., 1994; 
Novikov et al., 1997), and 50% after root transection (Zhang et al., 2005).   As in sensory 
neurons, the majority of cell death has been demonstrated to occur over an approximately 
two-week time course, and similar molecular pathophysiological events have been 
implicated. 
 
Zhang et al., (2005) assessed the use of NAC as a neuroprotective agent in a murine model 
of ventral root avulsion and rhizotomy.   L5/6 spinal motor neurons were pre-labelled with 
retrograde tracers, and NAC was administered to treatment groups by either intraperitoneal 
doses of 750mg/kg/d or 150mg/kg/d, or intrathecally, using an implanted osmotic 
minipump to deliver 2.4mg/d.   Ventral root rhizotomy caused death of 28% of the ventral 
horn medial gastrocnemius motor neuron population, and a 21% reduction in soma area, 
while root avulsion killed 53% of such cells with a 31% reduction in soma area in 4 weeks.   
Intraperitoneal NAC treatment provided dose responsive neuroprotection after rhizotomy, 
with only 7% neuronal death at 8 weeks in the high dose group; the 17% death for low 
dose intraperitoneal NAC not reaching statistical significance – intrathecal NAC was of 
even more benefit, with only 5% of cells succumbing.   After root avulsion, low dose 
intraperitoneal NAC allowed significant 60% neuronal survival, although this was not as 
effective as the 70% survival found in the intrathecally treated group. 
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Of potential clinical relevance, one-week delay in institution of intrathecal NAC did not 
have a significant deleterious effect on neuroprotective ability, however, the total death 
rate rising from 30-32% to 42% after a 2-week delay (Zhang et al., 2005). 
 
NAC can therefore provide neuroprotection both for sensory neurons after postganglionic 
axon division, and rescue motor neurons after proximal axotomy. 
 
1.2.4.3.5 ALCAR & NAC provide mitochondrial protection 
Evidence for the putative mechanism of ALCAR and NAC‟s neuroprotective effect being 
mitochondrial stabilization was also been assessed, using transmission electron microscopy 
(Hart et al., 2004a, Wilson et al., 2003).   Axotomised neurons demonstrated cytoplasmic 
disruption such as mitochondrial swelling, loss of architecture, crystal disruption, 
vacuolation or rupture.   Further, there was disruption of the endoplasmic reticulum, and 
nuclear changes of apoptosis such as chromatin condensation, nuclear irregularity or 
fragmentation.   In cells that had received low dose ALCAR, only some cristal disruption 
was noted, and with high dose ALCAR or NAC cell ultrastructure was generally normal, 
with only occasional mitochondrial swelling (Figure 1.3).   The striking preservation of 
mitochondrial morphology lends weight to the proposition that the neuroprotective effect 
of these agents is mediated by alleviation of oxidative stress by ameliorating other 
detrimental bioenergic processes. 
 
1.2.4.3.6 ALCAR increases sensory neuron regeneration 
Past experiments in vivo and cell culture systems had suggested that ALCAR had the 
ability to enhance neurite outgrowth and regeneration after nerve injury (Fernandez et al., 
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1989; Taglialatela et al., 1991; Manfridi et al., 1992), which had been attributed to up-
regulation of the neuron‟s responsiveness to NGF.    
Figure 1.3: Effect of NAC on mitochondrial morphology.   tEM of L5 DRG neuronal 
somata with no injury (A), two weeks after axotomy (B) and two weeks post axotomy with 
NAC treatment (C) - The mitochondrial disruption seen in B is prevented in C by NAC 
treatment (scale bar = 500nm) (Modified from Hart et al., 2004a with permission). 
 
 
However, increased neurite activity may simply represent augmented regeneration 
potential of the larger sensory neuron pool as a result of neuroprotection. 
 
To investigate the potential regeneration promoting effects of ALCAR in isolation, McKay 
Hart et al., (2002b) performed standard murine sciatic nerve division, and after a two-
month delay, by which time neuronal loss is essentially complete, repaired these lesions 
with reversed sciatic nerve isograft.   ALCAR was administered intraperitoneally at 
50mg/kg/d beginning on the day of nerve grafting.   At six weeks post repair, regenerating 
fibres crossed the full extent of the harvested nerve/graft construct, but there significantly 
greater axonal regeneration in the ALCAR treated group than in controls.   These data 
suggest that ALCAR treatment, independent of its neuroprotective effect can augment the 
capacity of sensory neuronal fibres to regenerate through a nerve graft.  
 
In a separate experiment ALCAR associated regeneration was assessed by visualisation of 
myelinated fibres distal to the sciatic repair site, by immunohistochemistry against protein 
gene product 9.5 in hind paw footpad skin as a marker of very small nerve (including non-
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myelinated fibre) dermal reinervation, and by wet muscle weights of the gastrocnemius as 
an index of muscle re-innervation (Wilson et al., 2010).   The results showed that the mean 
number of myelinated fibres and myelin thickness distal to the nerve coaptation were 
improved by ALCAR administration compared to sham treated groups.   ALCAR also 
increased ingrowth of small nerves into the footpad dermis by 210% compared to sham 
treatment and led to less wet muscle mass loss.   These findings suggest that ALCAR will 
act to globally promote and foster peripheral nerve regeneration of heterogeneous sensory 
populations‟ as well motor fibres. 
 
1.2.4.3.7 Small delays in commencement of ALCAR therapy do not adversely affect 
neuroprotective effect. 
Observations of clinical logistics demonstrate that after an acute injury there is often a lag 
period of days or hours before a patient with a peripheral nerve injury arrives at a specialist 
reconstructive centre.   The effect of delayed administration of ALCAR was investigated 
after sciatic nerve transection (Wilson et al., 2007).   Delays between 6 and 24 hours in 
treatment commencement had no effect on the neuroprotective effect of ALCAR with no 
neuron loss in these groups compared to DRG from the contralateral control side.   Even a 
prolonged delay of a full week after injury led to less neuronal apoptosis than in animals 
with no treatment although these differences did not reach statistical significance. 
 
1.2.4.3.8 NAC Treatment prevents apoptosis in susceptible neuronal population by 
affecting the balance of apoptotic markers. 
It has been reported that not all neuronal sensory subpopulations in the rat DRG undergo 
the same rate of apoptosis after sciatic nerve injury; with the vast majority of cell death 
occurring in the cutaneous afferent neurons whereas muscle propreoceptive sensory 
neurons are spared (Welin et al., 2008).   To further investigate this phenomenon, levels of 
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apoptotic related gene activity within these two cell subpopulations was analysed by 
staining neurons with a retrograde tracer, isolating individual labelled cells from frozen 
section samples by using laser microdissection and subjecting aggregates of each cell type 
to quantitative real time PCR (polymerase chain reaction) amplification to study mRNA 
levels of specific genes (Reid et al., 2009).   mRNA from the anti-apoptotic BCL-2 protein 
and the pro-apoptotic BAX and apoptotic effector caspase 3 were quantified both with and 
without NAC treatment in nerve transection groups.   Axotomy leads to up-regulation of 
BAX and caspase 3 in apoptosis prone cutaneous sensory neurons, and down regulation in 
the more robust muscle afferent population.   NAC treatment led to further down-
regulation of pro-apoptotic markers in muscle afferents and also caused significant down-
regulation of BAX and caspase 3 in cutaneous fibres.   The pro-apoptotic marker BCL-2 
did not alter expression levels in either cell subpopulation after axotomy alone, but was 
significantly up-regulated in both groups by NAC treatment. Leading to a high BCL-
2:BAX ratio in subpopulations not destined to die. 
 
These finding add more evidence suggesting that the neuroprotective effect of NAC is not 
purely mitochondrial protection by scavenging of reactive oxygen species but involves a 
more complex system including alteration of signalling and translation events.   NAC 
rescue of PC12 cells in culture involves activation of the Ras-ERK signalling pathway 
(Yan & Green, 1998), and such NAC mediated Ras-ERK signalling  has  more recently 
been demonstrated to up regulate BCL-2 in a cell culture model of Alzheimer‟s disease 
(Hsiao et al., 2008).           
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1.3. MRI IMAGING OF THE PERIPHERAL 
NEUROMUSCULAR SYSTEM 
1.3.1 THE NEED FOR MRI IN ASSESSMENT OF NERVE INJURY  
A significant hurdle in commencing a clinical study of neuroprotection in a human 
population is the inability to use histological methods of neuronal counting in live subjects.   
Surveillance of neuronal loss and rescue in humans must therefore rely on clinical 
assessment of nerve function, neurophysiological assessment or some non-invasive 
imaging technique.  Several systems for in vivo assessment of nerve function have been 
proposed, both for murine models and in human subjects. 
 
There are many cited strategies to draw inferences of neuromuscular function in rodents, 
these have a wide spectrum of invasiveness, and all have some drawbacks.   
Electrophysiology and Nerve Conduction Testing can measure the velocity of propagation, 
peak amplitude and area of a compound action potential, but can give inappropriate 
interpretation of return of function (Varejão et al., 2001; Kanaga et al., 1996).   
Electromyography (Wessig et al., 2004; Bendszus et al., 2004; Grant et al., 1999) and 
other methodologies such as foot withdrawal response to electrical stimulation (De Konig 
et al., 1986), muscle wet weight, single muscle contractile force measurement (Varejão et 
al., 2001) and animal gait track analysis (Shenaq et al., 1989) do not give full and reliable 
information on the level of regeneration.  
 
Assessment of nerve recovery in people is no simpler, and in surgical practice often only 
clinical tests of motor function and sensory distribution are used.   EMG is the current 
„gold standard‟ for motor assessment, but it is investigator dependent and painful, 
unsuitable for testing of children and anticoagulated/coagulopathic patients, and presents 
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difficulty if serial examination is needed.   Further, anatomical considerations can limit 
utility of EMG, such as proximal lesions (root avulsion) or limb mutilation (Koltzenburg & 
Bendszus, 2004).   EMG however does have utility in monitoring various aspects of the 
response to injury, but can only detect regeneration at the stage of fibres reinnervating 
targets (Grant et al., 1999). 
 
Testing of sensory function is complicated by the range of sensory modalities subserved by 
the skin, and the different fibre types involved.   The basic discrimination of light touch, 
pressure, vibration, heat, cold and fast pain and possibly itch (Ganong, 1997) is 
complicated by central processing of these elements to derive compound sensations or 
„synthetic senses‟ such as vibratory sensibility, stereognosis, and functional tactile gnosis 
(the ability to recognise and identify textures and shapes) (Lundborg & Richard, 2003).   
Some higher sensory modalities are still being discovered, such as the c tactile afferent 
system of hair baring skin that projects to temporal insula, thought to be involved in the 
emotional and hormonal response to skin-to-skin caress (Olausson et al., 2002). 
 
 In a recent systematic review of a battery of testing modalities for sensory functions, only 
monofilaments and shape-texture identification met the criteria for a standardized test 
(Jerosch-Herold, 2005).   The last of these testing methods has been refined into a 
commercially available set of objects and testing protocol named the Shape-Texture 
Identification test (STI™) (Rosen & Lundborg, 1998).   Probably the most used sensory 
clinical test is „two point discrimination‟ (2PD) (Grant et al., 1999), but Lundborg & 
Rosen (2004) have commented that over reliance on this technique has lead to “enormous 
implausible variability” in reported sensory recovery after injury. 
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In man, as well as in animal models therefore a modality was lacking that could distinguish 
between individual elements of the nerve injury/repair sequence, including death of the 
sensory neuron pool, axon regeneration and organ re-innervation.   It is in this role that 
MRI demonstrates great possibilities (Grant et al., 2002). 
 
1.3.2 MRI NEUROGRAPHY 
The potential of Nuclear Magnetic Resonance (NMR) to create a biological imaging 
technique was realised and pioneered by Damadian in 1971.   He realised that the nuclear 
magnetic relaxation times of normal and neoplastic tissue differed (Damaidian, 1971), 
leading to patenting of a „cancer scanner‟ in 1974 (United States Patent and Trademark 
Office 1974); to the first human MR image in 1977, and marketing of the first commercial 
MRI scanner in 1980 (Figures 1.4 & 1.5). 
 
 
 
Figures 1.4 & 1.5: „Indomitable‟ the World‟s 
first MRI scanner, and the first human MR 
image - an axial section through thorax showing 
the chest wall and centrally the heart. 
(From http://fonar.com) 
 
By applying principles of back projection, gradient and frequency encoding, the Fourier 
transform and echo-planar imaging, MRI techniques have been evolved to the current 
standard by contributors such as Ernst, Lauterbur and Mansefield (The Nobel Assembly 
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2003).   Controversially (Culver, 2003), these three latter scientists have been awarded 
Nobel prizes for their work concerning MRI, but Damadian has so far not received this 
honour.  
 
Detailed discussion of the physics and hardware technicalities involved in generation of an 
MR image are beyond the scope of this review, however, some basic principles are 
required.   The basis of MR imaging is recording the radiofrequency (RF) energy 
emissions released as the magnetic moment of unpaired protons relax from precession at 
the Larmor frequency towards their natural alignment within a strong, generated magnetic 
field after cessation of a RF pulse (Westbrook, 2002).   By use of a 2D Fourier transform 
function, the data from the sums of phase and frequency encoding per voxel can be 
transformed into an image (Elster, 1994).  
 
Of relevance to neural imaging studies are the concepts of T1 recovery, T2 decay and pulse 
sequencing.   T1 recovery is the regaining of longitudinal magnetization after cessation of a 
RF pulse and is caused by „spin lattice energy transfer‟ from nuclei to their surroundings, 
T2 decay is caused by the exchange of energy from one nucleus to another causing loss of 
spin phase coherence.       Crucially, the T1 and T2 properties of hydrogen nuclei in fat and 
water differ, and therefore by changing parameters of the RF pulses, gradient applications 
and intervening time periods („Pulse sequence‟) specifically the „time to repeat‟ (TR) and 
„time to echo‟ (TE) images can be produced with different fat to water contrast, so called 
T1-, or T2-weighted images (T1w & T2w) (Schild, 1990; Westbrook, 2002).   Neurological 
MR imaging studies have used a variety of pulse sequences including the conventional 
„spin echo‟ or „gradient echo‟ sequences and more complex fast or turbo sequences, these 
frequently have elaborate, often commercially patented, acronyms; but at the most basic 
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level are designed to achieve specific contrast or reduce imaging time (Shild, 1990; Elster, 
1994). 
 Of potential interest to our group, MRI can be used to visualise: 
 
1. Nerve response to injury and regeneration. 
2. Small neural structures at an almost microscopic level of detail, and accurately assess 
their volume. 
3. DRG in humans and rats. 
 
1.3.2.1 MRI of Nerve after Injury 
Possibly the first MR neurogram, of rabbit forelimb nerves, was generated using fast spin-
echo sequence with fat suppression (Howe et al., 1992), this was made possible by 
anisotropic properties of nerves whereby water diffuses longitudinally along nerves more 
readily than in other directions (Grant et al., 2002). 
 
Similar technology allowed publication of the first human MR neurogram of an isograft 
repaired human tibial nerve, by the same group (Filler et al., 1993).   Even as early as this, 
obvious signal intensity differences between myelinated nerve and regenerating graft were 
documented.  
 
After this landmark, several groups began to MR image nerves in pathological conditions, 
commonly in compression syndromes.   The Carpal tunnel syndrome was assessed using 
T1w, T2w, proton density and short -inversion recovery (STIR) scanning (Britz et al., 
1995).   This group found T2 signal increase in the median nerve in the carpal tunnel of all 
symptomatic patients, and quantitatively greater STIR signal hyperintensity in the nerves 
of those patients with worse clinical disease.   These findings correlated to EMG results, 
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and both signal and configuration changes improved to some extent after clinically 
successful carpal tunnel release. 
 
More proximally, the same group demonstrated similar results at the elbow, assessing ulnar 
nerve entrapment and compression in the cubital tunnel (Britz et al., 1996).   Again, MRI 
was both sensitive and specific when compared to intraoperative findings, and interestingly 
somewhat more sensitive than „gold standard‟ EMG (97% vs. 77% correct diagnosis of 
compression).   Around the same time, the first evidence was published that neural T2 
signal enhancement will normalise after nerve repair, but remains hyperintense for a 
prolonged period after irreversible damage (Daley et al., 1997). 
 
In response to these successful human case reports, several groups began to use animal 
models of nerve injury, and very high field research magnet scanners with novel phased 
array coils to systematically study MRI of nerve, key objectives were to establish the time 
points of signal change after injury and during regeneration, and to establish what 
physiological parameters gave rise to these NMR differences. 
 
Initial workers correlated MR changes to histology, finding T2 change at the lesion site and 
distally, and eventual normalisation; these differences seeming to mirror the onset and 
completion of WD and nerve œdema (Does & Snyder, 1996; Cudlip et al., 2002).   Further, 
T2 spectroscopy can provide information about fluid compartmentalisation, when „myelin‟, 
„intracellular water‟ and ‟extracellular water‟ were examined, degenerating nerves showed 
decreased amplitude of the „myelin‟ component and increased T2 signal of the „intra-„ and 
„extracellular‟ peaks, suggested to reflect breakdown of distal stump axons and intraneural 
œdema (Stanisz et al., 2001) 
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Aagaard et al., (2003) compared transient nerve injury (crush), with irreversible (cut and 
capping) of the rat sciatic nerve to serial MRI and functional recovery by gait track 
analysis.   Multi-time point histology was also used, immunostained for neurofilament on 
cross-sectional area of nerve 5mm distal to the cut or crush.   By the first scan at post-
operative day 7, nerve injured by either method was strongly T2 hyperintense.   However, 
in crushed nerves, this normalized between post-operative day 21-28, this being around the 
same time that gait track analysis regained normality, and histologically increasing 
numbers of regenerating, myelinated axons were found distal to the injury, with scanty 
myelin degradation products (MDPs).   In contrast, in the cut nerve group, T2 and STIR 
hyperintensity was qualitatively greater, and persisted until post-operative day 60 (Figure 
1.6).   No neurofilament positive regenerating axons were found in the distal nerve stump, 
but there was significant quantity of MDPs until POD 60.   It was therefore demonstrated 
that nerve regeneration correlates with T2w signal normalisation, but that this will occur at 
60 days even in degenerating axons.   At no point were any changes in T1w signal noted. 
 
Figure 1.6: Axial STIR sequence MRI of rat hind quarters, showing normal sciatic nerve 
in the thigh („L‟ arrow) and T2 hyperintensity in the distal stump of the axotomised right 
nerve („R‟ arrow) 28 days post-injury, scale bar = 1cm (Modified from Aagaard et al., 
2003). 
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In a similar study Bendszus et al., (2004) added more frequent time points of MR imaging, 
beginning at one day post-operatively, and different imaging parameters (T1w, T2w, double 
spin echo, TRIM sequences and gadolinium contrast enhanced fat suppressed T1w images) 
and compared MR results with EMG recording as well as immunohistology.   Notably, this 
study was performed with a 1.5 Tesla scanner, which is comparable to machines used in 
human clinical practice (Elster 1994).   To assess the relative contribution fluid distribution 
within the nerve to T2w signal response histological sections were digitised, and assessed 
using 2D surface area analysis. 
 
MRI signal changes were first detected between the time of loss of voluntary movement 
activity and the finding of spontaneous pathological activity, i.e. in the time after 
functional loss of impulse propagation and the first detectable proof of denervation.   T2 
signal elevation correlated with the massive histological axonal degeneration and 
breakdown of cell integrity during WD.   Initially however, the extracellular compartment 
of the proximal stump cross sections was not enlarged, suggesting that the T2 change is not 
likely to be attributable to water proton shift, in the early stages.    However, by one-week 
post-lesion, endoneural œdema was marked, and this was likely to be responsible for the 
subacute plateau of T2 signal enhancement.   Re-detection of voluntary activity correlated 
with normalisation of MRI signals, and histological return of normal fibre density and 
extracellular space volume (Bendszus et al., 2004). 
 
The same group pioneered use of a MR contrast agent Gadofluorine-M which, by gaining 
access to degenerating nerves through breaches in the blood-nerve barrier that occur during 
WD, persistently highlighted degenerating fibres.   Further, because enhancement is 
reversible on successful regeneration, moving zones of proximodistal nerve growth were 
made visible (Bendzus et al., 2005). 
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MRI has therefore been shown to be a sensitive tool to detect axonal lesions and motor 
regeneration, as distinct from neuropraxic grade injury, which has only local T2 signal 
hyperintensity at the site of compression (Britz et al., 1995), and that this axonal trauma 
can be visualised as early as 24h post-lesion which is before detectable EMG denervation 
activity (Bendszus et al., 2004). 
 
There have been several proposed reasons for the observed T2w signal change, these 
include increase water content, or transient increased permeability of the blood-nerve 
barrier during neuronal injury (Seitz et al., 1989).   However, as discussed by Aagaard et 
al., (2003), as water proton content increase should be accompanied by increase in the T1w 
signal, which does not occur.   Ingress in inflammatory cells, such as macrophages, into the 
degenerating nerve stump can be detected by MRI (Bendszus & Stoll, 2003), and might be 
expected to change the T2w signal, however, histological finding of similar numbers of 
such inflammatory cells in axotomised and neurotomised nerves at post-operative day 60, 
after MR signals have normalised stand against this proposal (Aagaard et al., 2003). 
 
Aagaard et al., 2003 propose that a likely explanation for the observed signal differences is 
myelin turnover, the changes in intensity being correlated with the presence, and 
subsequent clearance of MDPs.   In axonotmesis injury, the MDPs have a shorter half-life 
in the distal nerve stump as they are re-cycled for ensheathing of regenerating nerves 
(Muller et al., 1986), and therefore MDPs are cleared at an earlier time point.   Further 
evidence for this „myelination‟ proposal of signal change comes from the enhancement on 
both de- and re-generating neurons with gadoflouraine-M, which binds to fibrillary 
structures and vesicular formations of myelin debris.   This enhancement was noted until 
complete regeneration was seen (Bendszus et al., 2005). 
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A More recent study of signal changes post axotomy was reported by Bher et al., (2009), 
using a 4.7T experimental scanner and analysing T2-weighted fast spin echo sequences.   
This group demonstrated T2 hyperintensity in the distal stump of sciatic nerves which had 
been either tansected and repaired or permanently divided.   In coapted nerves T2 
hyperintensity was obvious by 6 days post injury, reached a plateau phase between days 
14-21 before returning to normal between days 35-42 and reaching normality by 63 days 
post-operatively.   In the permanent division group signal change occurred faster, to a 
greater extent and for an increased duration, but mirroring the findings of (Aagaard et al., 
2003) that even when nerve regeneration does not occur dist stump signal changes will 
eventually normalise.   Comparison with histological fibre counting and analysis of 
presence and amount of myelin present in the distal stump after both injury models is 
interesting; in repaired nerves, histological detection of fibre regeneration crossing the 
coaptation site and into the distal stump at 14 day correlates well with beginning of 
normalisation of T2 signal, as did final resolution of signal changes as day 42 correspond to 
progressing fibre accumulation, size increase and myelin thickness.  As in the study by 
Aagaard et al., (2003) however, no convincing explanation for the eventual return to 
normality in the non-regeneration group were suggested.               
 
MRI neurography therefore has the potential to visualise degenerative changes in neurons 
before there is unambiguous EMG changes of axonotmesis, image re-generation before 
neurites reach sentinel muscles (Koltzenburg & Bendszus, 2004) and potentially help 
diagnosis between different grades of nerve injury. 
 
1.3.2.2 Microscopic and Volumetric Analysis with MRI 
Two of the properties of MRI which have progressed rapidly in recent years are increasing 
image resolution, allowing near microscopic levels of detail to be achieved, and combining 
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MR scans with image analysis software to calculate surface area of elements in planar 
pictures and reconstruct these to calculate the volume of three dimensional neural 
structures. 
 
1.3.2.2.1 Microscopic Resolution 
The eventual picture resolution of an MR image is a function of the scanned volume 
element (voxel), which is the 3D element of body tissue rendered as one digital pixel on 
the resulting reconstructed cross sectional scan (Westbrook 2002).   The intrinsically low 
signal-to-noise ratio (SNR) of MRI becomes increasingly problematic when fine resolution 
images are produced, due to the small amounts of water in each voxel, but resolution can 
be increased by using stronger main magnetic field strength, thinner section slices, longer 
acquisition times and custom designed hardware such as imaging coils (Jacobs & Cherry, 
2001; Natt et al., 2002; Farooki et al., 2002).   Spatial resolutions as low as 10μm have 
been achieved by several groups at field strengths ranging from 4.7-14T; imaging of such 
small areas has been described as micro-MRI (μMRI) (Jacobs & Cherry 2001; Ullmann et 
al., 2010).  
 
Post mortem studies allow longer imaging time, and therefore higher resolution, but do not 
take advantage of the intrinsic non-invasive nature of MRI.   Examples of such very high 
resolution imaging are the μMRI atlas of mouse development of Jacobs et al., (1999) 
(Figure 1.7), and the resolution of post mortem human median nerve to a resolution fine 
enough to visualise fascicular architecture and the intraneural connective tissue layers  
(Bilgen et al., 2005) (Figure 1.8). 
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Figure 1.7: Post-acquisition reconstruction of 3D spin-echo MRI of 
the 10.5 dpc mouse embryo.   There is no scale in the original paper; 
however the average crown-rump lenth at this stage is 3.3-3.9mm 
(Theiler, 1989) (figure from Jacobs et al., 1999). 
Figure 1.8: T2 weighted dual-echo spin-echo sequence of human median 
nerve demonstrating perineunium (up arrow) and fascicular architecture 
within the endoneurium (arrow head).   There is no scale in the original 
paper (Figure from Bilgen et al., 2005). 
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In vivo μMRI has associated difficulties of potential movement of the subject and 
necessarily shorter scanning time as anæsthesia can only practically be maintained for a 
limited period.   Natt et al., (2002) cite a large spectrum of voxel sizes used for imaging 
mouse brain in vivo ranging from 78x156x343μm at 7T to 98x156x1500μm at 11.7T. 
 
This group, using a 2.3T field with T1w 3D FLASH sequences were able to achieve section 
thickness of 156-938μm, and managed to image structures as small as the hippocampus 
and medial Habenular Nucleus, which are normally only visualised using microscopic 
histology.   The acquisition time in these experiments was 1-1.5 hours, which included set 
up, animal arrangement in a stereotactic frame, scout image generation and definitive 
scanning.   Interestingly, in the same paper, intra-ocular injection of „smart contrast‟ agent 
(Mg
2+
 as an analogue of Ca
2+
) was used to delineate fibre tract projection pathways.   
Hyperintense signal was located to the retina, optic tract, lateral geniculate nucleus and 
superior colliculus, demonstrating the potential therefore of μMRI to be used for 
neurophysiological axonal tracing in living animals. 
 
In vivo μMRI imaging has also been applied to humans (Farooki et al., 2002).   Healthy 
volunteers had the median nerve in the carpal tunnel imaged in a narrow bore 8T clinical 
„limb‟ scanner.   In comparison to „standard‟ 1.5T clinical scans nerve anatomy was 
demonstrated in much higher resolution (slice thickness 2mm) allowing epineural and 
fascicle identification, although there was not the same signal-to-noise ratio and clarity as 
the ex vivo studies of Bilgen et al., (2005). 
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1.3.2.2.2 Volume Estimation 
Investigators undertaking volumetric studies often use variations on 3D volumetric 
sequences, these techniques stimulate all of the tissue within a „region of interest‟ with an 
RF pulse, and acquire data from the full volume of this tissue, these data are „sectioned‟ 
into 2D slices by a phase encoding stage of the image reconstruction.   3D sequences are 
believed to provide more accurate basis for volume estimation as each image slice is more 
homogeneous and isotropic than those acquired by standard sequential slice acquisition 
(Sprawls 1988; Johnston et al., 1999).   
 
Several groups have demonstrated volumetric analysis of neural structures using sequential 
MRI slices, either using simple measurement or more sophisticated computer assisted 
calculation, both in human studies and animal models (Gadeberg et al., 1999; McDaniel et 
al., 2001; Wolf et al., 2002; Marziali et al., 2004; Nagel et al., 2004). 
 
The earliest of these studies aimed at assessing disease load in human multiple sclerosis 
patients by measuring the total brain plaque volume (Gadeberg et al., 1999).   In an 
experimental method analogous to stereological assessment of tissue volume with an 
optical dissector, the group used a transparency printed with counting grids applied to hard 
copy MRI films to assess lesion surface area, and extracted a depth measurement from the 
number of 3mm slices over which lesions extended.   Interestingly, but somewhat 
discouragingly, by applying the same scanning parameters to a contrast filled „phantom‟ 
this group estimated the error measurement in their surface area assessments to be between 
15-200% (dependent on object size).   This was attributed to an element of overprojection 
due to the thickness of slices, and partial volume effect, which causes inaccuracy at 
detecting edges of elements due to each voxel being attributed a grey scale pixel value 
based on the average signal value of all the tissues contained within it (Tofts et al., 2005).   
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These authors suggested that development of hardware advances allowing thinner slices 
would reduce this error, and suggest a mathematical formula to reduce overprojection bias 
(Gadeberg et al., 1999). 
 
Probably the first use of volumetric neurological in vivo μMRI was reported by McDaniel 
et al., (2001), who used a mouse model of ischæmic forebrain neurodegeneration scanned 
using a custom made surface coil, with head restraint, in a 7.1T 15cm bore scanner.   
Parameters included 3D Spin-echo (T1) and 3D diffusion-weighted spin-echo pulse 
sequences and total scan time was 1.36-2.4h.   Volumetric analysis of the forebrain and the 
ventricles was performed by assessing the surface area of each structure in each slice with 
image analysis software, and multiplying total cross sectional area by slice thickness.   This 
group did document a forebrain volume reduction during 30 days after an ischæmic insult, 
which paralleled the histological detection.   However it is noted that the calculation of 
structure volume used in this paper for both MRI and histological analyses does not have 
the statistical robustness as the Cavalieri principle, with its insistence on assessing a 
systemic random sample of sections and beginning the field of interest outside of the 
sample. 
 
At almost the same time as Natt et al., (2002) demonstrated that μMRI could image 
structures such as the hippocampus at microscopic detail, an American group published a 
μMRI protocol to calculate the volumes of rat hippocampus, cingulate cortex and granular 
cortex (Wolf et al., 2002).   This group used a 7T scanner and moderate spin-echo 
sequences to get in vivo in plane resolution of 125μm.   The method of volume assessment 
was derived by tracing structure outline on axial images using an image analysis package 
and then using a software function to calculate the 3D volume, however the mathematical 
model used by this system was not discussed in the paper.   Although volume values for 
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many structures are given, this paper does not compare these MRI measurements to those 
of alternative paradigms. 
 
In one of few human volumetric MRI studies Marziali et al., (2004) used 3D gradient echo 
sequences to produce normative data on pre-pubescent human pituitary gland size, and 
managed to reduce measurement error to 0.2-0.4% when the system was assessed with a 
„phantom‟. 
 
One of the potential sources of error in these volumetric μMRI assessments is the manual 
tracing of image element surface area, as this is user dependent.   In the study of Nagel et 
al., (2004) advances in image analysis processing allowed an automation of this step.   The 
per-slice surface area of cerebral œdema and infarct produced after middle cerebral artery 
occlusion and reperfusion was calculated by manually selecting one „seed point voxel‟, 
which is defiantly within the œdematous area, the software then includes in the count all 
pixels in direct connection with the „seed point‟ that have a pre-determined grey scale 
value.   This technique is of potential value if the area of imaging interest has a reasonably 
large signal difference from the surrounding tissue. 
 
Interestingly, in all of the in vivo volumetric studies cited, there is little mention of the 
logistical difficulties of scanning such animals, except by Wolf et al., (2002) who states 
that deep anæsthesia was needed, and that paralysis and mechanical ventilation could be 
used to reduce motion artefact. 
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1.3.2.2.3 MRI of DRG 
For many years MR has been used in human spinal and radicular imaging, and for 
diagnosis of orthopædic and neurological disease.   There has been particular interest in the 
DRG as inflammation and œdema of these structures is implicated in the generation of the 
neurological pain that accompanies intervertebral disc herniation (Mulleman et al., 2006).   
Early anatomical MRI studies verified that the spinal roots, DRG and nerves could be 
identified running within the skeletal structures (Kostelic et al., 1991; Sasaki 1995; 
Hasegawa et al., 1996) but there have been few morphological or volumetric analyses.    
 
Castillo & Mukherji (1996) demonstrated subjective enlargement of DRG and nerves in 
four case studies of patients with differing neuropathies.   Aota et al., (2001) assessed DRG 
swelling in the setting of disc prolapse, by assessing ganglia œdema by width 
measurement, and impingement by showing indentation.   This study demonstrated that 
MRI can assess at least semi-quantitatively morphological change in human DRG. 
 
There has been much work published concerning MR imaging of the brachial plexus, 
especially its anatomy in relation to infraclavicular nerve blocks (Raphael et al., 2005; 
Sardesai et al., 2006), and including demonstrable neural atrophy and fibrosis after 
radiotherapy (Iyer et al., 1996). 
 
Until 2007, no studies using true volumetric MRI analysis of human or animal DRG 
volumes could be found until West et al., (2007b) used 3D volumetric assessment of DRG 
applied to an established rat model of sciatic nerve transection.   Histological DRG volume 
reduction had been shown to be a statistically valid proxy measure of post-axotomy 
neuronal death (Hart et al., 2002a; Wilson et al., 2002), and this study demonstrated that 
μMRI is a suitable non-histological tool for following this reduction in volume over time. 
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In the study, rats were scanned ex vivo four weeks after unilateral axotomy, and their DRG 
were then harvested and processed for histology, allowing neuronal cell counts and 
ganglion volume estimation assessed by the optical fractionator and the Cavalieri equation 
(Hart & Terenghi, 2004).   For the volumetric analysis of the MRI images were digitised 
and quantified by image analysis software.   The cross sectional of the DRG was traced 
manually in each slice, and surface area calculated by the software. 
 
MRI demonstrated a significant reduction in DRG volume of the axotomised side 
compared to non-axotomised side and ganglia in non-operated control rats.   Further, there 
was a strong and significant correlation between MRI and stereological assessment of 
volume loss (p<0.001).   There was similarly a relationship between MR DRG volume and 
histological cell count (West et al 2007b).    
 
In summary, the use of MRI was demonstrated to provide a reliable index of DRG volume 
loss, and a proxy measure of neuronal apoptosis after nerve injury. 
 
1.4. AIMS OF THIS PROJECT 
The currently poor sensory functional recovery after upper nerve injury is largely 
attributable to apoptosis of a large population of DRG sensory neurons, which are therefore 
lost to the regenerative effort after nerve repair, thus lowering eventual innervation density.   
This death of sensory neurons that occurs after peripheral axotomy has been characterised 
by analysis of some of the apoptotic elements responsible for cell death and two clinically 
useful neuroprotective agents have been found to minimise this neuron loss and promote 
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nerve regeneration.   3D μMRI can be used as a viable proxy measurement of DRG volume 
reduction which reflects this neuronal cell loss in an ex vivo murine model. 
 
The global aims of this project are to further investigate: 
 The duration of NAC therapy needed to achieve maximal neuroprotection. 
 The use of volumetric MRI analysis as an index of DRG volume change in response 
to nerve injury and pharmacological intervention. 
 The application of MRI to assess signal changes in rat sciatic nerve after transection 
and during regeneration, including after neuroprotectant therapy. 
 The ability of a high frequency ultrasound system to image rat sciatic nerve in health 
and after injury.  
 The effects of ALCAR and NAC on survival and behaviour of isolated primary 
sensory neurons in vitro. 
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2.1 BACKGROUND & EXPERIMENTAL DESIGN 
Primary sensory neuronal cells, located in the dorsal root ganglion (DRG) undergo cell 
death in a time dependent manner after sciatic nerve transection (Groves et al., 1997; 
Vestergaard et al., 1997; McKay Hart et al., 2002a); this results in the cell death of around 
40% of DRG neurons by two months post injury (McKay Hart et al., 2002a).    Previous 
work has established the ability of the neuroprotective agents NAC and ALCAR to prevent 
such neuronal apoptosis, and has determined optimal dosing regimens for each substance 
(McKay Hart et al., 2002b; Wilson et al., 2003; Hart et al., 2004a; West 2007a).   In these 
studies neuroprotectant was administered every day and treatment continued until the end 
of the experimental time point.   The effect of shorter durations of treatment, such as 
whether neuronal cell death would resume after withdrawal of neuroprotectant support, is 
unknown.   If the potential benefits of neuroprotectant therapy are to be translated to the 
clinical arena the proposed duration of treatment must be considered. 
 
 The investigation reported here was designed to investigate the effect of NAC treatment 
duration on neuronal survival after axotomy.   Four groups (n=4) of adult male Sprague 
Dawley rats underwent standardised sciatic nerve transection and capping operations.   The 
animals in these groups were then treated with NAC at 150mg/kg/d for 7 days, 14 days, 30 
days and 60 days respectively, with all groups surviving for the full 60 days (Figure 2.1).   
L4 and L5 DRG were histologically processed for stereological neuron counting.  
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2.2   MATERIALS & METHODS 
2.2.1 PRACTICAL PROCEDURES 
2.2.1.1   Animals 
All animals used during the investigations were young adult male outbred albino Sprague 
Dawley rats (Harlan Sprague Dawley Inc.), mean starting weight 243.65g (SD 26.43g).   
The animals were housed in the Biological Services Facility of the University of 
Manchester, where daily veterinary advice was available.   All work was performed under 
the auspices of the Animals (Scientific Procedures) Act 1986 (ASPA 1986), after 
completion of an in house training programme approved by the Universities Accreditation 
Scheme. 
 
2.2.1.2   Anæsthesia, Monitoring and Analgesia 
All surgical procedures were performed under Isoflourane® inhalational anæsthesia (5% 
Isoflourane delivered in 100% oxygen at 2l/min).   Full anæsthesia was characterised by 
loss of the righting reflex, pain withdrawal but with stable spontaneous respiration.    On 
Figure 2.1: Diagrammatic representation of the experimental design of the NAC 
treatment duration study 
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the operating table this anæsthetic plane was maintained via a nose mask with 1.5-2.5% 
Isoflourane delivered in 100% oxygen at 0.5L/min, and confirmed by frequent assessment 
of the corneal reflex and withdraw response to hind paw web space pressure and direct 
visualisation of respiratory motion.   Following surgery the animals were recovered by 
turning off the anæsthetic vaporiser but maintaining the flow of 100% oxygen until some 
spontaneous movement was observed.   Once conscious, the animals were transferred to a 
warming cabinet (35°C) with provision of softened food and water.   Once fully recovered 
the animals were again removed into larger communal cages (2-4 animals per cage) and 
returned to their normal housing environment.   After invasive procedures, postoperative 
analgesia was provided with a single subdermal injection of the opioid buprenorphine 
(Temgesic
TM
) at 0.03mg/kg during recovery from anæsthesia. 
 
2.2.1.3   Sciatic Nerve Transection and Capping (SNTC) 
After induction of anæsthesia the animal was positioned on its side and the fur over the 
hind limb shaved.   The area was disinfected using 0.5% clear chlorhexidine gluconate and 
a 2cm wound was made 1cm caudal to the hip joint following the line of the femur.   The 
skin was retracted and blunt dissection used to make a muscle splitting incision in the 
biceps femoris and gluteus superficialis muscles exposing the sciatic nerve running in the 
plane deep to these and superficial to the adductor and semimembranosus muscles. 
 
Under operating microscope magnification (x3.8) a 1cm long segment of nerve was freed 
from its connective tissue envelope using blunt dissection and atraumatic epineural nerve 
handling.   The nerve was double ligated with a 6/0 polyamide 66 (Ethilon
TM
) suture at a 
level corresponding to the upper border of the rectus femoris muscle.   The nerve was then 
transacted with a single cut of straight bladed microsurgical scissors between these sutures.   
The cut ends of the nerve were sutured into the pre-made sterile silicone caps using 9/0 
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polyamide 66 (Ethilon
TM
) to act as a physical barrier to regeneration.   To further prevent 
any regeneration or distal to proximal stump signalling, the capped ends were turned away 
from each other and buried in separate intramuscular pockets with 5/0 polyglactin 910 
(Vicryl
TM
) sutures. 
 
The muscle layers were closed with a single continuous 4/0 polyglactin 910 (Vicryl
TM
) 
suture.   The skin was apposed using the same material, firstly with a continuous 
subcuticular stitch with buried knots, followed by simple interrupted superficial stitches.     
 
2.2.1.4   N-acetylcysteine Treatment 
Animals which had undergone sciatic nerve transection and capping were treated with 
NAC at 150μg/kg/day given by intraperitoneal injection into the lower abdominal quadrant 
on the side contralateral to the operation.   NAC used was Parvolex® (UCB Pharma) 
which was supplied as 10ml glass vials of 200mg/ml, containing the additives, sodium 
hydroxide disodium edetate and water for injection.   The solution was stored at 4°C and 
was made up daily for injection with sterile normal saline (NaCl 154mmol/l) to a volume 
of 0.5ml.   The animals were weighed every third day during the duration of treatment and 
the doses adjusted appropriately.   No complications at the injection site occurred during 
the experiments. 
 
2.2.1.5   Animal Euthanasia 
In order to humanely kill the animals before tissue harvesting, the animals were placed 
individually into an air filled induction box, which is then filled with 100% carbon dioxide 
(CO2) at a rate of 2L/min for 5 minutes.   Subjected to this slowly rising concentration of 
gas, the animal gently lost consciousness; death was confirmed by cervical dislocation. 
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2.2.1.6   Dorsal Root Ganglia Harvest 
Following MR scanning (cf. Chapter 3), a midline dorsal skin incision was made from the 
mid-thoracic region to the base of the pelvis, and the skin removed bilaterally down to the 
muscular fascia over the animal‟s rump and hind limbs.   The pelvis and lumbar vertebræ 
were exposed by removal of the paravertebral and posterior abdominal wall muscles.   The 
sciatic nerve or its divided branches were exposed by dividing the overlying muscles 
similarly to the surgical procedure.   On the operated side, the nerve stump was inspected 
to ensure that the caps had remained in situ and that regeneration had not occurred.   The 
proximal stump was then followed cephalad to the sciatic notch of the already exposed 
pelvis.   The sacroiliac joints were disarticulated and the posterior part of the sacrum and 
the vertebral transverse processes were removed with bone nibblers to allow exposure of 
the intrapelvic course of the sciatic nerve and its constituent spinal nerves up to the exit of 
these nerves from the intervertebral foramina.    
 
Using micro-rongeurs the rest of the neural arch of the lumbar vertebræ was removed 
exposing the spinal cord, roots and the DRG.   The L4 and L5 DRG were verified by 
counting caudally from the L1 vertebra and were removed by cutting with micro-scissors, 
leaving a length of the roots proximally and spinal nerve distally to allow correct 
orientation during later stages of tissue processing.   The freed DRG were then placed in 
labelled vials containing 4% paraformaldehyde.    In all experiments L4 and L5 from both 
the axotomised and contralateral, non-operated sides were collected, the latter acting as 
internal controls. 
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2.2.2   HISTOLOGICAL TECHNIQUES 
2.2.2.1   Fixation, Cryoprotection, Blocking and Storage 
Harvested DRG were fixed in 4% paraformaldehyde for 72h at 4°C, followed by washing 
in PBS solution and immersion in a cryoprotection solution of 15% sucrose with 0.1% 
sodium azide in PBS.   Three changes of this solution were made over 48h, again at 4°C.   
After cryoprotectant equilibration the spinal nerve and rootlets of the DRG were trimmed 
and the tissue immersed in OCT (Bright®) embedding medium, using 10x10x12mm 
aluminium foil „boats‟ made using a Perspex template.   The filled boats, containing the 
appropriately aligned DRG, were snap frozen over liquid nitrogen and then stored at -40°C 
until sectioning. 
 
2.2.2.2   Cryostat Microtomotomy 
Frozen sectioning was performed on a Leica™ CM30505 Cryostat, with the chamber and 
chuck temperatures set to -24°C.   DRG were cut transversely at 50μm and thaw mounted 
on to glass slides coated with Vectabond™ reagent (Vector Laboratories Inc) to increase 
tissue adhesion.   All sections from the DRG were collected, with twenty sections being 
positioned serially onto each slide, aligned using a pre-marked template applied to the back 
of the slide.   The DRG were randomly aligned with respect to their axial plane within the 
OCT block, therefore providing variability in the exact orientation of the sectioning which 
is a prerequisite of Cavalieri volume estimation (Gundersen and Jensen, 1987).   Enough of 
the proximal nerve roots and distal spinal nerve were included in the sectioning to ensure 
that the whole of the DRG neuron containing tissue was sectioned.   Sections were placed 
in racks and dried at 50°C overnight before staining. 
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2.2.2.3  Fluorescent staining 
DRG tissues were stained with a combination of bisbenzimide H33342 (Hoechst; λEx. 
343nm, λEm. 483nm) and propidium iodide (PI; λEx. 536nm, λEm. 617) (Appendix 4).   
Bisbenzimide is an intercalating fluorescent nuclear stain, binding DNA between the 
adenine/thymine base pairs (Ciancio et al., 1998); propidium iodide binds 
stoichiometrically to both DNA and RNA, and stains cytoplasm if the tissues have been 
permeabilised (Riccardi & Nicoletti, 1996).   Staining was carried out in a Perspex slide 
incubator with all solutions applied directly to the slide in an attempt to reduce section loss.   
Axotomised and control DRG from each animal were always stained simultaneously.   
After staining, the slides were mounted using fluorescence protecting Vectashield™ 
medium (refractive index 1.44).   Coverslips were sealed using DPX, and the slides stored 
in light exclusion boxes at 4°C prior to quantification. 
  
2.2.4 STEREOLOGICAL NEURON ESTIMATION 
2.2.4.1 Neuron population estimation – The Optical Fractionator  
Estimates of the neuronal population in the sciatic pool vary with counting technique used, 
but are in the region of 14000-20000 neurons in L5 and around 30000 in L4/L5 (Bergman 
& Ulfhake, 1998; Tandrup, 1993; Groves, 1997; McKay Hart et al., 2002a).   This large 
population favours stereological estimation rather than serial reconstruction.   The 
statistically unbiased optical fractionator technique combines neuron counting using an 
optical dissector with the fractionator method of systemic random sampling (West et al., 
1993; Dorph-Petersen et al., 2001). 
 
The equipment used for stereology comprised of an Olympus BX61 epiflourescence 
microscope fitted with motorized stage allowing controlled movement in the X-Y planes, 
and which monitors the excursion of the objective lens in the z-axis during focussing.   An 
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Olympus WU fluorescent filter (excitation 330–385 nm, dichroic mirror 400 nm, emission 
>420 nm) allows simultaneous visualisation of both the PI and H33342 staining, with a 
live video output to a computer installed with Stereo Investigator™ 6 software (SI) 
(MicroBrightField, Inc). 
 
A systemic random selection of neuron containing sections is sampled; under x10 
magnification, and with the filter set to visualise PI staining, those DRG sections 
containing neuronal cell bodies were identified.   A random number generator was used to 
allocate one of the first four of these as the start section; this and each subsequent 4
th
 
section were quantified until the full neuron containing region had been sampled, ensuring 
a representative sample of >10 sections for each DRG.   The neuron containing area of 
each section was outlined and the SI program overlaid a randomly orientated virtual 
sampling grid onto this selected area, ensuring that quantification sites were also chosen 
according to the rules of systematic random sampling (Figure 2.2). 
Figure 2.2: Summary of the sampling undertaken by Stereo Investigator® software.   A - 
A single section of DRG stained with propidium iodide (showing neuronal cytoplasm red) 
and Hoechst 33342 (nuclei are pale blue) viewed at x10 magnification under the WU-
fluorescent filter.   B – Tracing boundaries; demonstrating the difference between the 
neuron containing area (yellow outline) and the whole DRG perimeter (blue) (cf. Chapter 
3).   C – The application of the randomly orientated sampling grid (white) applied with 
relation to the neuron containing region (yellow outline), and its relationship of this to the 
counting frames/dissectors (red and green boxes) used for optical dissection.   Note that if 
any part of the traced area enters a sampling grid site a dissector will be applied, even if 
that dissector does not cover part of the section.   Scale bar = 50μm. 
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Switching to a narrow plane of focus using a parafocalised x60 oil immersion objective 
lens and the H33342 filter the optical dissection was commenced.   With the microscope 
stage under control of SI each site on the sampling grid was visited.   A three-dimensional 
virtual counting frame (dissector) was then constructed by SI within the thickness of the 
tissue section; each dissector has three mutually perpendicular inclusion and exclusion 
faces (Figure 2.3).  
 
Focusing through the section, neurons were counted if their nuclei came into focus within 
the counting frame providing that no part of the nucleus crossed one of the exclusion faces.   
Application of these counting rules assures population estimates are not affected by cell 
size, shape, distribution or density (Gunderson et al., 1998a, 1998b; Hart & Terenghi, 
2004) (Figure 2.4).   To compensate for neurons plucked from the leading edge of the 
tissue during sectioning a „guard zone‟ is included between the top of the section and the 
start of the dissector (Dorph-Petersen et al., 2001). 
Figure 2.3: Caption over. 
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Figure 2.3 (Previous page): Diagram of Optical dissector - The superior facing, viewer 
facing and right facing surfaces are „inclusion‟ planes; neurons crossing these, but not their 
opposite counterparts are counted.  
. 
 
 
 
Estimated neuron populations can be calculated because the ratio of DRG actually sampled 
to the whole neuron containing volume is known i.e. the fraction of the total number of 
sections, the fraction of the sectional area and the fraction of the dissector depth to the 
measured section thickness (Table 2.1).   Multiplication of the reciprocal of these fractions 
gives a neuron estimate for the whole DRG: 
 
 
 
 
Figure 2.4: Optical Dissection, x60 magnification view of same tissue as 
figure 2.2.   Neuron nuclei „1‟ and „2‟ are in focus within the bound of the 
dissector and are thus counted.   Neuron „3‟ was in focus at a plane superficial 
to the ceiling of the dissector and is thus excluded.   Neurons „4‟ and „5‟ have 
yet to come into focus, if they do so within the depth of the dissector „4‟ will 
be counted, however „5‟ would cross an exclusion plane and therefore not be 
counted.   Scale bar 20μm. 
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N = Q.(tnw/d).(1/asf).(1/ssf) 
Where: 
N = Population neuron estimate 
Q = Measured neuron count 
tnw = Number weighed section thickness 
d = Depth of dissector 
asf = Area sampling fraction 
ssf = Section sampling fraction 
 
Number weighed section thickness is used in this calculation rather that mean section 
thickness in order to minimise the biasing effect of any homogeneous non-uniform tissue 
shrinkage (Dorph-Petersen et al., 2001).   The measured section thickness at each counting 
site received a number weighting proportional to the quantity of neurons counted in that  
dissector; the mean of these weighted thicknesses is used. 
 
 
Table 2.1: Parameters for Stereological 
Neuron Estimation 
Section Periodicity 4 
Sampling Grid (x) 250 μm 
Sampling Grid (y) 250 μm 
Sampling Grid Area (xy) 62500 μm2 
Counting Frame Depth (z) 12 μm 
Counting Frame Width (x) 110 μm 
Counting Frame Height (y) 110 μm 
Counting Frame Area (xy) 12100 μm2 
Counting Frame Volume (xyz) 145200 μm3 
Upper guard zone (z) 6 μm 
Section Thickness (cut) 50 μm 
Section Sampling Fraction 0.25 0.25 
Number Weighted Mean Section 
Thickness 
Measured 
Area Sampling fraction (Grid to Frame) 0.194 
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2.2.5 DATA ANALYSIS AND STATISTICS 
All analyses were performed blind to the axotomised side of the animal.   Significance of 
differences between axotomised vs. control sides were analysed using student‟s t-test while 
one-way ANOVA with Bonferonni post-hoc testing was used for intergroup analysis.   All 
statistical comparisons were carried out using GraphPad Prism®(v 4.03) software. 
 
2.3 RESULTS 
There were no significant differences between the non-axotomised control side neuron 
counts between groups.   No significant neuronal loss was demonstrated in animals treated 
every day from injury until death (t –test of axotomised vs. control p = 0.2).   All groups 
with partial therapy had lower neuron counts in the axotomised ganglia than the control 
side quantitatively related to the period of NAC administration, with a reducing degree of 
significance when compared using intra-group t-testing (7d control vs. axotomised p < 
0.005; 14d control vs. Axotomised p < 0.05; 30d control vs. axotomised p < 0.05) (Table 
2.2, Figure 2.5). 
 
As well as absolute neuron counts, data relating to neuron loss were analysed; with neuron 
loss being calculated as „control neuron count - axotomised neuron count‟, with the 
difference being expressed as a percentage of the control count, inter-group comparisons 
were made by one-way ANOVA with Bonferonni post-hoc comparisons. 
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 There was no significant neuronal loss in the 60d treatment group compared against no 
loss (-0.17%, SD 0.74%, ANOVA vs. 0 p > 0.05).   In the partially treated groups there 
was highly significant neuron loss with only 7 days treatment compared to the 
experimental control of full treatment (19.16%, SD 1.47%, ANOVA vs. 60d p > 0.005) 
and 14 days (9.24%, SD 2.10%, ANOVA vs. 60d p<0.005) and less strongly significant 
loss for 30 days (5.64%, SD 2.00%, ANOVA vs. 60d p>0.05) (Table 2.2 and Figure 2.6). 
Table 2.2: NAC Treatment Duration Study - L4+L5 Neuron Counts 
Treatment 
Duration 
Control Ganglia 
(L4+L5) mean 
(SD) 
Axotomised Ganglia 
(L4+L5) mean (SD) 
Mean Neuron 
Loss 
Mean 
Percentage 
Neuron Loss 
7 Days 30940 (1095) 24999 (441) 5941** 19.16%** 
14 Days 30202 (170) 27410 (512) 2792* 9.24%* 
30 Days 31578 (1017) 29790 (930) 1787* 5.64%* 
60 Days 32279 (380) 32038 (388) -56 -0.17% 
Where ** = p<0.005 and * = p<0.05 on intra-group t-testing 
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Figure 2.5: Effect of NAC duration of treatment on
L4+L5.   Plotted as combined neuron counts with
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2.4  DISCUSSION 
2.4.1 METHODOLOGY AND EXPERIMENTAL DESIGN 
2.4.1.1 Animal Model 
The animal model of mid-thigh sciatic nerve transection and capping is a well recognised 
technique, is relatively simple to perform and has been consistently confirmed to prevent 
any spontaneous nerve regeneration (Hart et  al. 2002; Wilson et  al. 2003; Hart et  al. 
2004a; Wilson et  al. 2007; West et al., 2007).   The use of the upper border of the 
quadratus femoris muscle as an anatomical landmark for the site of nerve division serves to 
standardise the injury, since the proximity of a transection to the DRG affects neuron loss 
(Ygge 1989).  
 
No problems were encountered during recovery from Isoflourane anæsthesia, and 
observation of normal animal behaviour and lack of signs of discomfort postoperatively 
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Figure 2.6: Effect of neuron loss with treatment
duration with NAC.   Aterisks represent
significance in one-way ANOVA vs. 60d treatment
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suggests that buprenorphine analgesia is effective.   The method of wound closure was 
modified from that of previously published work by the addition of a subcuticular suture 
underlying the usual superficial interrupted stitches after three animals suffered wound 
dehiscence on the first postoperative day.   Wound opening did not recur after this 
modification. 
 
Animals tend to chew the nails and toes of denervated feet after sciatic transection 
(McVean, 1975; Weber, 1993), with this „autotomy‟ behaviour primarily affecting the 
lateral aspect of the foot and third to fifth digits.   There is sparing of the medial foot and 
toes, reflecting their innervation by the saphenous branch of the femoral nerve which is not 
injured during sciatic transection (Devor et al., 1979).   Veterinary consultation was sought 
for all animals which had autotomised to any extent, and early withdrawal from the study 
and sacrifice advised for any rat in which this was deemed to adversely affect animal 
welfare.   Autotomy rates and animal loss were significant enough to lead to at least one 
repeat of the experiment, eventually reaching group numbers of n=4, however, rates of 
autotomy encountered were within the range of previously published studies (Blumenkopf 
& Lipman, 1990; Lewin-Kowalik et al., 2002; Clavijo-Alvarez et al., 2007).  
 
2.4.1.2 Experimental design 
Critical appraisal of this experiment raises some methodological questions which must be 
discussed.   The first of these is animal number within groups, previous experiments by our 
research group have published data based on analysis of 6 animals per group (McKay Hart 
et al., 2002a, Hart et al., 2002; Hart et al., 2004a) or n = 5 per group (Wilson et al., 2003; 
West et al., 2006a; Wilson et al., 2007) and this is the first experiment in which n = 4 has 
been submitted.   The use of n = 4 was not through choice, but reflected surviving animals 
who had not undergone significant autotomy.   While using higher numbers of subjects 
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adds increased validity to statistical findings, in the present study as stands, significant 
differences between groups were found; it has to be accepted that the effect of two similar 
counts with a group may have exaggerated significance as group number reduces.  
 
The second issue is the fact that this study does not include absolute (no operation) control, 
sham operation control and no-treatment groups.   This again pertly reflects autotomy 
attrition from groups as only animals surviving for the full sixty days have been included – 
decisions regarding experimental planning were made in consultation with the Home 
Office Inspector.   In defence of the presented methodology, all previous work using 
similar techniques has shown no significant neuronal cell loss for absolute control groups 
or sham operated groups, and there is no reason to assume that this study should be any 
different (Hart et al., 2002a; Hart et al., 2002b; Wilson et al., 2003; Hart et al., 2004a; 
West 2007a).   Further, the findings of West et al., 2007b suggest that using non-operated 
side internal controls gives a more sensitive index of neuronal loss that comparison with 
another group of absolute control animals.   Exclusion of a „no treatment‟ group represents 
logistical restraints due to animal autotomy and guidance by the Home Office Inspectorate 
and cognisant of the principle of „reduction‟ in laboratory animal work.   All previous 
experiments by our research group that have included two month survival point for 
control-operated animals have reported predictable loss of around 35%  (McKay Hart et 
al., 2002a, McKay Hart et al., 2002b; Hart et al., 2004).  Lacking repeat data specific to 
this experiment, tentative comparison with these findings will be made.      
           
2.4.1.3 Stereology 
Optical dissection combined with systemic random sampling is a robust, theoretically 
sound technique.   It avoids the statistical bias of assumption based estimation techniques 
(Hedreen, 1998; West, 1999) and, by the inclusion of adequate guard zones at the top and 
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bottom of the section, does not suffer from underestimation inherent in a physical dissector 
due to lost neurons (West 1993).   Use of the dissector for DRG neuron populations has 
been verified against empirical measurements (Pover & Coggeshall, 1991).     
 
The use of fractionator sampling when estimating neuronal populations is theoretically 
more valid than using a density based calculation as was used in earlier work  (McKay 
Hart et al., 2002a; McKay Hart et al., 2002b; Wilson et al., 2003; Hart et al., 2004a) 
because the final neuron count is independent of the size of the sampled region.   The 
fractionator technique therefore does not rely on the accuracy of the contour tracing of the 
neuron containing area – hence excluding one observer dependent measurement variable.   
For all assessed ganglia, greater than 100-200 neurons were counted, which is a 
prerequisite for accurate population estimate (West 1999), and the proportion of the size of 
the counting frame to the counting grid was well over 4% (Harding et al., 1994). 
 
The L4+L5 neuron populations in non-axotomised ganglia measured in the NAC treatment 
duration studies were equivalent to those described previously by members of our group 
(Hart et al., 2002; Wilson et al., 2003; Hart et al., 2004a; Wilson et al., 2007; West et al., 
2007b) and by others using optical (Bergman & Ulfhake, 1998; Tandrup, 1995) and 
physical (Groves et al., 1997) dissectors.    Standard deviations of neuron populations for 
L4+L5 in the NAC treatment duration study were generally within the range of those in 
previous optical dissector experiments, (400-10000 neurons) with a few unexplained 
exceptionally low values, possibly reflecting two or three animals having similar counts in 
an experiment with lower animal number per group (cf. 2.4.1.2), standard deviations would 
be likely to increase with biological variation if more animals were analysed.    
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2.4.3 N-ACETYL CYSTINE TREATMENT DURATION 
The potential to promote primary sensory neuronal survival after peripheral nerve injury 
using the novel paradigm of pharmacotherapy with NAC or ALCAR has been well 
established and the optimal doses of each agent determined with dose response analyses 
(Hart et al., 2002b; Wilson et al., 2003; Hart et al., 2004a; West et al., 2007b). 
 
All previous experiments have demonstrated that with optimal dose therapy (NAC or 
ALCAR) given continuously from the day of axotomy until death of the animal,  complete 
neuroprotection is achievable, the results of the 60d treatment group in the present NAC 
treatment duration study again verify this possibility.   Of prime importance to clinical 
translation of NAC/ALCAR treatment, is to investigate the logistics of such therapy; it was 
demonstrated that for sensory neurons, a delay in beginning ALCAR therapy for up to 24h 
post injury, such as is likely to occur in clinical practice, did not adversely affect neuronal 
survival at two week post injury (Wilson et al., 2007).   However, a delay of seven days, 
while still providing some benefit over no treatment, allowed ≈20% cell death to occur.   
These finding demonstrate the clinical necessity of starting treatment as soon as possible 
post injury to maximise benefit.   It is noted that this delay in treatment experiment used 
ALCAR, and that a similar study has not been performed evaluating sensory neurons with 
NAC treatment.   The only data pertaining to NAC and treatment delay comes from a study 
of spinal cord motor neuron neuroprotection with high dose intrathecal NAC after spinal 
motor root avulsion; one week delay in treatment did not significantly alter neuron loss 
versus full treatment, but effects were deleterious with a two weeks delay (Zhang et al., 
2005). 
 
The NAC treatment duration study was designed to investigate how long treatment should 
continue.   The time points selected for analysis were chosen cognisant of the work of 
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McKay Hart et al., (2002a); which demonstrated that after axotomy with no treatment, 7 
days was first point at which neuronal loss became significant, 14 days corresponded to the 
time of peak apoptosis rate, and that the majority of cell death had occurred by two months 
post axotomy.   Thirty days was also chosen as an intermediate period, where the rate of 
apoptosis was beginning to level, but some death still occurring.    
 
With no treatment at two months post axotomy there was a 35% neuronal loss (McKay 
Hart et al., 2002a & b).   In all groups in the treatment duration study there was 
substantially less neuronal death (7 day treatment ≈19%; 14 day treatment ≈9%; 30 day 
treatment ≈6%; 60 day treatment ≈0%) suggesting that even relatively short duration of 
treatment has a significant neuroprotective effect.   This was the first study  in which a 
period of time elapsed between cessation of treatment and DRG harvest, and it can be 
concluded that rather than apoptosis being simply delayed by NAC therapy, the 
neuroprotective effect is long-lasting; a large proportion of cells which wound have died 
with no treatment have actually survived. 
 
The molecular mechanisms of the pro-survival effect of NAC remain incompletely 
understood, but it probably reflects synergistic effects of NAC to modify multiple cellular 
systems (cf. 1.2.4.3).   NAC has innate reducing activity (Aruoma et al., 1989; Kamata et 
al., 1996; Yan et al., 1995) and supplements intracellular glutathione levels (Yan et al., 
1995), both of which may affect neuronal redox status, possibly resisting oxidative stress, 
which is implicated in the ætiology and execution of the apoptotic programme within 
denervated neurons (Martin et al., 1998; Novikov et al., 2005).   Further, NAC has anti-
proliferative activity (Sekharam et al., 1998) and causes modification of intracellular 
signalling and transcription events such as activation of p21Ras, a signalling pathway 
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essential for neuroprotection of PC12 cells after trophic factor withdrawal (Kamata et al., 
1996).   
 
McKay Hart et al., (2002a) found little difference between neuronal losses at two months 
versus six months with no treatment; therefore it is likely that not all axotomised cells will 
undergo apoptosis even without any neuroprotective treatment.   It seems likely that NAC 
therapy could function by two broad mechanistic paradigms, although these need not be 
mutually exclusive.   NAC could reduce the toxic effects of axotomy directly, for example 
by free radical scavenging or activation of the downstream effectors of the neurotrophin 
signalling cascades; this would lower the magnitude of the noxious stimulus delivered to 
the entire neuronal population as a result of neurotrophin withdrawal, and therefore it 
would increase the number of individual cells receiving a „dose‟ of toxicity below that 
cell‟s „lethal‟ threshold.   Alternatively, NAC could affect specific subpopulations of 
neurons, raising their tolerance to pro-apoptotic stimuli, such as BCL-2 to BAX ratios at a 
transcriptional level (Reid et al., 2009), or blocking abortive entry of some populations into 
the cell cycle (Ferarri et al., 1995).   Specific neuronal subpopulations have been 
demonstrated to react differently to axotomy, with cutaneous fibres sustaining a higher rate 
of death than muscle propreoceptive fibres with this being mirrored by up-regulation of 
pro-apoptotic molecule transcription as detected by real time (RT)-PCR in cutaneous fibres 
(Welin et al., 2008; Reid et al., 2009).   Treatment of axotomised animals with NAC in this 
model reduced transcription of pro-apoptotic Caspase 3 and modifies BCL-2 to BAX 
mRNA expression ratio such that anti-apoptotic BCL-2 predominates (Reid et al., 2009).   
The reasons and mechanisms behind such subpopulation behaviours remain unknown.  
 
Translation from a murine model to clinical therapy in the human population may not be 
direct, and to date no studies of neuroprotectant administration after nerve injury in man 
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have been performed.  Before translation, significant decisions to be investigated such as a 
choice of proxy measure of neuronal population change (cf. Chapter 3), dosing regimen 
(West et al., 2007a), dosing method given NACs significant first-pass metabolism is likely 
to reduce the effectiveness of oral administration (Cotgreave et al., 1987; Cotgreave, 1997) 
and duration of therapy. 
 
In the human clinical scenario of a mixed nerve injury, treatment with NAC rather than 
ALCAR seems to have intuitive merit as NAC can also protect motor neurons (Zhang et 
al., 2005), although this benefit needed higher doses than to prevent death of cutaneous 
sensory populations.   The optimum dose of NAC for sensory cell protection post-sciatic 
neurotomy in rats has been demonstrated to be around 150mg/kg/d (West et al., 2007a).   
However doses delivered clinically may need to be adjusted in proportion to the 
mechanism of nerve injury i.e. crush, transection or avulsion, which have been 
demonstrated to affect degree of neuronal apoptosis (Groves et al., 1997; Degn et al., 
1999; McKay Hart et al., 2002a; Zhang et al., 2005).   Also the additional need to protect 
motor neurons has to be taken into consideration, as for their survival intraperitoneal doses 
up to 750mg/kg/d is needed (Zhang et al., 2005).   Furthermore, the site of injury along the 
nerve‟s proximo-distal axis has to be evaluated, as more proximal injuries such as brachial 
plexus pathology resulting in a greater degree of neuronal death (Ygge, 1989).    
 
Intraperitoneal injection such as used in this model by-passes first pass hepatic metabolism 
and is thus proposed as equivalent to intravenous (IV) therapy in man.   NAC has a long 
history of IV use in paracetamol (acetaminophen) overdose with a good record of safety 
other than minor hypersensitivity reactions in 0.2-3% of patients (Prescott et al., 1979; 
Mant et al., 1984; Mahadevan et al., 2006).   The plasma half-life of NAC in humans is in 
the region of 5.6h in human adults (Olsson et al., 1988; Prescott et al., 1989) meaning that 
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by the end of a 24h period only about 1/16
th
 of a once daily dose would be present in 
plasma.   The current dosing regimen for paracetamol intoxication is continuous infusion 
(150mg/kg over 15m followed by 50mg/kg over 4h and finally 100mg/kg over 16h), giving 
a total of 20 ¼ hours of treatment (British National Formulary 2009).   Given that a patient 
with a mixed nerve injury is likely to be an inpatient for several days is would seem to 
make practical sense to treat patients either with multiple IV doses per day or a continuous 
NAC infusion such as used above for paracetamol toxicity for the duration of their pre-, 
and post-operative inpatient stay.   Treatment may be more difficult to continue once a 
patient is otherwise fit for discharge; the oral bioavailability of total NAC is only around 
9% (Olsson et al., 1988) suggesting that very high doses of oral NAC might be needed to 
provide adequate intracellular concentrations.   In the NAC dose response study a small but 
significant neuroprotective effect was found with  treatment at 10mg/kg/d (West et al., 
2007a), it could be that oral dosing, while less potent than IV administration may still 
confer some benefit in the post-op patient population.   An alternative strategy might 
include continuous subcutaneous infusion of NAC; bronchodilator administration by such 
means on an ambulatory, out-patient basis is well established to treat the subset of severe 
asthmatics unresponsive to traditional therapy (Cluzel et al., 1990).   Animal studies to 
investigate subcutaneous administration of NAC are lacking, but would be easy to perform 
in future.               
 
Extrapolation of the results of the treatment duration study presented here to clinical 
application of NAC therapy would suggest that a large proportion of sensory neuronal cells 
at risk from apoptosis after nerve injury could be saved with one month‟s NAC therapy, 
but the maximal effect is likely only to be achieved by maintaining treatment until 
regenerating axons come again in contact with an endogenous source of neurotrophic 
support.   Nevertheless, in the light of the prolonged regeneration time required after 
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proximal neurotomy, and given the often suboptimal patient compliance with long-term 
medication (Chapman, 2004), especially in the younger patient population (Staples & 
Bravender, 2002) to whom nerve injury most commonly occurs (Jaquet et al., 2001), it is 
reassuring to believe that a relatively short duration of NAC therapy may support 
substantial primary sensory neuronal survival. 
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CHAPTER 3 
 
Assessment of Magnetic Resonance 
Imaging to Assess the  
N-acetylcysteine Treatment Duration 
Study 
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3.1 BACKGROUND & EXPERIMENTAL DESIGN 
Before translation of the potential benefits of NAC neuroprotective therapy to the human 
clinical arena (cf. 2.4.3) there is the need to develop a reliable, non-invasive measure or 
proxy-measure of dorsal root ganglion neuronal populations because current clinical tests 
of nerve regeneration such as two-point-discrimination, are subjective, variable and 
unreliable (Lundborg & Rosen, 2004; Jerosch-Herold, 2005).   Magnetic Resonance 
volumetric analysis of neuronal structures has a clear precedence in human neurobiology 
(cf. 1.3.2.2) and based on this idea, the previous work by our group suggests that ex vivo 
L4 ganglion MRI volumetric analysis could provide a non-invasive and non-irradiating 
index of DRG volume and therefore proxy measure of neuron loss (West et al., 2007b).    
In this chapter, the ability of the MRI scanning protocol (West et al., 2007b) to correlate 
the survival of DRG neuronal populations with the effect of the NAC treatment duration 
study (cf. Chapter 2) will be assessed.    
 
The MRI protocol used in this study images both right and left L4 DRG and as such allows 
for using the non-axotomised ganglia as an internal control.   A series of assumptions must 
be made if L4 only MRI DRG volumetry is to be used as a sole outcome measure of an 
experiment; first that assessment of L4 only versus L4 plus L5 totals for neuron counts is 
valid, second that DRG volumetry does function as a proxy measure of neuronal cell death 
and third, that MRI imaged DRG volume provides a valid index of both histological DRG 
volume and neuron counts.   Each of these assumptions will be tested using the results of 
the NAC treatment duration study. 
 
The experimental NAC treatment was identical to that shown in chapter 2 (cf. 2.1; 2.4.1.2) 
with four groups of four animals undergoing standardised sciatic nerve transection and 
capping, and being treated with 150mg/kg/d intraperitoneal NAC for 7 days, 14 days, 30 
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days or 60 days with all animals surviving for the full 60 days before MRI scanning and 
histological quantification of L4 and L5 DRG volume and stereological neuron counts.             
 
3.2 MATERIALS AND METHODS 
3.2.1 SURGERY, NAC TREATMENT AND MORPHOMETRY  
Surgery, animal welfare, preparation of the histological slides and stereological neuron 
counting of axially sectioned L4 and L5 from control and axotomised DRG were carried 
out as described  in chapter 2 (cf. 2.2.1.1 - 2.2.4.1), with slide labelling being coded so as 
to blind the researcher to the animal and side of origin.    
 
3.2.2 MAGNETIC RESONANCE IMAGING OF THE L4 DORSAL ROOT 
GANGLION 
MRI scanning of each animal was performed on the day of animal euthanasia at 60 days 
post sciatic nerve transection.   The operating schedule was designed so that only 2-3 
animals reached the 60d time point on any given day, allowing scanning immediately after  
the animal was killed and minimising delay of DRG harvest and fixation post-mortem.   
Imaging was carried out on a 7T actively shielded 15cm horizontal bore MRI scanner 
(Magnex UK Ltd, Abingdon) driven by SMIS console software (Magnetic Resonance 
Research Systems, Guildford UK) housed in the Department of Imaging Science in the 
University of Manchester (Figure 3.1).   A 2cm custom built transmit/receive surface 
radio-frequency coil was used for all DRG imaging (Figure 3.2). 
 
 
  Chapter 3 
Alex. E. Hamilton: MD Thesis, 2011. 88 
 
 
Figure 3.1: The University Of Manchester‟s 7T small animal MRI scanner. 
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3.2.2.1 Animal positioning 
After the animal had been killed, it was positioned within a plastic „probe‟ in order to hold 
it steady within the magnet bore (Figure 3.2b).   The surface coil was centred over the area 
of the L4 DRG (1cm cranial to a line transecting the tips if the iliac crests (West et al., 
2007a)) and held tightly in place with masking tape, ensuring that the coil was level in all 
planes.   The rat/probe/coil assembly was pushed into the magnet bore, ensuring that the 
centre of the coil was positioned as close to the isocentre of the magnetic field as possible 
 
3.2.2.2  Signal optimization 
Prior to imaging three signal optimization stages were performed to achieve the best 
signal-to-noise ratio. 
1 - Once in the scanner bore an oscilloscope was used to „tune‟ the surface coil, i.e. 
adjusting the „tune‟ capacitor of the coil in order to match its resonance frequency to that 
of the hydrogen nuclei that are to be imaged. 
Figure 3.2: The 2cm surface coil.   This is secured to the animal‟s back, 
with the copper wire loop centred over the L4 area.   Scale bar 1cm. 
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2 - Using the Fourier Transform function of the SMIS console the magnet was actively 
„shimmed‟ by making Progressive small changes in the current flowing through the „shim 
coils‟ of the main magnet are made in order to maximize the homogeneity of the field over 
the area of interest (Elster 1994), in order to obtain the optimal signal from the animal. 
3 - After the pilot imaging stage (vide infra), but prior to starting the final 3D sequence, a 
single coronal slice sequence was run with the phase-encode gradient set to zero.   This 
allowed modification of the radio-frequency attenuator off-set and flip angle to maximise 
signal without causing image clipping. 
 
3.2.2.3 Pilot scans and 3D imaging 
In order to verify that the area of interest of the animal is at the isocentre of the field (thus 
producing most signal) and to target the final image block correctly in all three anatomical 
planes, a series of pilot images are generated on each animal (for sequence parameters see 
Appendix 7).   The on-screen display of the SMIS console will display images from the 
last sequence scanned, SMIS allows positioning of the orientation of slices of the next 
sequence to be run over the existing image of the last scan, allowing accurate positioning 
of the final 3D sequence to be fixed with respect to the three orthogonal anatomical planes.   
The full set-up, optimisation and scanning time for each animal was between 2-3 hours. 
 
3.2.2.3.1 Scout Image:   A very rapid scan (time ≈2 sec) in all three planes, on which the 
isocentre of the main field was marked.   This verified that the animal was positioned 
correctly within the bore, and that the surface coil was positioned over the target area and 
level (Figure 3.3). 
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Figure 3.3: Scout Images. The three very low resolution images: A. axial, B. coronal C. 
sagittal.   The dark cross seen at the centre of each image represents the planes of the 
scanner‟s isocentre of magnetic field; these images are used to verify correct placement 
of the animal and surface coil within the main scanner, with care being taken to match 
the region of the L4 DRG to the isocentre marks in each axis.   Scale bar = 1cm. 
 
3.2.2.3.2 Low Resolution Sagittal Image:   An eight slice scan positioned over the axial 
scout image.   This allows identification of the long axis of the spinal cord and DRGs (blue 
arrow in Figure 3.4), and placement of the central image of the next scanning sequence to 
be positioned as close to the long axis of the cord as possible.   
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3.2.2.3.3 Coronal Image:   Initially, an eight slice low resolution scan positioned over the 
lumbar area of the sagittal images (Figure 3.5).   This included pelvic wings, and the 
spinal cord and DRGs in longitudinal section.   Using the tips of the iliac crests as 
landmarks, the L5 DRG and counting rostrally, L4 DRG are identified.   If the anatomy 
was not clearly demonstrated in this initial sequence a longer high resolution coronal 
sequence was used, giving more slices and better definition. 
Figure 3.4: Low resolution sagittal image demonstrating 
the spinal cord (blue arrow), the bony vertebral body of L4 
(yellow arrow) and spinous process of L5 (red arrow), the 
animal‟s dorsal skin is to the top of the picture and head to 
the right.  Scale bar 0.5cm. 
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3.2.2.3.4 Axial 3D Image:   The final scan used a transverse 3D gradient echo volume 
acquisition imaging slab with a 30x30x8mm field-of-view, positioned over the image of 
the coronal scan to include the full extent of the L4 DRG bilaterally.   Scan time was 43 
minutes, generating 32 axial images, with an 117x117μm2 resolution and 0.25mm slice 
thickness, cutting the DRG across their short axis for an 8mm segment (Figure 3.6).   To 
maximise signal for each animal the 3D pulse flip angle and radio-attenuator off-set 
(RAOS) was selected for each animal.   A single slice 2D gradient echo sequence with the 
same TE and TR as the 3D sequence was positioned parallel to the plane of the surface coil 
(i.e. coronal), and crossing the DRG was run with the phase encode set to zero; multiple 
flip angle and RAOS values were entered until the resultant signal was maximised without 
causing image clipping.   Such choosing of the pulse angle gives the resultant images T1 as 
well as proton density weighting. 
 
 
Figure 3.5: High resolution coronal MRI image, the animal‟s 
head is toward the top of page.   The L4 and L5 DRG swellings 
are easily identified leaving the central spinal cord.   The 
relationship of the L5 ganglia to the tips of the iliac crests 
(yellow spot) is noted.   The red box represents placement of the 
imaging block over L4 DRG and the slice orientation of the 
subsequent axial 3D sequence.   Scale bar 0.5cm. 
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Figure 3.6: 3D axial MRI images of spinal cord and DRG (marked in red on the animal‟s 
right).   Representative sample of slices from the 32 image stack, proceeding cranially A-
D, the DRG emerges from the intervertebral foramen traverses rostro-medially to merge 
with the spinal cord.   Scale bar 0.5cm. 
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3.2.2.4 Magnetic Resonance DRG Image Analysis and Volume Calculation 
Using the SMIS software each slice was converted to .tif format and exported to the 
analysing computer using a digital storage medium.   The data were quantified using 
Image-Pro Plus® v5.1 (Media Cybernetics) program.   The full run of 32 images was 
opened, from these 21 sequential slices, starting with the last slice in which the L4 
intervertebral disc was visible and proceeding in a cranial sequence, were selected.  Thus a 
constant 5.25mm DRG segment, beginning from a fixed anatomical landmark was 
quantified for each animal. 
 
On each slice, working at x2 magnification, the contour of the DRG was traced bilaterally; 
the calibrated software deriving a measurement of cross sectional pixel area for the section 
of DRG in each slice.   The proximal end of the DRG lies in close approximation with the 
spinal cord and cauda equina, in this region, often became difficult to distinguish DRG 
from the neighbouring neural tissue.   In these cases, the perimeter of the cord was traced 
in the most proximal image in which it could be clearly defined and this outline applied to 
subsequent slices.   Conversion of pixel areas as measured on Image Pro Plus to actual 
sectional area in square millimetres is straight forward, as the MRI parameters are set to 
produce an image of 256x256 pixels representing a field of view of imaging of 30x30 mm; 
the area represented by each pixel is therefore is equal to (30
2
/256
2
) or 0.013733mm
2
, 
multiplication of the measured pixel area by this constant gives the area of each measured 
section in mm
2
. 
 
The volume of the DRG segment was calculated according to the principle of the 16
th
 
century Italian mathematician Bonaventura Francesco Cavalieri (Gundersen & Jensen 
1987; Gosh 1998).   Cavalieri states that the volume of any object is equal to its mean 
cross-sectional area multiplied by its height; more practically, if even an irregularly shaped 
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object is sectioned into a series of equidistant slices with constant separation between such 
sections, the object‟s volume will equate to the sum of each cross-sectional area multiplied 
by the section separation.   Gundersen and Jensen (1987) note that certain rules must be 
applied to this basic premise if the measurement is to remain unbiased; while any 
orientation of the planes of section relative to the object is permissible, the plane 
orientation and separation must remain constant.   Further, the positioning of the sectioning 
construct over the object must be randomised, i.e. the position of the first plane to hit the 
target object is not allowed to be predetermined.   The accuracy of the Cavalieri volume 
measurement as represented by the coefficient of error (CE) improves as the distance 
between sections decreases and the number of sections analysed increases, at least ten 
sections are recommended to achieve CE of less than 5% (Gadeberg et al., 1999). 
 
 Application of the Cavalieri principle to the MRI image analysis allows calculation of 
DRG volume by multiplication of the sum of the cross-sectional area from the 21 analysed 
images by the known section thickness thus: 
V-MRI = Σa-MRI . t-MRI 
Where 
V-MRI = MRI calculated volume of the DRG segment 
Σa-MRI = Sum of the MRI measured cross sectional area from the 21 slices 
t-MRI = MRI slice thickness (0.25mm - as set in the MRI sequence parameters) 
 
 
 
3.2.3 HISTOLOGICAL DRG VOLUME MEASUREMENT 
 Histological volume measurements were performed on the same axially sectioned, 
fluorescently stained DRG tissue sections as used for stereological neuron counting in the 
NAC treatment duration study and utilising the same microscope and imaging suite (cf. 
2.2.4.1).   Beginning with a randomly preselected member of the first four histological 
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sections to contain neurons as viewed from the proximal end of the DRG at x10 
magnification using the propidium iodide filter each 4
th
 subsequent section was analysed 
until a total of 14 sections had been quantified (analysis of 14 sections included the entire 
neuron containing area in all ganglia) (Figure 3.7).   
 
Analysis of the DRG histological volume was again made cognisant of Cavalieri‟s 
principle with the cross sectional area and mean actual post-processing section thickness 
for each DRG being measured.   For each section using the Olympus BX61 microscope 
with the x10 lens and propidium iodide filter the perimeter of the entire DRG complex 
including the neuron containing area and the associated axon tracts was traced, but by 
convention excluding adherent connective tissue and the axons of the often adherent grey 
rami communicantes, giving a measurement of cross sectional area for each analysed tissue 
section (cf. Figure 2.2b).   In the frequent event that the full extent of the DRG section did 
not fit within one monitor screen view at x10 magnification, the SI software, in control of 
the motorised x-y microscope stage was able to slightly move the field of view, while 
maintaining superimposition of elements of the perimeter tracing already performed.     
The mean post processing section thickness was also directly measured in a manner 
analogous to sampling for stereological neuron counts.   Over each traced full DRG 
perimeter a randomly orientated sampling grid was constructed (cf. Figure 2.2c), under x60 
magnification, using the combined H33342 and PI filter and with the stage under control of 
SI each systematically randomized sampling site was visited (Table 3.1). 
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Figure 3.7: DRG histological sections.    Representative images from an axially 
sectioned DRG; every 4
th
 serial section is seen at x10 magnification using the PI filter.   
Heading proximo-distally from A-O the joining of the spinal roots can be seen in A and 
B, passing through the neuron containing region of the DRG proper (B – N) with the 
neurons (Bright red staining) tapering out toward the axon only spinal nerve (Dull 
punctate staining) (O).    Section B is the first section in which neuronal cell bodies can 
be identified and a selection of this and thirteen subsequent sections is demonstrated to 
cover the full neuron containing region (B-O).   Scale bar (M) = 50μm 
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At each site the section thickness was measured by recording the position of the z-depth of 
the microscope focus axis as the point at which cell nuclei first come into focus, be they 
neurons or glia, and the depth at which the last nuclei just leave the plane of focus.   This 
directly measured the section thickness at each site, from which mean thickness per section 
and per ganglia was easily derived. 
       
The Histologically measured DRG volume is therefore calculated as per Cavalieri‟s 
principle, thus: 
Vhist = (Σa-hist .t-hist)/ssf 
Where 
Vhist  = Histologically calculated volume of the DRG. 
Σa-hist = Sum of the measured cross sectional area from the 14 sample sections. 
t –hist = Mean of the measured section thickness from all sampled sites in all sample        
            sections.  
ssf = Serial section fraction (0.25, as every 4
th
 section was quantified)   
 
Table 3.1: Parameters for Histological DRG Volume 
Measurement 
Section Periodicity 4 
Sampling Grid (x) 250 μm 
Sampling Grid (y) 250 μm 
Sampling Grid Area (xy) 62500 μm2 
Section Thickness (cut) 50 μm 
Section Sampling Fraction 0.25 0.25 
Mean Section Thickness Measured 
 
 
3.2.4 DATA ANALYSIS AND STATISTICS 
Student‟s t-testing was used for compassion of paired data, such as assessing differences 
between axotomised and non-axotomised sides.  One way ANOVA was used for 
comparison between groups with Bonferonni post-hoc testing.   Correlation between 
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different measurement modalities were assessed using Spearman‟s Rank Coefficients.   All 
statistical comparisons were carried out using GraphPad Prism® (v 4.03) software. 
 
3.3 RESULTS 
To validate the experimental design of this MRI study it was necessary to verify several 
hypotheses; firstly that analysis of L4 only neurons will yield similar results compared to 
L4&L5 counts.   Second, that DRG volume and volume reduction is an appropriate proxy 
measure of neuron counts and loss.   To test accuracy of the MRI imaging protocol, it is 
required to correlate the MRI measured volume to both histological volume and neurons 
counts.   Finally, the validity and utility of MRI imaging will be confirmed by comparison 
of the overall neuron counts in the NAC treatment duration study against MRI only 
measurement.  
 
3.3.1 TESTING L4 ONLY NEURON COUNTS AGAINST L4 & L5 
3.3.1.1 Correlation of L4 Neuron counts and percentage neuron loss to L4&L5  
Absolute neuron counts for L4 only versus L4&L5 combined counts assessed by animal 
and by contralateral side correlate well (Figure 3.8), with Spearman‟s  r = 0.81 and P < 
0.005, which is unsurprising as the L4 count forms part of the combines L4&L5 total. 
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Comparison of neuron loss between L4 and L4&L5 rather than absolute volume show an 
equally strong correlation (Spearman‟s r = 0.92, p < 0.005) (Figure 3.9).  
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Figure 3.8: Scatter plot demonstrating correlation of
absolute neuron counts between L4 and L4&L5
Spearsman's Correlation coefficient =0.81, p <
0.0005
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Figure 3.9: Scatter plot demonstrating correlation of
percentage neuron loss in axotomised ganglia against
the control ganglia per side as measured by L4 only or L4&L5.
Correlation is highly significent
(Spearsman's correlation coefficient = 0.92, p < 0.0005)
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3.3.1.2 Assessment of the NAC treatment duration study using only L4 neuron counts 
Using the data of the NAC treatment duration study (cf. Chapter 2) absolute neuron counts 
for L4 only closely mirror the results for L4+L5 (cf. 2.3) (Table 3.2;  Figure 3.10).   There 
were no significant differences between the non-axotomised control ganglia between 
groups.   The 60 day treatment group had no significant difference between axotomised 
and control ganglia (t-test p = 0.7), verifying the neuroprotectant effect of continuous NAC 
therapy.   Using L4 only neuronal counts, there were differences between groups with 
different treatment duration with a similar pattern as seen for combined L4&L5 counts; 7d 
control vs. axotomised p < 0.005; 14d control vs. Axotomised p < 0.005; 30d control vs. 
axotomised p < 0.05.  
 
 
 
 
 
Table 3.2:  NAC Treatment Duration Study - L4 Neuron Counts 
Rx 
Duration 
Control Ganglia 
(L4) mean (SD) 
Axotomised Ganglia 
(L4) mean (SD) 
Mean 
Neuron 
Loss 
Mean Percentage 
Neuron Loss 
7 Days 15715 (761) 11966 (220) 3749** 23.70%** 
14 Days 15020 (227) 13719 (240) 1301** 8.67%** 
30 Days 16329 (761) 16104 (853) 1280* 7.80%* 
60 Days 15724 (235) 16050 (585) 120  1.01% 
Where ** = p<0.005 and * = p<0.05 in intra-group t-testing 
  Chapter 3 
Alex. E. Hamilton: MD Thesis, 2011. 103 
 
 
Analysis of L4 neuron loss as a percentage of the non-axotomised ganglia again displayed 
a similar pattern to L4+L5 losses, highly significant loss after 7 days (23.70%, SD 2.77%, 
ANOVA vs. 60d p>0.005) and less significant loss after 14 days (8.67%, SD 1.17%, 
ANOVA vs. 60d p>0.05) and 30 days treatment (7.80%, SD 2.9%, ANOVA vs. 60d 
p>0.01) (Table 3.2; Figure 3.11).   The only noteworthy difference between L4 and 
L4&L5 analysis was that L4 only counts showed  higher mean percentage loss for the 7 
day treatment group than does L4&L5 (24% vs. 19%), this difference just reaching 
significance when analysed by a non-pared t-test (p = 0.043).     
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Figure 3.10: Effect of NAC duration of
treatment on L4 ganglia only neuron counts.
Plotted as neuron counts with SD.
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3.3.2 TESTING L4 HISTOLOGICAL VOLUME AGAINST L4 NEURON COUNTS 
3.3.2.1 Correlation of L4 histological volume to L4 neuron counts  
Absolute histological DRG volume correlates strongly to neuron counts (Spearman‟s 
correlation coefficient 0.68, p < 0.0005) (Figure 3.12).   Further, there is an even more 
significant relationship between modalities when their percentage loss after axotomy and 
differing duration of NAC treatment are compared (i.e. percent neuronal loss vs. percent 
DRG volume loss) (Spearman‟s correlation coefficient 0.94, p < 0.0005) (Figure 3.13). 
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Figure 3.11: Effect  NAC treatment duration on
neuron loss, measured by L4 neuron count only.
Plotted as percentage nearon loss with SD.
Astriks represent significance in one-way ANOVA
vs. 60d treatment (** = p < 0.005, * = p < 0.05)
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Figure 3.12: Scatter plot demonstrating correlation between
histological L4 DRG volume and L4 nouron counts.
Spearsman's correlation coefficient = 0.68, p < 0.0005
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Figure 3.13: Scatter plot demonstrating correlation of
percentage loss in axotomised L4 ganglia against
the control L4 ganglia per side as measured by neuron count
or histological volume.   Correlation is highly significent
(Spearsman's correlation coefficient = 0.94, p < 0.005)
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3.3.2.2 Assessment of the NAC treatment duration study using L4 histological 
volume. 
Quantitative L4 histological volumetric data in the different treatment groups were similar 
to the results seen for both L4&L5 neuron counts.  There were no significant differences 
between the internal contralateral control ganglia (Table 3.3; Figure 3.14).   The 60 days 
treatment group showed no significant differences between control and axotomised sides 
(t-test p = 0.69).   Partial duration NAC therapy post axotomy showed reduction in 
histological volume of the axotomised ganglia with a pattern that was duration dependent; 
being highly significant at 7d (p = 0.002) significant at 14d (p = 0.02) but not reaching 
significance at 30d treatment (p = 0.17).     
 
Analysis of L4 DRG histological volume loss showed significant reduction with only 7 
days NAC treatment (18.18%, SD 4.11%, ANOVA vs. 60d p < 0.005) or 14 days (9.89%, 
SD 3.66%, ANOVA vs. 60d p < 0.05), but not reaching significance at 30 days (5.47%, SD 
5.48%, ANOVA vs. 60d p > 0.05) (Figure 3.15).    
Table 3.3: NAC Treatment Duration Study - L4 Histological DRG Volume 
 
Control ganglia L4 
histological volume 
mean (mm
3
) (SD) 
Axotomised ganglia 
L4 histological 
volume  mean (mm
3
) 
(SD) 
L4 mean 
histological 
volume loss  
(mm
3
) (SD) 
Mean 
histological 
volume loss 
(%) 
Treatment 
Duration 
7 Days 1.67 (1.27) 1.37 (1.37) 
3.04 
(6.49) 
18.18%** 
14 Days 1.51 (1.03) 1.36 (3.88) 
1.52 
(6.54) 
9.89%* 
30 Days 1.89 (2.81) 1.78 (1.89) 
1.12 
(1.29) 
5.47% 
60 Days 
1.96  
(2.93) 
1.97 (3.12) 
-6.86 
(3.18) 
-0.25% 
Where ** = p>0.005 and * = 0.05 
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Figure 3.14: Effect of NAC duration of treatment
on L4 ganglia only histological volumes.
Plotted as volume with SD.   Asterisks relate to
intra-group t-testing: ** = p < 0.005; * = p < 0.05
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Figure 3.15: Effect of NAC treatment duration on L4
histological volume.   Plotted as percentage
histological volume loss with SD.   Asterisks represent
significance in one-way ANOVA vs. 60d treatment
(** = p < 0.005; * = p < 0.05)
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3.3.3 TESTING MAGNETIC RESONANCE IMAGING 
3.3.3.1 Correlation of MRI L4 Volume against Histological L4 Volume 
L4 volume measured by MRI correlated reasonably to histological L4 volume (Spearman‟s 
correlation coefficient 0.54, p < 0.005) (Figure 3.16), with a much stronger  correlation 
observed for assessment of percentage volume loss (Spearman‟s correlation coefficient 
0.86, p < 0.005) again confirming the superiority of assessing percentage of intra-group 
loss against absolute measures (Figure 3.17).   As in this instance both MRI and 
histological measurement are assessing the same subject (L4 DRG volume),   The MRI 
protocol measures a 5.25mm long section of tissue (21 slices of 0.25mm thickness) while 
the histological methodology assesses volume over a pre-shrinkage length of 2.8mm of 
DRG (14 sections of 50μm with a section sampling fraction of 0.25) and therefore MRI 
measurement of L4 volume returns a higher absolute volume measurement per ganglion, 
however correlation between these differing measures is significant.          
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Figure 3.16: Scatter plot demonstrating correlation
between MR L4 volume and Histological L4 volume.
Spearsman's correlation coefficient = 0.54, p = 0.0022
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3.3.3.2 Correlation of MRI L4 Volume against L4 Neuron Counts 
The purpose of using MRI assessment of L4 volume is to assess if it is a valid proxy 
measure of DRG neuron population and neuron loss following sciatic nerve injury, and 
preceding analyses were of relevance in testing the methodological „soundness‟ of MRI 
quantification.   MRI L4 volume results correlated well to L4 neuron counts (Spearman‟s 
correlation coefficient = 0.48, p < 0.05) (Figure 3.18), although there was a better 
relationship observed on comparison of MRI volume and histological volume as these data 
are obtained from analysis of the same tissue structure.   A yet stronger correlation was 
observed between percentage neuron loss and percentage MRI measured L4 volume loss 
(Spearman‟s correlation coefficient = 0.83, p < 0.005) (Figure 3.19). 
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Figure 3.17: scatter plot demonstrating correlation between
MR assessed L4 volume loss and histological L4 volume loss.
Spearman's Correlation Coefficient = 0.86, p < 0.005)
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Figure 3.19: Scatter plot demonstrating correlation
between MRI L4 volume loss and L4 neuron loss.
(Spearman's correlation coefficient = 0.83, p <
0.005)
MRI L4 volume loss (%)
L
4
 N
e
u
ro
n
 L
o
s
s
 (
%
)
3.5 4.0 4.5 5.0 5.5 6.0 6.5
11000
12000
13000
14000
15000
16000
17000
18000
Figure 3.18: Scatter plot demonstrating correlation of
MRI L4 volume to L4 neuron count.
(Spearman's correlation coefficient = 0.48, p < 0.05)
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3.3.3.3 Assessment of the NAC treatment duration study using L4 MRI volume 
The results of the NAC treatment duration study were analysed using MRI L4 volume 
measurement (Table 3.4). 
 
The MRI data showed the same trend of changes as observed with neuron counts (L4 or 
L4&L5) and with L4 histological volume analyses (Figure 3.20).   There is no significant 
difference between control ganglia of different groups, and two month NAC treatment also 
prevented MR volume reduction (t-test of contralateral control vs. axotomised side p = 
0.34).   MRI detected highly  significant difference in DRG volume when animals were 
treated with NAC for only 7 days post axotomy (t-test of control vs. axotomised p < 
0.005), and less significant reductions in the other treatment groups (14d axotomised vs. 
control p < 0.05; 30d axotomised vs. control p < 0.05).    
 
Comparison of MRI volume loss between groups again showed the same general trend as 
both the neuron counts and histological DRG volume quantification (Figure 3.21), with no 
significant loss detected for 60 days treatment.   A highly significant volume reduction was 
detected in the 7 day treatment group (18.1% +/- 4.1% vs. 1.5% +/- 2.9%, 7d vs. 60d 
p>0.001), but there was no significant volume loss detected in groups treated for 14 days 
(7.4% +/- 3.6% vs. 60d p>0.05) or 30s day (7.1% +/- 3.5% vs. 60d p>0.05).   In both cases 
there was detection of volume reduction in the axotomised side, but the large standard 
Table 3.4: NAC Treatment Duration Study – MRI Measured L4 Volume 
Treatment 
Duration 
Control Ganglia 
(L4) mean volume 
mm
3
 (SD) 
Axotomised Ganglia 
(L4) mean volume mm
3
 
(SD) 
Mean Volume 
Loss (mm3) 
(SD) 
Mean 
Percentage 
Volume Loss 
(SD) 
7 Days 5.36 (0.40) 4.39 (0.42) 0.97 (0.15)** 18.11%** 
14 Days 4.59 (0.38) 4.25 (0.33) 0.34 (0.17) 7.42%* 
30 Days 5.18 (0.66) 4.80 (0.28) 0.38 (0.21) 7.10%* 
60 Days 4.99 (0.44) 4.91 (0.41) 0.08 (0.14) 1.52% 
Where ** = p < 0.005; * = p < 0.05. 
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deviations in these measurements prevented these from reaching significance when 
compared to the 60 day group. 
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Figure 3.20: Effect of NAC duration of treatment
on MRI measured L4 volume.   Plotted as mean
 volume with SD.   Asterisks relate to
intra-group t-testing: ** = p< 0.005, * = p< 0.05.
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Figure 3.21: Effect of NAC treatment duration on MRI
measured L4 DRG volume.   Plotted as percentage
volume loss with SD.   Asterisks represent significance
in one-way ANOVA vs. 60d treatment (** = < 0.005)
L
4
 M
R
I 
v
o
lu
m
e
 l
o
s
s
 (
%
)
  Chapter 3 
Alex. E. Hamilton: MD Thesis, 2011. 113 
 
3.4 DISCUSSION 
3.4.1 METHODOLOGY 
3.4.1.1 Histological volume quantification  
The histological protocol to measure DRG volume was designed to comply with the 
Cavalieri method of volume estimation (Gundersen & Jensen, 1987).   The Analysis of a 
set number of sections (n=14) pre-determined to include all sections containing neuronal 
cell bodies allows a better comparison between ganglia of different sizes and the similarly 
constant length of tissue measured by the MRI protocol than would assessing the volume 
of only neuron containing sections such as performed in earlier stereological experiments 
of our research group  (McKay Hart et al., 2002a McKay Hart et al., 2002b; Wilson et al., 
2003; Hart et al., 2004a; Wilson et al., 2007).   Gundersen & Jensen (1987) suggest that 
the co-efficient of error (CE) in the Cavalieri estimate will reduce to acceptable value by 
analysing greater than ten sections – the fourteen sections included in volume measurement 
reduced CE to an acceptable mean 0.02188 (0.01 – 0.03).   The second assumption of the 
Cavalieri method is the first section to cross the region of interest must not be pre-
determined; this rule was met by beginning the measurement from a randomly chosen 
section from the first four to contain neurons.   The final pre-requisite is that the orientation 
of sectioning is random and that the plane of sectioning does not change; lining up the 
DRG in the OTC blocking medium before freezing for sectioning is only judged „by eye‟ 
and so the exact plane of sectioning for each DRG is subject to variation.   Once sectioning 
had started however, the whole of the ganglia was processed, with no re-positioning of the 
OTC block or the microtome chuck ensuring that all sections shared the same orientation. 
 
All histological tissue shrinks during processing and variability in such size reduction 
could introduce an element of bias into the volume analysis (Dorph-Petersen et al., 2001).   
To minimise such the effects, all sectioning and staining followed strict protocols to ensure 
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that all groups of ganglia were exposed to the same environmental conditions during 
processing.   Frozen sectioning and staining by water-soluble fluorescent media do not 
containing any dehydration steps, hence effect of shrinkage should be minimised (Bergman 
et al., 1999; Hart & Terenghi, 2004).   Further, measurement of post-processing tissue 
thickness, assessed from a systematic random sample of sites across each ganglion, was 
used for volume calculation, and in this way the shrinkage which occurs, especially during 
the „air-drying‟ step of sectioning is accounted for in the methodology. 
 
3.4.1.2 MRI volumetry 
The protocol used to locate and image the L4 DRG bilaterally was the same as that used in 
one previous study (West et al., 2007b) and is also designed cognisant of Cavalieri‟s 
principle.   Briefly, consistent placement of the animal within the magnet bore and the 
three-axis pilot scans allow relatively easy localisation of the L4 DRG bilaterally and the 
DRG are imaged in the axial plane, along their long axis, ensuring that the maximal 
possible number of sections is acquired, reducing the coefficient of error (Gundersen et al., 
1988).   Quantification of a fixed number of images, based on an anatomical landmark 
ensures that a consistent length (5.25mm) of spinal nerve/DRG/roots complex is measured.    
 
Choice of a 3D sequence was influenced by the high resolution offered, and the generation 
of rectangular slices of more precise thickness than those acquirable with standard 2D-
scanning (Johnston et al., 1999).   Slice thickness was reduced as much as possible 
(0.25mm) in order to minimise the effects of overprojection while still delivering high 
signal images (Gadeberg et al., 1999).   Image analysis of the MRI scans is carried out to 
the ultimate precision of a digital pixel (0.0.14mm
2
) and using the Image Pro Plus software 
suite.   Although there is the possibility to introduce some variability by manual contour 
tracing and difficulty in identifying cut-off points between anatomical structures, these 
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measurement errors are likely to be constant when all analysis is performed consistently by 
the same observer.   Further when using the Cavalieri principle to measure volume, even 
reasonably large inaccuracy in contour tracing does not adversely affect the eventual 
coefficient of error if a large enough number of section is analysed (Gundersen et al., 
1988). 
 
3.4.2 VALIDITY OF L4 NEURON COUNT AS A MEASURE OF L4&L5 COUNT 
The vast majority (98%) of sciatic nerve component neurons are present in L4 and L5 with 
a small contribution from L6 (Swett et al., 1991).   However, equal distribution between 
L4 and L5 cannot simply be assumed, especially as segmental distribution in the thoracic 
neuronal pool does not seem to be homogeneous (Ygge et al., 1981).   These findings and 
studies reporting different neuronal populations between sides when only one metameric 
level of the lumbar ganglia had been analysed (Schmalbruch, 1987a & b; Groves et al., 
2003) have led to the vast majority of DRG neuron population studies citing results for 
combined levels.   Previous studies demonstrated reduced coefficient of variation (9%) 
when analysing L4&L5 over L4 or L5 alone (14%), (Hart & Terenghi, 2004) and studies in 
which NAC or ALCAR has been administered report findings using combined L4&L5 
counts (Hart et al., 2002b; Wilson et al., 2003; Hart et al., 2004a; Wilson et al., 2007). 
 
The MRI equipment can only image one ganglion pair as the surface coil is too small to 
span multiple levels.   The assumption that L4 only analysis, as used in the MRI protocol 
would mirror combined counts therefore needed to be confirmed.   Using the neuron 
counts as generated in the NAC treatment duration study (cf. Chapter 2), a close correlation 
was demonstrated between L4 and L4&L5 absolute neuron populations as well as 
percentage neuron loss although L4 only analysis did tend to overestimate L4&L5 neuron 
loss.    If the NAC treatment duration study is repeated using only L4 neuron counts the 
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trend of results is unaffected.   In the NAC treatment duration study there was little 
difference between control ganglia neuron counts for L5 or L4 (L5 mean 15441, SD 446; 
L4 mean 15697, SD 535), and this variation was within the range cited by our and other 
groups (Hart & Terenghi, 2004).   In the axotomised treated groups, there was a trend for 
L4 only count groups to show a greater loss of neurons than L4+L5; this phenomenon 
being more evident for the higher value losses in the 7 day treatment group.   Overall, the 
present results of neuronal counts of L4 rather than L4&L5 combined ganglia neuron 
counts showed a good correlation and yield similar information with regard to the effect of 
NAC treatment duration as shown in Chapter 2. 
 
3.4.3 VALIDITY OF L4 VOLUME AS A MEASURE OF L4 NEURON COUNT  
Previous work by our group has demonstrated a reduction in the volume of the neuron 
containing region of the DRG accompanies neuron loss post axotomy, and that these 
reductions follow the same time course (McKay Hart et al., 2002a).   Further, volume as 
well as neuron counts are maintained by ALCAR treatment (Wilson et al., 2003).   The 
MRI pilot study (West et al., 2007b) also studied L4 neuron count to histological volume 
relationship, finding a strong correlation similar to that presented here.      
 
Repeating the treatment duration study with L4 histological volume only shows a similar 
pattern to the L4&L5 combined neuron count data both for L4 volume alone and degree of 
volume loss further evidencing the validity of single ganglion volume assessment as a 
proxy measure of neuronal loss.   The only potentially significant difference between the 
NAC duration study as assessed by L4&L5 combined neuron count compared to 
histological L4 quantification is loss of „significance‟ of the 30 day treatment group in the 
volumetric study.   However, in the 30 day treatment L4 volume group both t-testing 
against the non-axotomised group and ANOVA of volume loss against the 60 day 
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treatment group only just failed to reach accepted levels of significance; it is possible that 
these results may become more distinct if the experiment was repeated with larger group 
numbers.                                   
 
3.4.4 VALIDITY OF MRI L4 VOLUME AS A MEASUREMENT OF NEURONAL 
LOSS. 
The reasonably strong correlation of MRI L4 volume to both histological L4 volume and 
L4 neuron count shown in this study support the premise that MRI will be useful research 
tool; indeed both the MRI-to-volume and MRI-to-neuron count correlations in the NAC 
treatment duration study were stronger than those discussed previously (West et al., 
2007b), possibly reflecting the larger number of subjects included in this experiment.   In 
the data presented here, the correlation between volume measurements is stronger than that 
between MRI volume to neuron populations (ρ = 0.54 and 0.48 respectively), intuitively 
this would be the logical situation, as two measures of the same innate structure, albeit by 
different methods would seem to be more likely to be related than MRI volume to neuron 
count.            
 
Analysing the NAC treatment duration study using MRI L4 volume as the only outcome 
measure highlights some important similarities to assessment of combined L4&L5 neuron 
counts but also some significant and potentially important caveats.   The general pattern of 
volume reduction in axotomised ganglia being maintained, intra-group t-testing reached 
significance for all partially treated groups in spite of the lager standard deviation and 
coefficient of variance values for MRI assessment versus L4&L5 neuron counting.   
Significant MRI volume loss was only detected for 7 days of NAC treatment on inter-
group ANOVA, although some degree of loss was documented for 14 and 30 days as well.   
As discussed with regard to histological volume measurement, not detecting a significant 
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reduction for an experimental group with a given assessment methodology is not the same 
as a significant difference not being present.   Over-reliance on only MRI assessment and 
statistical significance rather than trends could lead to the potentially misleading statement 
that „all treatment groups with longer than 7 days treatment show no significant volume 
loss compared to full treatment for 60 days‟.   Whilst this statement is true according to the 
data presented here, it can easily be seen that such an interpretation could lead to a 
spurious overestimation of the ability of NAC to influence biological events, and care must 
be taken when interpreting findings.   
 
3.4.5 COMPARISON WITH OTHER NEUROLOGICAL VOLUMERTRIC MRI 
STUDIES 
Since the first publication of this protocol by West et al., 2007b no other groups have 
adopted DRG MRI volumetry, and so direct comparison with other work is not possible.   
As discussed earlier however (cf. 1.3.2.2) the techniques of very high resolution micro-
MRI have been demonstrated to visualise small neuronal structures (Natt et al., 2002; 
Osechinskiy & Kruggel, 2009) and independently to allow volume assessment of CNS 
structures in a variety of animal models and human pathological conditions (Gadeberg et 
al., 1999; Marziali et al., 2004; Moats et al., 2003; Mikko et al., 2000; Nagel et al., 2004; 
Wolf et al., 2002; Gudziol et al., 2009).   Within the capabilities of animal research micro-
MRI equipment is the possibility to produce histological resolution such as the 10μm slice 
thickness imaging atlas of zebrafish brain reported by Ullmann et al., (2010), which at the 
time of publication was the highest resolution achieved in the vertebrate nervous system.   
Diffusion weighted sequences have been reported to be able to measure individual axon 
diameter in the rat corpus callossum (Barazany et al., 2009). 
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Few studies which investigate neural MRI volumetry utilise histological volume and/or 
stereological neuronal population control; however those which have done so have verified 
the accuracy and validity of imaging.   Comparison of histological stereology to MRI 
volume quantification has been applied to other pathological models, such as specific brain 
regions in neurodegenerative disease after neuro-vascular insults (Bobinski et al., 2000; 
McDaniel 2001; Nemanic et al., 2002; Zarow et al., 2005).   Bobinski et al., (2000) 
compared post-mortem MRI scanning brains of Alzheimer‟s disease (AD) patients to 
histological volumetric and stereological neuronal counting quantification of areas of the 
hippocampus, subiculum and parahippocampal gyrus; demonstrating very strong 
correlation between volume measurements, with MRI tending to underestimate histological 
volume by ≈5%.   The authors report finding strong correlation between neuronal counts 
and MRI volume, however as absolute result values are not stated the relationship between 
these modalities cannot be commented upon.   In a similar experiment Zarow et al., (2005) 
compared post-mortem hippocampal neuron counting and volume measured using an 
optical dissector, to the last clinical MRI and neurocognitive assessments carried out on 
patients with AD or vascular dementia.   This group found close correlation between 
neuron count, histological volume and MRI volume, as well as between MRI volume and 
clinical findings.   While the published data does not allow calculation of the agreement 
between MRI and histological values in terms of a „loss‟ value, it gives strong 
reinforcement to the concept that MRI assessed volume can be used as an index of a 
complex clinical phenomenon in humans, such as cognitive function, or as we propose 
peripheral nervous system regeneration.   Similar correlation between in vivo MRI 
hippocampal volume and clinical performance tests in AD patients was reported by 
Csernansky et al., (2004) 
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Turning to animal models, McDaniel et al., (2001) investigated the effect of forebrain 
ischæmia in transgenic mice known to be hyper-susceptible to such an insult.   Measuring 
volume of the dorsal hippocampus by planimetric histology and micro-MRI in a 7T 
research scanner a histological volume reduction of ≈15% was demonstrated 30 days after 
10 minutes of uni-hemispheric ischæmia which compared with a lesser, but still significant 
7% reduction on MRI.   Nemanic et al., (2002) studied the effect of intracerebral injection 
of neurotoxic agents, assessing the effect by MRI volumetric analysis of damaged 
hippocampal tissue using two different pulse sequences (T1 weighted and Fluid attenuated 
inversion recovery (FLAIR) sequences).   This group demonstrated almost 1:1 volume 
reduction ratio between FLAIR and histology, and a slight underestimation of volume loss 
for T1 weighted imaging.   Prabhu et al., (2000) compared histological and MRI 
assessment of growth of tumours in a mouse glioma model, again finding strong 
correlation of volume between modalities, with a slight MRI underestimation.  
 
In the majority of studies comparing MRI to histological volume of anatomical structures 
including the results presented here and the pilot study of DRG quantification (West et al., 
2007b), MRI seems to consistently underestimate volume loss as assessed by histology, 
even when the effects of tissue shrinkage are compensated for (Bobinski et al., 2000).   
This phenomenon seems to extend to other highly sensitive imaging modalities, as both 
micro-MRI and micro-computed tomography (CT) underestimate the volume of tumours in 
a rat model of glioma (Engelhorn et al., 2009).   There are some exceptions to this pattern, 
such as the study reported by Herz et al., (2006) assessing MRI and histological volume of 
ischæmic areas produced after cerebral vessel occlusion in rats; in this study, although 
there was close correlation between modalities MRI significantly returned larger volume 
assessments.   The explanation for this however is likely to be attributable to the MRI 
sequence choice in this experiment, as the images were heavily T2 weighted, and likely 
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therefore to analyse areas of neuronal loss, but also surrounding cerebral œdema, which 
would not be quantified by subsequent histology.   In the DRG imaging protocol, such 
peri-lesional swelling wound not be relevant, as the 3D sequence used has relatively 
neutral weighting, and at two months post axotomy the post injury swelling of the DRG 
has been shown to be resolved (McKay Hart et al., 2002a)     
 
3.4.6 CONCLUSION 
MRI has a well documented pedigree for volumetric assessment in the nervous system, 
being verified against both histological and clinical control. 
 
The series of assumptions necessary to use L4 MRI volume as a proxy index of combined 
L4&L5 neuron populations appear to be valid, and MRI has again been demonstrated to 
return significant and scientifically useful results, being demonstrated to act as a sensitive 
proxy measure of neuron populations.    When compared against combined L4&L5 neuron 
counts (acting in this experiment as the „gold standard‟ of neuronal population assessment) 
MRI L4 DRG volumetric assessment provides a remarkably similar pattern of findings, 
however, a caveat must be acknowledged, cognisance of which will be needed for effective 
future experimental planning.   MRI volume measurements have greater innate variability 
than neuron counting and therefore less „resolving power‟ than stereology and should lead 
future experimental design to involve group endpoints that are likely to result in fairly 
large neuron/volume differences.   The results of our group mirror the findings of many 
others that MRI assessment of volume will tend to underestimate comparable histological 
analysis, whilst not detracting from the innate utility of the technique; this also should be 
born in mind in future experimental planning.   The MRI protocol is maybe less suited to 
experiments dealing with sequential small changes in volume such as a dose response 
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experiment or the NAC treatment duration study as used here as compared to a more 
binary treatment versus control experimental paradigm. 
 
The principle of MRI as a proxy measure of DRG neuron population and apoptosis after 
axotomy has again been shown to be valid, and worth pursuing, both as a research tool and 
to be taken forward into the human clinical arena.   The eventual ideal of a NAC 
interventional trial in human patients with peripheral nerve injury with volumetric MRI of 
the DRG as one of the a primary assessments of outcome along with clinical tests of nerve 
recovery hopefully moves one step closer with the favourable results of MR in this report.   
It is possible that some of the methodological difficulties of micro-volumetric scanning in 
animals may be less problematic in human scanning where the DRG will have a volume 
that is orders of magnitude greater than the tiny rat DRG which may facilitate imaging and 
volumetric analysis.   As yet unpublished pilot data from our research group using a 4T 
clinical research MRI scanner and the assistance of professional radiologists have managed 
to image volunteer DRG in cross section with what appears to be a good signal to noise 
ratio, although these studies are in a very early stage, they seem to demonstrate that human 
patient volumetric MRI of the DRG will be feasible bring the long anticipated goal of a 
clinical trial of NAC a step closer to fruition.           
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CHAPTER 4 
Further Imaging Studies of the Peripheral 
Nervous System 
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4.1 BACKGROUND AND EXPERIMENTAL DESIGN 
No attempt had been made previously (West et al., 2007b), or during the NAC treatment 
duration study to image live animals due to the potential loss of image resolution 
associated with in vivo scanning.   However, the potential of such in vivo MRI imaging 
would be of benefit to future studies, as it would allow the monitoring of physiological 
events in the same animal over a period of time by using serial imaging.   For this reason, a 
pilot study was carried out, scanning a live, anæsthetised rat in order to examine the 
feasibility and associated effects on image quality of this type of investigation.  
 
Both Magnetic Resonance Imaging (MRI) and Ultrasound (US) scanning are in frequent 
use in clinical Plastic and Reconstructive Surgery to diagnose lesions of the peripheral and 
central nervous system and for pre-operative planning, with applications ranging from 
imaging peripheral nerve injury to the brachial plexus or arm/forearm nerves (Cokluk et 
al., 2004; Cokluk & Aydin, 2007) upper limb major nerve tumours (Stelow et al., 2004; 
Gruber et al., 2007).   Over a decade MRI has been demonstrated to be able to identify 
effects of axonal injury on the distal stump of a peripheral nerve in human patients (Filler 
et al., 1993; Britz et al., 1995; Britz et al., 1996; Daley et al., 1997).   Subsequent animal 
studies by a number of groups (cf. 1.3.2.1) have further investigated this phenomenon 
demonstrating that changes in T2 and other more sophisticated sequence parameter signals 
can be seen at the site of nerve injury and normalise with nerve regeneration (Aagaard et 
al., 2003; Bendszus et al., 2004; Behr et al., 2009).   To define an imaging protocol to 
mirror these studies would obviously represent an opportunity to assess by MRI the effects 
of the neuroprotective agents; particularly as ALCAR has been demonstrated to enhance 
peripheral nerve regeneration in histological studies (Hart et al., 2002c; Wilson et al., 
2009).  
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Ultrasound of peripheral nerves is a commonly used clinical test (Khachi et al., 2007) but 
is usually limited by resolving power of clinical ultrasound equipment to imaging studies 
of the main upper limb nerves in the arm and forearm); there are no reports of US imaging 
of human digital nerves.   High frequency ultrasound (HFUS) technology is now becoming 
available to research science (Andonian et al., 2009; Sullivan et al., 2009; Marion et al., 
2010).   The much higher wavelength of sonar energy emitted by an HFUS probe allows 
visualisation of structures at very high resolution, at the trade off of reduced tissue 
penetration.   A Vevo 660® high frequency ultrasound system (VisualSonics, Toronto, 
Ontario, Canada) was kindly made available to this researcher for a brief time in order to 
carry out pilot studies imaging neural tissue by the Imaging Research and Development 
Team from AstraZeneca (Alderly Park, Cheshire, UK).                 
Three experimental investigations therefore form the substance of this chapter: 
1. Volumetric L4 DRG MRI scanning in vivo. 
2. Attempts to visualise the rat sciatic nerve using the University of Manchester‟s 7T 
small animal MRI scanner. 
3. Use of high frequency ultrasound to visualise the rat sciatic nerve and nerve 
regeneration. 
4. Use of high frequency ultrasound to visualise volunteer human digital nerve in the 
index finger.  
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4.2 MATERIALS, METHODS & EXPERIMENTAL DESIGN 
 4.2.1 EXPERIMENT ONE: In Vivo Volumetric L4 DRG MRI Scanning 
A young adult male outbred albino Sprague Dawley rat (Harlan Sprague Dawley Inc.), 
weight 252g was anæsthetised by inhalational oxygen driven Isoflourane as described for 
operating in the NAC treatment duration study (cf. 2.2.1.2).   Induction was carried out in a 
preparation room adjacent to the MR laboratory, and after reaching an appropriate plane of 
anæsthesia, the animal was transferred to the scanning probe and the surface coil applied as 
described in 3.2.2.1.   As ongoing anæsthetic is administered via a non-metallic tube, this 
can be maintained in position over the animal‟s snout and placed within the bore of the 
scanner.   Repeat clinical examination to monitor anæsthesia is not possible when the 
subject is within the magnet bore, and so respiratory rate, monitored by a piezoelectric 
pressure pad (Graseby Medical) was used as the sole index of animal welfare within the 
scanner.   The L4 DRG volumetric scanning protocol and subsequent image analysis steps 
were followed exactly as described in Chapter 3 (cf. 3.2.2.2 – 3.2.2.4).   After scanning, the 
animal was removed from the scanner, assessed for signs of life before being killed by 
cervical dislocation.   The dead animal was re-imaged following the same protocols and 
image analysis as used during anæsthetised scanning.   
 
4.2.2 EXPERIMENT TWO: Attempted MRI of the Rat sciatic Nerve 
To image the sciatic nerve the same 2cm surface coil utilised in the DRG volumetric 
protocol was used for some scans, while others used a 8cm internal diameter custom made 
volume coil (Figure 4.1) into which the whole animal in its plastic „probe‟ holder were 
inserted.   This alternative coil gave less „magnified‟ views of the whole animal rather than 
a ≈2cm diameter sphere of highly detailed image.   A number of different MRI sequences 
were used to image animals in this experiment, including those which had been designed 
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for the DRG imaging protocol and others selected from the sequence library of the SMIS 
software console (Appendix 7).    
 
 
4.2.2.1 Operative interventions in the MRI of peripheral nerve experiment 
4.2.2.1.1 Unrepaired Sciatic Nerve Transection (MRI)    
Rather than capping the ends of transected nerves in silicone and burying the nerve/cap 
construct in local muscle which may seriously distort local anatomy (cf. 2.2.1.1 – 2.2.1.3) a 
less invasive transection model was used in the sciatic nerve anatomical experiments.   
Following otherwise identical pre-operative preparation, a much more limited ≈5-8mm 
skin incision was made over the area of the hind limb which experience had taught would 
be directly above the upper border of the rectus femoris muscle.   At this level the sciatic 
nerve was dissected free of its surrounding connective tissue and a 1mm segment excised 
by sharp dissection with no attempted repair.   The skin was closed as described previously 
Figure 4.1: The 8cm internal diameter volume coil.   The full animal was 
positioned within the coil (cf. the Surface coil - Figure 3.2) 
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4.2.2.1.2 Sciatic Nerve Crush   
 Anæsthesia and nerve exposure were identical to above, however rather than being divided 
the nerve was crushed using No 5a jeweller‟s forceps for two periods of ten seconds.   
Before closure, the nerve was inspected to ensure that there was no loss of continuity. 
 
4.2.2.1.3 Intraneural Injection of manganese chloride 
Manganese Chloride (MnCl2) is a paramagnetic agent used as contrast media in MRI 
studies (Elster 1994)   In biological neuronal systems it has been shown to be taken up by 
nervous tissue as an analogue of calcium and distributed along neuronal tracts (Natt et al., 
2002; Matsuda et al., 2010).   Following the protocol of Natt et al., (2002) 120mMol 
solution of MnCl2 (Sigma) in normal saline was injected into the sciatic nerve at the upper 
border of rectus femoris after standard anæsthesia and exposure.   The contrast solution 
was delivered intraneurally by means of a micro-needle drawn from a glass tube after 
heating over a Bunsen flame.   Accurate dispensation of contrast agent was achieved by 
securing the micro-needle with a short section of glass tubing onto a Hamilton syringe 
(Hamilton, Switzerland), with the join being sealed with molten paraffin wax.   Manganese 
chloride solution was drawn up by evacuating the Hamilton syringe enough to fill the 
attached glass micro-needle and a segment of the pre-calibrated Hamilton syringe.   5μL of 
contrast was slowly introduced under the perineurium of the nerve under magnified vision, 
the needle held in place for ten minutes before extraction to minimise spillage of contrast 
solution from the nerve.   Ten times greater volume of contrast was used than in the study 
of Natt et al., (2002) due to the greater size of the sciatic nerve in relation to the optic tract.   
Thereafter wound closure and animal analgesia and recovery was following previously 
described methodology. 
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4.2.2.2 Study design 
Literature suggests that segments of nerve undergoing Wallerian degeneration demonstrate 
signal changes on MRI, particularly using T2 weighted sequences (Aagaard et al., 2003; 
Bendszus et al., 2004; Behr et al., 2009).   A series of experiments were designed to assess 
imaging of rat sciatic nerve using the 7T magnet and the custom built 2cm surface or 
5.8cm volume coils.   These included: 
 
 Surface coil positioned over lateral aspect of a normal hind limb. 
 Surface coil positioned over lateral aspect of a hind limb 7 days after sciatic nerve 
crush lesion.   A time point at which Aagaard et al., (2003) detects signal changes in 
injured nerve. 
 Surface coil positioned over lateral aspect of a hind limb 7 days after sciatic nerve 
transection.   A time point at which both Aagaard et al., (2003) and Behr et al., (2009) 
identify increases T2 signal in distal nerve stumps. 
 Surface coil positioned over lateral aspect of a hind limb 12 hours and 20 hours after 
intraneural injection with the paramagnetic contrast agent manganese chloride (5μl 
120mM aqueous solution) (cf. Natt et al., 2002). 
 Volume coil surrounding full hind quarters of an animal with a normal nerve. 
 Volume coil surrounding full hind quarters of an animal 7 days after sciatic nerve 
crush. 
 Volume coil surrounding full hind quarters of an animal 7 days after sciatic nerve 
transection. 
 Volume coil surrounding full hind quarters of an animal  with a nerve injected with the 
paramagnetic contrast agent manganese chloride (12h and 20h post injection) 
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For each of these conditions a range of scanning sequences and parameters (Appendix 2) 
were used including proton density and T1 weighted gradient echo sequences, T2 weighted 
fast spin echo sequences, diffusion weighted and 3D gradient echo scans similar to that 
used in the DRG quantification.   Images were first displayed on the SMIS console 
monitor, before being converted to .tif format for export. 
 
4.2.3 EXPERIMENT THREE:  High Frequency Ultrasound of the Rat Sciatic Nerve 
4.2.3.1 Operative and Practical Techniques in the High Frequency Ultrasound Study 
4.2.3.1.1 Unrepaired Sciatic Division (US) 
For the ultrasound experiments, in order not to have dermal scar tissue overlying the nerve, 
which would potentially interfere with ultrasound transmission, a slightly larger more 
proximal skin and muscle incisions than those used for unrepaired sciatic nerve transection 
was utilised (cf. 4.2.2.1.1).   Gentle retraction of these tissues still allowed easy access to 
the nerve, but offset the position of the final scar.   As nerve regeneration was required for 
these experiments, the nerve was dissected free of its surrounding connective tissues and 
cleanly divided and the nerve stump ends put in close approximation to each other.   
Wound closure was not modified.   Despite the larger incision required in this model no 
problems with wound breakdown were encountered. 
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4.2.3.1.2 Animals and pre-scan preparation 
All animals used in the ultrasound studies were adult male Sprague Dawley rats, and were 
„schedule one‟ killed prior to scanning.   Post mortem the rump and hind leg was shaved, 
and further fur removal was facilitated by use of a commercial calcium thioglycolate 
depilatory cream (Veet® Hair removal cream, Reckitt Benckiser plc). 
 
4.2.3.1.3 Ultrasound Scanning 
 All ultrasound imaging was performed using a VisualSonics® Vevo® 660 micro-imaging 
system, kindly loaned by Astra Zeneca UK (Figure 4.2).    
    
A single element, mechanically scanned, 3cm diameter 40MHz Real-Time Micro 
Visualization (RMV)-40A transducer was used to generate B-mode real time images of rat 
sciatic nerve on the integrated display monitor.   Other parameters included a master gain 
of 21.00dB, 10x10mm field of view and 30 Hz frame rate.   Commercial water based gel 
was used as a probe-skin interface (Parker Laboratories Inc, New Jersey).   This system 
had a focal depth of 6mm generating high resolution images.   Image capture and analysis 
were performed using the software accompanying the Vevo system. 
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4.2.3.2 Study Design 
There was no previous literature suggesting that such an HFUS system had been used for 
nerve imaging using any animal model.   The aim was to identify the intact rat sciatic 
nerve, the divided nerve and lesions in continuity.   Additionally, it was unknown if the 
neuroinflammatory changes occurring during Wallerian degeneration would cause 
detectable change in the echogenicity of the distal stump after nerve transection. 
 
The first pilot study was to scan a single normal animal to identify whether the HFUS 
system could visualise the sciatic nerve.   Following this, two animals underwent identical 
unrepaired sciatic nerve transection operations in which the severed nerve ends were left in 
Figure 4.2: The VisualSonics Vevo 660 High frequency Ultrasound Scanner.   The scan 
head (red arrow) is seen suspended from a holding gantry to the left of the picture, while 
the system casing and monitor are to the right. 
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close approximation but not coaptated.   These animals were allowed to survive for 2 and 8 
days respectively, before „schedule one‟ termination and scanning allowing assessment of 
nerve response to injury and early regeneration.   After scanning the course of the sciatic 
nerve was dissected under x3.8 loupe magnification (Surgical Acuity, Middleton, 
Wisconsin) to allow direct comparison of scanned images to gross appearance.   
 
4.2.4 EXPERIMENT FOUR: High Frequency Ultrasound of the Human Digital 
Nerves 
 
In this brief study the scan head of the Vevo 660 HFUS system was simply applied to the 
volar/ulnar aspect of the left index finger of three volunteers, using ultrasound transmission 
gel as an interface.   Attempts were made to identify the components of the ulnar 
neurovascular bundle at the midpoint of the proximal and middle phalanges and the dorsal 
digital veins; common sites of injury.        
 
4.3 RESULTS 
4.3.1 EXPERIMENT ONE: In Vivo Volumetric L4 DRG MRI Scanning. 
In vivo scanning of anæsthetised animals using the DRG imaging protocol had not been 
previously attempted.   As a pilot study therefore, one animal was scanned alive under 
respiratory and temperature monitoring and again after „schedule one‟ killing on the same 
day.   The spinal cord and DRG could be distinguished in the live scan.   Comparison with 
the images produced by post mortem scans (Figure 4.3) demonstrates that in vivo imaging 
gave lower signal-to-noise ratio, marked horizontal striation, „smearing‟ of the image in the 
vertical axis and loss of signal toward the deeper areas of the animal in the scan taken from 
the live animal.   In the in vivo scan, the signal is noted to deteriorate more markedly at the 
extremes of the sequence stack, and with distance from the surface coil (placed on the 
animals back) than in the post mortem images; the first and last few images of the 
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sequence, and the lower portion of each image appeared markedly degraded.   It is 
interesting to note that blood vessels such as the abdominal aorta and paraspinal vessels are 
highlighted, presumably reflecting a time-of-flight angiography effect (Westbrook 2002).   
However, there does not seem to be any „ghosting‟, possibly due to the 3D-gradient echo 
nature of the acquisition which is less affected by phase encoding artefact.   Images from 
the two scans were analysed to measure the DRG volume as described previously (cf. 
3.2.2.4).   The results showed that the mean volume for the L4 ganglion was 4.5mm
3 
in the 
ex vivo scan and 7.6mm
3
 in the in vivo images.    
 
4.3.2 EXPERIMENT TWO: Attempted MRI of the Rat sciatic Nerve 
Despite interpretation of the resulting images by four observers cognisant of the pertinent 
neuroanatomy, the sciatic nerve could not be reliably identified using this technique.   In 
many scans imaging the thigh longitudinally or obliquely (cf. Aagaard et al., 2003), 
longitudinal structures were observed coursing parallel to the femur towards the popliteal 
fossa and thus following the topography of the nerve. 
 
These structures would often display high intensity on T2 weighed images; but when 
analysing the images as a sequence, they would be present in too great a number of slices 
to be consistent with the diameter of the nerve (Figure 4.4). 
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This longitudinal structure is likely therefore to represent the intramuscular tissue plane 
deep to the gluteal muscles in which the sciatic nerve lies, rather than the nerve itself.   Of 
interest, on fast spin echo T2 weighted scans of animals which had undergone operations 
there was often diffuse signal hyperintensity in this region compared to the contralateral 
side (Figure 4.5).   However, again this structure was present at the same level in too many 
sections to be the sciatic nerve, and this hyperintensity was interpreted as more likely 
reflecting post traumatic œdema rather than any intrinsic neurophysiological phenomenon.   
In many of the post-operative or normal animals this region of interest would display 
marked T2 hyperintensity bilaterally on fast spin echo images, (Figure 4.4d, Figure 4.5) a 
finding at odds with Behr et al., (2009) who found un-operated nerve and its surrounding 
muscles to be isointense.     Further, in scans transecting the thigh or leg distal to the knee 
joint in an axial plane (cf. Bendszus et al., 2004; Behr et al., 2009) no structures 
representing the three distal branches of sciatic nerve (tibial, popliteal and sural nerves) in 
cross section could be differentiated from the surrounding muscle tissue either post injury 
or using differing sequences (Figure 4.6). 
Figure 4.3: In vivo (left) and ex vivo (right) MR images of comparable sections of the 
same animal.   Scale bar = 0.5cm. 
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Figure 4.4: (A-C) Images from T1-wighted gradient echo sequence of rat body and hind 
limbs around the region of the knee joint acquired using the volume coil.   Animal had 
undergone sciatic crush 7 days previously.   Image D is from a T2-weighted fast spin echo 
sequence of the same animal; the higher level of noise is noted.   The breach in the 
integrity of the superficial muscle layers at the level of the wound is noted.   Running 
distally from beneath the wound is a longitudinal structure following the course of the 
nerve towards the popliteal fossa which is hyperintense on the T2-weighted image.   
However, the same structure is also seen in slices B and C, at the same level; these slices 
are some 1cm distal to slice A, the structure cannot therefore be the 1mm diameter sciatic 
nerve.   Further, in the more distal sections the leg below the knee has been cut in cross 
section (marked red in B), there is no evidence of any structure resembling the tibial or 
peroneal nerves visible in either sequence.   Scale bar = 0.5cm.          
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Figure 4.5: T2 weighted axial fast spin echo sequence of rat hind limbs 7d 
after unilateral sciatic division.   There is clearly greater enhancement in 
the area of the popliteal fossa and intramuscular plane on the operated side 
(left of picture, red arrow), but still a remarkably high signal intensity on 
the un-operated side. The femoral head is marked by the yellow arrow.  
Scale bar = 0.5cm. 
Figure 4.6: Caption over. 
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Sans of animals in which the sciatic nerve had undergone intraneural injection with 
manganese chloride, similarly failed to demonstrate the sciatic nerve at the site of injection 
(Figure 4.7), but rather occasionally demonstrated diffuse and non-specific T1 signal gains 
appropriate sequenced images.   Natt et al., (2002) had described uptake and retrograde 
transport of MnCl2 allowing tracing of neural pathways, but at neither time point at which 
injected nerves were imaged was any signal change in the DRG noted (Figure 4.8). 
 
Figure 4.6 (Previous page): T2 weighted fast spin echo sequence transecting the distal 
legs in cross section just distal to the knee joint in an animal which was 7 days after left 
sided sciatic transection.   The tibiae (red arrow) and fibulae (yellow arrow) are seen as 
dark areas bilaterally but no hyperintense areas that could represent the distal branches of 
the sciatic nerve can be identified.  Scale bar = 0.5cm 
 
Figure 4.7: T1 weighted high resolution oblique gradient echo sequence 
cutting through the thighs in a plane parallel to the femur 12h after 
intraneural injection of manganese chloride into the left sciatic nerve.   
Generalised disruption of the muscle planes caused by dissection is seen (red 
arrow), as is non-specific foci of signal increase, but no single structure 
traceable over multiple sections can be identified as the sciatic nerve.   Scale 
bar = 0.5cm.      
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Figure 4.8 - T1 weighted high resolution axial gradient echo sequence 
at the level of the L4 DRG from an animal 20h after intraneural 
injection of manganese chloride into the left sciatic nerve.   The DRG 
can be visualised each side of the spinal cord at the centre of the bulk of 
paraspinal muscles in the superior half of the image (red arrow marks 
right DRG).   There is no convincing signal change between each side 
as would be expected after retrograde transport of paramagnetic 
contrast.   Scale bar = 0.5cm. 
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4.3.3 EXPERIMENT THREE:  High Frequency Ultrasound of the Rat Sciatic Nerve 
4.3.3.1 Identification of the Sciatic Nerve 
One normal adult male Sprague Dawley rat was scanned over the region of the sciatic 
nerve post mortem.   The full course of the sciatic nerve was easily identifiable in both 
longitudinal and cross sectional axes from the emergence through the sciatic notch until its 
trifurcation (Figure 4.9 & Figure 4.10).   Further; the sural and peroneal branches were 
observable for the majority of their superficial course.   The tibial nerve was not 
identifiable for its full course; being lost from view as it proceeded deeper into the cleft 
between the heads of gastocnemius muscle leaving the plane of penetration of the scan 
head (Figure 4.11). 
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Figure 4.9 - HFUS image of the trunk of the rat sciatic nerve in 
longitudinal section (red arrow), emerging from under the echo 
impenetrable bone of the pelvis (dark crescent at the left hand side of 
image).   The contrast of the hyperechoic epineurium and less bright neural 
tissue is appreciated  
Figure 4.10 - HFUS image of the rat sciatic nerve in cross section, 
marked with real time measurement by the Vevo package (the cross 
sectional area being 0.89mm 
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4.3.3.2 Detection of injured Sciatic Nerve 
To assess the ability of HFUS to detect differing degrees of nerve injury two animals 
underwent non-repaired sciatic nerve transection and were scanned ex-vivo after 2 and 8 
days respectively.   After 2 days an obvious gap in the continuity of the nerve was detected 
by HFUS, and verified on inspection (Figure 4.12). 
Figure 4.11 - HFUS image just distal to the trifurcation of the 
sciatic nerve in cross section,identifying the three branches. 
Figure 4.12: Comparison of HFUS image 2 days after sciatic nerve transection with gross 
appearance.   An obvious gap at the site of injury can be seen of the HFUS image, which is 
verified by the dissection image (arrows). 
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At 8 days after injury a less marked disruption of the nerve architecture could be seen 
using ultrasound which corresponded to a partly regenerated lesion in continuity on visual 
examination (Figure 4.13). 
 
At neither time point were any differences observable in the image signal from nerve 
segments proximal and distal to the injury, seeming to demonstrate that HFUS scanning 
shows purely anatomical features of regeneration rather than be affected by the underlying 
neuropathology.      
 
4.3.4 EXPERIMENT FOUR: High Frequency Ultrasound of the Human Digital 
Nerves 
Following the success of the animal sciatic HFUS scanning the ability of the unit to 
visualise the components of the human digital neurovascular bundle was assessed.    In all 
three volunteers, both structures of the left index digital neurovascular bundle could be 
visualised at both the proximal and distal phalanx (Figure 4.14).   Using real time video 
Figure 4.13: Comparison of HFUS image 8 days after sciatic nerve transection with gross 
appearance.   While far from normal, the scanned image seems to demonstrate a continuity 
between the previously divided nerve ends.   Gross appearance verified these findings, a 
confluent connective tissue bridge spanning the injury site. Injury sites marked by arrows.   
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imaging, pulsatile motion of the digital artery and compressibility of the surrounding 
dorsal veins could be used to differentiate from the digital nerve.   Locating the digital 
nerves was qualitatively slightly more difficult that identifying the sciatic branches in the 
rat despite their similar diameters, further, the quality of the human images was not as 
highly detailed, with a slightly greater signal to noise ratio presumably due to the thicker 
layer of keratinised epidermis and tough dermis on the volar aspect of the human hand 
compared to the flank of the rat. 
 
4.4 DISCUSSION 
4.4. EXPERIMENT ONE: In Vivo Volumetric L4 DRG MRI Scanning 
In vivo imaging presents a few logistical issues not encountered with dead animals; holding 
the surface coil in position securely over the rat‟s hind quarters without embarrassing the 
animal‟s respiration requires some compromise of coil security.   Further, the animal 
cannot be seen when within the magnet bore, making assessment of depth of anæsthesia 
Figure 4.14: The human left index finger ulnar digital nerve 
(red arrow), visualised by HFUS at the midpoint of the 
proximal phalanx. 
  Chapter 4 
Alex. E. Hamilton: MD Thesis, 2011. 145 
 
more challenging.   Comparison of the in vivo to post mortem scans (cf. Figure 4.3) 
demonstrates a number of artefacts, the signal-to-noise ratio is worse in the live animal 
images with a greater degree of „unsharpness‟, there is marked horizontal striations with 
the image appearing „smeared‟ in y-axis.   This is most likely to reflect motion artefacts 
due large regular global movements such as the respiratory excursion and cardiac cycle, as 
smaller more local motion caused by pulsatile flow in medium and small blood vessels, 
and less predictable movements such as peristalsis in the abdominal viscera.    
Quantification of the DRG profiles obtained during the in vivo and post mortem scanning 
demonstrates a 69% increase in the measured mean volume of the DRG in the live scan.   
It is unlikely that a volume change of such magnitude could occur as a post-mortem 
artefact, and therefore this apparent enlargement must be substantially attributable to the 
reduced image quality produced in vivo.   Such large artefactual effects on the apparent 
volume of the DRG were felt to be too great to allow further animals to be sacrificed in any 
more numerous studies of live scanning until solutions could be employed to improve the 
resolution of in vivo imaging.   
 
Various possible strategies to compensate for the effect of motion artefact have been 
explored.   Increasing the number of signal averages has been suggested (West et al., 
2007); however this greatly increases the scan time, which may become restrictive if 
imaging live animals.   The increased time needed to optimally position the coil and shim 
the magnet encountered on the in vivo trial lead to the rat being anæsthetised for 
approximately 2.5h, and any significant further elongation of this period must be viewed 
with caution. 
 
Navigator echoes are often used as a motion compensation device (Ehman & Felmlee, 
1989; Wang et al., 1996), this technique takes an additional line of non-phase encoded data 
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which, in k-space can be used to detect in-plane motion (Kadah et al., 2004).   
Unfortunately no navigator echo enabled sequences were included in SMIS® parameter 
library, and despite extensive searching, no literature emerging from other groups using 
such techniques and translatable to our hardware could be found.   
 
A third potential technique for reducing the effect of motion artefact is the use of 
respiratory and ECG gaiting (Burdett et al., 1993; Weber et al., 2006), in which a 
piezoelectric transducer and electrodes are used to externally monitor the animals 
respiratory motion and ECG respectively.   This information is fed into the MRI hardware 
and the sequence is run only during set periods of the cardiac and respiratory cycles.   This 
technique will also necessitate some lengthening of the image acquisition time, but is 
believed to be the most satisfactory option.   After some delay, funding sources were 
identified for purchase of such equipment, and compatibility issues relating to both the 
scanner and SMIS hardware seem close to being resolved and  which hopefully allow 
gaiting to be used in future experiments.                   
 
4.4.2 EXPERIMENT TWO: Attempted MRI of the Rat sciatic Nerve  
The failure of numerous attempts to visualise the rat sciatic nerve with the 7T hardware 
using a variety of MRI sequences, coil conditions, increasingly severe nerve injury models 
and contrast enhancement is surprising, frustrating and disappointing.   Image resolution is 
unlikely to be responsible for these difficulties as, in the DRG imaging protocols (amongst 
those used when attempting to locate the nerve) structures such as the paravertebral 
arteries, and joint space of the intervertebral facet joints could easily be identified, both of 
which are substantially smaller than the 0.8-1mm diameter sciatic nerve. 
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The difficulties most probably reflect lack of contrast between the neural structures and the 
surrounding muscle, despite the much higher lipid content of nerve in comparison to 
muscle.   It is noted that DRG are surrounded predominantly by bone of the intervertebral 
foramina and the subdural space, explaining why these issues were not relevant in DRG 
imaging.   The hardware used in the experiments of Aagaard et al., (2003) and Bendszus et 
al., (2004) were markedly different from our 7T scanner, both of the earlier studies using 
1.5T clinical scanners, with wide diameter surface coils and access to complex sequences 
such as FLASH, short τ-inversion, turbo inversion recovery, fat suppressed T1-weighting 
and double spin echo which were not available using the SMIS® parameter library being 
limited to T1 and T2 weighted gradient-, and spin-echo sequences.   It is less easy to 
explain why the findings of Behr et al., (2009) could not be mirrored, as the 4.7T research 
scanner used by this group seems to have had a limited number sequences available in its 
library (i.e. no complex sequences were used, or in fact mentioned in this group‟s paper), 
and yet multiple attempts over a significant time period assessed by this study could not 
localise the sciatic nerve with precision great enough to consider running a full experiment 
based on the technique.   Further, our methodology consistently found T2 signal 
hyperintensity in the area of the nerve on both sides after unilateral nerve injury and even 
in normal subjects.           
 
4.4.3 EXPERIMENTS THEE AND FOUR: High Frequency Ultrasound of the Rat 
Sciatic Nerve and Human Digital Nerve  
Ultrasound imaging of peripheral neural structures is becoming an increasingly recognised 
and useful clinical imaging modality (Khachi et al., 2007), with applications including 
diagnosis of carpal tunnel and other compression neuropathies (Lee et al., 1999), guiding 
regional anæsthesia blocks (Baldi et al., 2007; Hadzic et al., 2008) and investigation of 
nerve and nerve sheath tumours (Stelow et al., 2004; Gruber et al., 2007).   Current clinical 
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scanners used for superficial tissue imaging, such as nerve, muscle, tendon, breast and 
testes tend to use frequencies in the range of 7-18MHz (http://www.medical.siemens.com), 
the Vevo system offers up to 40MHz which therefore offers higher resolution imaging, but 
at the cost of reduced beam penetration, the focal plane for the RMV-40 scan head used 
being only 6mm.    
 
There have been both anatomical verification studies (Cartwright et al., 2007) and clinical 
(Cokluk & Aydin, 2007) investigations of imaging transections of the major upper limb 
neural structures (brachial plexus, radial, median and ulnar nerves), but no published work 
describing imaging of structures as small as the manual digital nerves could be identified.   
Animal studies have described ultrasound imaging of neuromata in the rabbit peroneal 
nerve after transection (de Kool et al., 2005). 
 
Imaging the rat sciatic nerve was relatively easy and the full course from the sciatic notch 
to well beyond the trifurcation into the main branches could easily be demonstrated.   
Further, imaging of injured nerve was straight forward, but was hampered if the scar tissue 
from the skin incision was interposed.   Although limited time availability with the scanner 
precluded investigating a wide range of time points, there was a clear difference in the 
images when comparing new and partly regenerating injuries corresponding to neurotmetic 
and axonotmetic grades of Sunderland‟s nerve injury classification (Sunderland 1951).   
HFUS clearly offers a new and powerful in vivo research tool potentially applicable for 
many applications in peripheral nerve research.   The animal experiments described here 
were all performed ex vivo as the limited time available with the scanner precluded 
application for an amendment to the researcher‟s animal licence to allow ultrasound 
imaging of live animals.   However, the HFUS scanning is entirely non-invasive, and 
because the images are generated and captured in real time there is no necessity for the 
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animal to lie still for prolonged time periods requiring anaesthesia.   It might also be 
possible that HFUS scanning could be undertaken without any form of anaesthesia or 
sedation, an obvious boon in terms on animal welfare.           
 
There is also an obvious potential for clinical translation of this technology, human digital 
nerves could be visualised, which does not seem to have been reported previously.   The 
relative simplicity of use of the hardware has the potential to act as a valuable operative 
planning modality.   The small „footprint‟ and ease of training of the HFUS equipment 
could easily be implemented into a clinical setting where patients with digital injuries and 
equivocal clinical findings could be scanned to assess continuity of the digital 
neurovascular bundle, potentially reducing otherwise unnecessary „exploratory‟ operations 
to explore a neuropraxic or axonotmetic nerve injury which need not have occurred.   Such 
operations, presenting the surgeon with „nothing to repair‟ inconvenience the patient, and 
have a significant health care cost associated with them.   HFUS in the animal model 
discussed here appears to have the ability to differentiate between such grades of injury 
and physical nerve disruption and therefore holds the potential to significantly benefit 
patients. 
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In Vitro Study of N-Acetylcysteine and 
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Neuronal Culture 
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5.1 BACKGROUND AND EXPERIMENTAL DESIGN  
5.1.1 Development of DRG Neuronal Culture. 
Cell or tissue culture of neuronal cells initially started during the first half of last century, 
with most research involving neuronal tissue isolated from central nervous system of 
embryonic or neonatal sources of tissue, (Harrison, 1907; Murray, 1965).   It was not until 
later that cultures of adult peripheral nervous system neurons, initially sympathetic 
autonomic neurons, could be maintained (Table 5.1).  
TABLE 5.1:  Landmarks in Development of Neuronal Tissue Culture 
Cell Type Tissue Animal Authors Year 
Unknown Unknown Chick Embryo 
Roux (Cited 
in Hamburger 
1997) 
1885 
Neurectoderm Neural Tube Frog Embryo Harrison 1907 
Autonomic 
Neuron 
Sympathetic Ganglia 
(Thoracic or Lumbar 
sympathetic trunks) 
Adult Human 
Murray and 
Stout 
1947 
Primary Sensory 
Neuron 
Dorsal Root Ganglion Chick Embryo Scott et al., 1969 
Primary Sensory 
Neuron 
Dorsal Root Ganglion Human Embryo Scott 1971 
Autonomic 
Neuron 
Sympathetic Ganglia 
(Superior Cervical 
Ganglion) 
Adult Rat 
Silberstein et 
al., 
1972a 
1972b 
Autonomic 
Neuron 
Sympathetic Ganglia 
(Thoracic or Lumbar 
sympathetic trunks) 
Adult Frog 
Hill and 
Burnstock 
1975 
Primary Sensory 
Neuron 
Dorsal Root Ganglion Adult Frog 
Padjen et al., 
(cited in 
Scott 1977) 
1975 
Primary Sensory 
Neuron 
Dorsal Root Ganglion Adult Mouse Scott 1977 
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The DRG dissociation and culture methodology used in this study follow the modifications 
of Scott‟s technique by Lindsay (Lindsay et al., 1988; Lindsay et al., 1996), which 
includes final suspension and culturing of neuronal cells in modified Bottenstein and 
Sato‟s (B&S) medium.   This has precisely controlled additives and therefore avoids the 
methodological uncertainty inherent in leaving serum present in the final culture.   This 
method has been successfully used by members of our research group (Caddick et al., 
2006; Kingham et al., 2007; Mahay et al., 2008) 
5.1.2 Effects of ALCAR/NAC in In Vitro systems. 
To date there have been no published experiments investigating the effect of NAC in 
cultured primary sensory neurons, and only one paper in which ALCAR was used to treat 
dissociated DRG from aging animals as a model of Alzheimer‟s disease  in which NGF or 
ALCAR at one dosage level, reduced neuron death over time (Manfridi et al., 1992).   
However ALCAR was not shown to improve growth rate of „axons‟ when assessing the 
same neurite bearing cells subsequently.      
NAC is neuroprotective for neuroma cells after withdrawal of neurotrophic support 
(Ferrari et al., 1995), prevents oligodendrocyte apoptosis after TNFα withdrawal (Mayer et 
al., 1994) and reduces the response and expression of apoptotic markers in PC12 cells 
stressed with reactive oxygen species generated by a range of chemicals.   The beneficial 
effect of NAC in PC12 survival experiments has been verified by other groups subjecting 
cells stressed by lead (Aykin Burns et al., 2005), hydrogen peroxide (O‟Loghlen et al., 
2006), and cyanide exposure (Satpute et al., 2008).   The prime aim of these experiments 
were to analyse the mitochondrial or signalling events occurring after stressing and 
antioxidant treatment and although cell survival assays are frequently cited, these studies 
do not discuss the effect of NAC on neurite production.   It is through such in vitro 
methodologies that NAC was found to increase intracellular synthesis of glutathione; 
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suppress NGF-induced c-fos and MAPK signalling, but not Ras (Katama et al., 1996)   
NAC ALSO up-regulates Ras-ERK pathway signalling (Yan et al., 1995; Yan et al., 1998) 
which in turn amplifies synthesis of the anti-apoptotic factor Bcl-2 mRNA (Hsiao et al., 
2008).   NAC also offers protection from free radical induced apoptosis; this requires 
signalling through at least two MAPK independent signalling cascades (O‟Loghlen et al., 
2006).    
ALCAR has been demonstrated to prevent the normal decrease in expression of NGF 
receptors in cultures of aged animal forebrain (Angelucci et al., 1988), and to up-regulate 
the response of cultured PC12 cells to NGF in terms of both survival and neurite outgrowth 
(Taglialatela et al., 1991).   Brain neurons from the cerebral cortex, striatum and thalamus 
treated with ALCAR after serum withdrawl derived a survival benefit and performed 
favorablly in a varity of tests of apoptosis (Ishi et al., 2000).   Survival of cultured 
forebrain neurons subjected to the neurotoxin N-methy-d-aspartate (NMDA) is partialty 
enhanced by  ALCAR (Forloni et al., 1994).          
5.1.3 Aims 
No studies could be found in which young adult DRG neurons had been exposed to NAC 
or ALCAR in vitro, giving rise to the possibility of studying the biological effects of these 
neuroprotective and regeneration promoting agents using methodology previously shown 
to be effective for DRG neuron culture.    
 
Previous work investigating NAC or ALCAR in cell line culture systems had used molar 
doses with huge variation, differing by orders of magnitude, particularly in studies using 
ALCAR.   Given that many neurite inducing agents demonstrate a bell shaped dose-effect 
curve (Calabresi, 2008), it was an initial aim to try to define high, medium and low doses 
of each agent that did not display detrimental effects on cell culture.   Representative high, 
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medium and low doses from the range used in previously published studies up to this 
threshold were selected (1mM, 5mM and 10mM for NAC and 100μM, 1mM and 10mM 
for ALCAR).            
 
The most interesting documented effects of these agents in vivo is to provide primary 
sensory neuronal neuroprotection post-axotomy and, at least for ALCAR, to enhance 
peripheral nerve regeneration (Hart et al., 2002c, Wilson et al 2010).   Hence an 
experiment was designed to assess axotomised cell survival in culture and neurite 
outgrowth analysis as equivalent measures of these two effects.   Cell survival and 
neuritogenesis in developing sympathetic peripheral neurons and PC12 cells are enhanced 
by, if not dependent on, NGF, the interaction of its various receptors and their downstream 
signaling cascades (Green & Kaplan, 1995; Kaplan & Miller, 1997, 2000; Kaplan & 
Stephens, 1994; Miller & Kaplan, 2001a, 2001b, 2003, 2007; Goold & Gordon Weeks, 
2005).   NGF was therefore chosen to act as a control arm for this experiment. 
 
5.2 MATERIALS AND METHODS 
5.2.1 DRG Neuronal Culture and NAC/ALCAR Treatment 
5.2.1.1 DRG harvest, dissemination, culture 
Young adult male Sprague-Dawley rats (Harlan Sprague Dawley Inc, UK) (n=3) were 
killed by concussion and decapitation.   The vertebral column and its surrounding 
paraspinal muscles were rapidly dissected free, placed in disinfected plastic Petri dishes 
before expedient transport to a laminar flow culture hood within the tissue culture 
laboratory. 
 
Within the culture hood, and using surgical loupe magnification (x3.8, Surgical Acuity, 
Middleton, Wisconsin) the vertebral columns were split in the sagittal plane and the spinal 
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cord removed, revealing the spinal roots entering the intervertebral foramina. The DRG 
were carefully pulled from their fascial connections with jewellers forceps, and collected in 
a Petri dish containing F-12 Nutrient Mixture (Invitrogen, UK) with L-glutamine 
(Invitrogen, UK) supplemented with 5ml/l penicillin/streptomycin (Invitrogen, UK) at 
37ºC.   Nearly all of the rat‟s DRG could be harvested, giving 40-45 ganglia per animal.   
Once suspended in this medium further microdissection was performed to excise the root 
or spinal nerve segments and connective tissue, leaving only the neuron containing part of 
the DRG swelling.   The clean ganglia were collected in a 35mm culture dish containing 
1.8ml F-12 nutrient medium as described. 
 
Isolation of neuronal cells from the DRG connective tissue was performed by chemical and 
physical dissociation, beginning with addition of 0.125% (v/v) collagenase type IV 
(Worthington, UK) to the F-12 medium   This was incubated for 60 minutes at 37°C in 5% 
CO2 after which the F12/collagenase mixture was removed with a sterile glass pipette 
(Poulten & Graf, Barking UK), and fresh F12 and collagenase added and incubated for a 
further hour.   After removal of collagenase, fresh F12 with 0.2% (v/v) trypsin 
(Worthington, UK) was added and the suspension returned to the incubator for 30min.         
After this period the medium was then removed and 30% (v/v) foetal bovine serum 
(Invitrogen, UK) in F-12 was used to inactivate the trypsin.   Ganglia were washed in F12 
and then mechanically dissociated by gentle trituration using a sterile glass Pasteur pipette 
until no DRG tissue clumps could be macroscopically identified.   This cell suspension was 
passed through a 70μm filter (BD Falcon, UK) to remove any residual clumps of cells as 
well as myelin and connective tissue fragments.   The suspension was centrifuged (Centaur 
2, MSE) at 200g for 5min and the medium aspirated from the pellet to remove dead cells 
and debris. 
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Tituration, resuspension and centrifugation steps were repeated at least twice to ensure 
adequate DRG dissolution.   Following the final centrifugation, all but the last 500µl of the 
supernatant was removed from the cell bolus and the cells were re-suspended in the 
remaining supernatant fluid.   This concentrated cell suspension was further separated from 
any residual debris by layering.   A track of 2ml of 15%(v/v) bovine serum albumin (BSA, 
Sigma, UK) BSA was prepared running down the side of a 15ml conical polypropylene 
tube (Falcon), the remaining cell suspension was gently pipetted down this BSA track to be 
collected on top of the BSA layer.   These tubes were centrifuged at 600rpm for 10min, 
after which all supernatant fluid and cell debris were gently removed to leave only the 
bolus of dissociated neurons. 
 
The neurons were re-suspended in 1.9ml modified Bottenstein and Sato‟s medium (F12 
medium supplemented with 0.1mg/ml transferrin, 20nM progesterone, 100µM putrescine, 
30nM sodium selenite, 1mg/ml BSA, 0.01mM cytosine arabinoside and 10pM insulin (all 
Sigma-Aldrich) and made up to the required volume to fill two eight well chamber slides 
per animal.   1900μl of neuron suspension from each animal were plated onto two sterile 8-
well chamber slides (Lab-Tek) pre-coated with LaminiN-1 (2µg/ml diluted in tissue culture 
water, Sigma-Aldrich),  which had been applied to the slides and incubated at 37°C, 5% 
CO2 for two hours before seeding the DRG neurons.    Neurons from each experimental 
animal were kept separated at all times. 
 
 5.2.1.2 NAC, ALCAR and NGF Treatment 
After seeding the neurons either further BS medium (for absolute control conditions) or 
NGF, NAC or ALCAR made up in BS medium to the required concentrations were added 
to each well respectively; additive concentration/dilution calculations were planned so that 
  Chapter 5 
Alex. E. Hamilton: MD Thesis, 2011. 157 
 
a further 100μl of treatment containing medium were added to each well, ensuring a final 
medium volume of 2ml for each condition.    
 
NAC and ALCAR were purchased as anhydrous crystals/powder (Sigma-Aldrich) which 
dissolved in BS medium and serially diluted to give appropriate molar concentrations 
whereby addition of 100μl of concentrate would give final culture concentrations of   
1mM, 5mM and 10mM for NAC; and 100μM, 1mM and 10mM for ALCAR.    As storage 
and weighing the NAC/ALCAR crystals cannot logistically be undertaken under sterile 
conditions each solution was passed through a 0.22μm pore syringe driven microbiological 
filter (Millipore) prior to final addition to the culture medium.   NGF control conditions 
were made up to 150ng/ml, reconstituted in F-12 (NGF 2.5, from mouse submaxillary 
glands, Sigma, UK), a concentration previously documented to stimulate neurite formation 
in similar DRG cultures (Mahay et al., 2008).   Neurons from each animal were seeded 
over two eight well chamber slides with a final volume of 2000μl in each well, treatments 
were administered as demonstrated in Figure 5.1, and slides were then incubated 
undisturbed at 37°C with 5% CO2 for 24h.  
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5.2.2 Culture Fixation, Histology and Image Analysis 
5.2.2.1 Immunohistochemical Staining 
After the 24h culture period, the BS medium was carefully removed by gentle pipetting not 
to disturbing adherent neurons; the cells were then fixed by addition of 1ml of 4% 
paraformaldehyde (Sigma-Aldrich, USA) in PBS at 4°C for 15 min.   Each well was then 
washed three times in 1ml PBS for ten minutes, the cells permeabilised using 1ml of PBS 
with 0.2% (v/v) Triton X-100 for 20 min followed by a further three PBS washes.   
Neurons were „blocked‟ by of addition of 2ml of 1% (w/v) normal horse serum (Sigma-
Aldrich, USA) in antibody diluent for 1h in a humid chamber following which the cells 
were incubated overnight in 1ml of 0.1% (w/v) primary monoclonal antibody against ß III 
tubulin (Sigma-Aldrich, USA) in antibody diluent at 4°C. 
Figure 5.1: Schematic representation of the distribution and treatment of 
neurons seeded from each experimental animal.   A final volume of 2000μl of 
BS medium, including additives was contained in each well.   Treatment 
conditions were BS medium only (Cont), 150ng/ml NGF (NGF), 10mM 
ALCAR (A-Hi), 1mM ALCAR (A-Md), 100μM ALCAR (A-Lo), 10mM NAC 
(N-Hi),  5mM NAC (N-Md) and 1mM NAC (N-Lo).   Culture duration was 
24h at 37°C with 5% CO2. 
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The next day, after a PBS wash cells were incubated in flourescein isothiocyanate (FITC; 
λEx. 495nm, λEm. 519nm) conjugated horse-anti-mouse secondary antibody (Vector 
Laboratories, Peterborough, UK) at 1% (w/v) in antibody diluent for 2 hours at room 
temperature.   After a final PBS wash, the plastic chamber construct was carefully removed 
from the underlying glass slide and coverslips mounted with Vectashield
®
 mounting 
medium for fluorescence with 1.5 μm/ml 4',6-diamidino-2-phenylindole (DAPI, λEx. 
345nm, λEm. 455nm, Vector Laboratories) 
 
5.2.2.2 Image Analysis and Statistical Analysis 
 
Slides were visualised under an Olympus BX60 fluorescent microscope using an 
appropriate FITC filter (Olympus, Japan), allowing visualisation of the green FITC 
staining of the neuronal cytoplasm in both the perikaryon and the neurites (Figure 5.2). 
Figure 5.2: x10 view of cultured neurons with FITC (green) staining. 
The cell bodies and the extensive mesh of neurites can be seen. 
Scale bar = 50μm. 
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Images were captured at x10 magnification using an Evolution QEi monochrome digital 
camera (Media Cybernetics, Bethesda, USA) using the same exposure time for all 
captures, and processed for export using Image-Pro Plus software (Media Cybernetics).   
The DRG culture experiment images were captured and analysed according to the 
principles of stereology (cf. 2.2.4).   In contrast to previous studies which have analysed a 
„random sample of representative‟ neurons (Caddick et al., 2006; Gardiner et al., 2005; 
Mahay et al., 2008) care was taken to generate as close to a non-biased „systematic random 
sample‟ as possible (West et al 1991).   For each well of the plates, a corner was chosen at 
random, and working from that point a systematic series of fifteen images were taken from 
each well, giving a total of thirty samples per condition per animal.    
 
Image analysis was performed using the Java based free-ware image processing software 
suite Image J (Abramoff et al., 2004; Rasband, 2007-2009) and consisted of counting the 
number of adherent cells in each field, and the number of such cells bearing neurites at 
least one cell soma long.   In line with non-biased quantification methodology, two edges 
of each field were designated as exclusion surfaces and neuron cell bodies crossing these 
were excluded from both counts.   The mean number of adherent neurons and proportion of 
neurite bearing cells were pooled from both wells with the same conditions for each 
animal, and the results from each animal recorded to derive an n=3 mean and standard 
deviation statistics for each control and treatment condition.   Comparison between 
different treatments was carried out by one-way ANOVA with Bonferonni post-hoc 
testing; all statistical comparisons were carried out using GraphPad Prism® (v 4.03) 
software.          
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5.3 RESULTS 
After 24h of culture there was evidence of neuronal adherence to the laminin substrate in 
all treatment groups as well as in both the absolute and NGF control conditions.   Further, 
there was a degree of neurite formation by some cells in all groups.   The extent of 
adherence and neurite formation are summarised in Table 5.2 and represented graphically 
in Figures 5.3 and 5.4 with representative images of the neurons in Figure 5.5.  
 
There were no significant differences in the mean number of adherent neurons between the 
control BS medium only group and any treatment group, including the NGF supplemented 
neurons, or between any two treatment groups (p >0.05 for all possible pair-wise ANOVA 
analyses).   Similarly, there was no significant difference in mean percentage of neurite 
bearing cells between the BS control group and the NAC or ALCAR treatment groups at 
any dose or between groups.   However, neurons treated with NGF displayed a much 
higher degree of neurite formation with 5-12 times greater number of neurite bearing cells 
than the BS control or treatment groups (p < 0.001 in ANOVA in all possible pair-wise 
comparisons).  
Table 5.2: Neuron Adherence and Percentage Neurite Formation 
Condition 
Neuron Adherence Neurite Formation 
Mean Number 
Adherent 
(Cells) 
Significance Vs. 
Control in ANOVA 
Neurite Bearing 
Cells (%) 
Significance Vs. 
Control in ANOVA 
Control 17.42 (1.49) N/A 2.90 (1.27) N/A 
NGF 16.5 (6.21) No (p> 0.05) 35.2 (3.46) Yes (p< 0.001) 
ALCAR High 10.68 (6.50) No (p> 0.05) 1.30 (1.41) No (p> 0.05) 
ALCAR Med. 19.55 (7.52) No (p> 0.05) 4.86 (6.39) No (p> 0.05) 
ALCAR Low 17.07 (5.05) No (p> 0.05) 2.48 (1.38) No (p> 0.05) 
NAC High 10.57 (7.41) No (p> 0.05) 4.63 (3.21) No (p> 0.05) 
NAC Med. 17.35 (8.51) No (p> 0.05) 1.73 (1.15) No (p> 0.05) 
NAC Low 15.58 (9.25) No (p> 0.05) 2.93 (2.34) No (p> 0.05) 
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Figure 5.3: Effect of ALCAR or NAC treatment on number of neuronal cells
adherent per x10 microscope field after 24h culture in BS medium only
(Control), 150ng/ml NGF (NGF), 10mM ALCAR (A-Hi), 1mM ALCAR
(A-Md), 100microM ALCAR (A-Lo), 10mM NAC (N-Hi),  5mM NAC (N-Md)
and 1mM NAC (N-Lo).   Plotted as mean per animal with SD, there are no
significant differences between groups.
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Figure 5.4: Effect of ALCAR or NAC treatment on percentage neurite bearing DRG
neurons per x10 microscope field after 24h culture in BS medium only (Control),
150ng/ml NGF (NGF), 10mM ALCAR (A-Hi), 1mM ALCAR (A-Md), 100uM ALCAR
(A-Lo), 10mM NAC (N-Hi),  5mM NAC (N-Md) and 1mM NAC (N-Lo).   Plotted as
mean per animal with SD, there are no significant differences between ALCAR or NAC
groups and BS medium control; NGF treatment promotes significantly greater neurite
formation (** = p < 0.001 Vs. all other groups in ANOVA)
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 Figure 5.5: Caption over. 
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5.4 DISCUSSION 
5.4.1 Methodology and Dosing Regime 
The DRG dissociation and culture technique used in this experiment has been used 
successfully previously by our and other research groups (Lindsay et al., 1988; Smith & 
Skene, 1997; Cafferty et al., 2001; Gardiner et al., 2005; Caddick et al., 2006; Mahay et 
al., 2008; Duran-Jimenez et al., 2009).   Laminin coating of glass slides as a growth 
interface and cellular adherence molecule has been shown not to influence either neuronal 
survival or secretion of trophic factors in culture (Lindsay et al., 1988; Mahay et al., 2008).   
Early DRG culture experiments suggested that untreated neuron will not extend neurites 
during the first 24h in culture, and that neuritogenesis is influenced by neurotrophic factors 
(Smith & Skene, 1997; Cafferty et al., 2001).       However, this study reproduces the 
results of others that a proportion of DRG neurons, in this case around 3%, can form 
neurites within this time frame in the absence of exogenous NGF; it has been hypothesized 
that this phenomenon can be attributable to soluble neurotrophic factors secreted from the 
neurons themselves in an autocrine fashion (Caddick et al., 2006).   In contrast, this and the 
above reports demonstrate that NGF treatment will stimulate extensive neuritogenesis 
within the first 24h in culture.   This relatively early time point was chosen to maximize the 
likelihood of detecting a neurotrophic effect of ALCAR or NAC treatment. 
 
 Rather than quantifying a random selection of neurons, as is frequently cited, efforts have 
been made in this experiment to apply the principles of stereology to image capture and 
Figure 5.5 (Previous page): Representative images of x10 magnification fields of DRG 
neurons cultured for 24h with BS medium only (Cont), 150ng/ml NGF (NGF), 10mM 
ALCAR (A-Hi), 1mM ALCAR (A-Md), 100μM ALCAR (A-Lo), 10mM NAC (N-Hi), 
5mM NAC (N-Md) and 1mM NAC (N-Lo).   Adherent cells are present under all 
conditions but the proportion of neurite bearing cells is clearly larger in the NGF treated 
population.   Scale bar = 50μm.   
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neuron analysis, producing a systematic random sample.   The exact number of neurons 
extracted and cultured from each animal will be different, both due to biological diversity 
and cell loss during the culture preparation.   To account for the effect of such variability 
three separate animals were used, and each treatment condition cultured in two separate 
wells, therefore increasing the degree of sampling for each experimental condition.   
Further, consistent sampling rules were followed in cell counting aiming to ensure that 
each cultured neuron has the same chance of being counted (cf. 2.2.4.1 & 2.4.1.3).   
Although further repeats of the experiment to increase sample numbers would further 
reduce the coefficient of variation, it is unlikely that there would be a change in the overall 
results.  
           
Choice of ALCAR and NAC dosage regime was difficult due to the huge variation of 
concentrations used in previous published in vitro studies; further, the finding that many 
neurite inducing agents follow a „bell shaped‟ dose effect curve necessitated selecting a 
range of concentration for each agent (Calabresi, 2008).   The doses selected are 
representative of those previously published up to the limit of 10mM, above which both 
ALCAR and NAC became cytotoxic in pilot studies, although higher doses that this have 
been cited in the literature.   The finding of no significant differences in neuron adhesion 
between the control, ALCAR/NAC or NGF cultures wound suggest that the range selected 
does not have any detrimental effects on neuronal survival and could safely be used in 
future experimental protocols.   A formal neuronal survival experiment, either with 
multiple quantification of the same active culture over time or multiple cultures fixed at 
different time points and quantified for neuron count and apoptosis detection could be used 
to further assess the putative in vitro neuroprotective effects, as suggested for ALCAR by 
Manfridi et al (1992).         
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The only assessment of neurite formation presented in this study is the proportion of 
neurite bearing cells.   More sophisticated assessments, such as number of neurites per cell, 
length of longest neurite and neurite density are often used in neuronal culture 
experiments; however these were not carried out in this study because there were so few 
cells bearing neurites in the ALCAR/NAC groups and BS medium only control.  
 
5.4.1 Effect of ALCAR and NAC  
Both ALCAR and NAC have been demonstrated to prevent neuronal apoptosis after 
peripheral nerve injury (McKay Hart et al., 2002b; Wilson et al., 2003; Hart et al., 2004a) 
and protect PC12 and embryonic CNS neurons from cell death induced by a wide range of 
chemical, oxidative and ischæmic insults in vitro (Ferrari et al., 1995; Mayer et al., 1994; 
Aykin Burns et al., 2005; O‟Loghlen et al., 2006; Satpute et al., 2008; Angelucci et al., 
1988; Ishi et al., 2000; Forloni et al., 1994).   Further, ALCAR treatment in murine models 
of sciatic nerve injury increases the rate of peripheral nerve regeneration and target organ 
re-innervation (Hart et al., 2002c; Wilson et al., 2009). 
 
Exact mechanisms by which these varying effects are expressed are incompletely 
understood and still under investigation, but they seem to fall into two overlapping 
„spheres of activity‟.   Firstly the agents are antioxidant directly, and by products of their 
metabolism, such as up-regulation of glutathione by NAC (Hart et al., 2004), may account 
for neuroprotective effects in culture with reactive oxygen species such as hydrogen 
peroxide and toxins which affect oxidative metabolism (O‟Loghlen et al., 2006; Aykin 
Burns et al., 2005; Satpute et al., 2008).   Many of the elements of the effector limb of the 
apoptosis cascade involve generation of reactive oxygen species (cf. 1.2.4) and 
supplementing the intracellular antioxidant pool may partly explain the DRG neuronal 
survival effect of these agents in vivo.   The second type of effects seem involve 
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interaction with the neurotrophin signalling pathways and involve modification of mRNA 
and protein expression, such as up-regulation of Ras (Yan et al., 1995; Yan et al., 1998), 
and Bcl-2 mRNA (Hsiao et al., 2008).   Such complex interactions contribute to post 
axotomy neuroprotection (Reid et al., 2009), and seem likely to be responsible for the 
regeneration enhancing effects. 
 
Given these neurotrophin like effects, this study was designed to asses if ALCAR or NAC 
could be a substitute for NGF which, along with BDNF, has been proposed as a main 
neurotrophin responsible for neurite outgrowth in DRG/Schwann cell co-culture 
experiments (Golz et al 2006; Mahay et al 2008).   The findings of the initial experiment 
presented here show that such simple substitution does not stimulate axonal regeneration 
directly.   There are many possible explanations for this negative finding in vitro when 
compared to the complexity of the neurobiological events of inflammation, Wallerian 
degeneration and guided regeneration that occurs in a live animal.   Previous culture based 
experiments have suggested that ALCAR causes increased expression of neurotrophin 
receptors on PC12 cells, and to up-regulate cellular response to NGF i.e. cells would 
produce neurites when exposed to low dose NGF which did not affect control cells.   
ALCAR and or NAC may therefore amplify the effect of the reduced amount of 
neurotrophins received by axotomised neurons post injury.   It would be useful in 
subsequent experiments to examine the effect of ALCAR/NAC when DRG neurons are 
exposed to a range of NGF doses.   Further, there is little published data concerning the 
effects of ALCAR/NAC on Schwann cells and experiments using co-culture and SC pre-
conditioned medium would be proposed. 
In summary, this study is only the first of many possible experimental protocols.   
Nevertheless, an ALCAR/NAC dosage regime has been established which spans the range 
of previously published in vitro work and which does not appear detrimental to DRG 
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neurons in culture.   Neither ALCAR nor NAC substitute for NGF intrinsically in this 
primary sensory neuron culture model, but many possibilities exist to further work.             
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CHAPTER 6 
Overview & Proposals for Future Work 
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6.1 OVERVIEW 
The existence of peripheral nerves was known to Hippocrates and Herophilus in the 4
th
 and 
3
rd
 Centauries BBC respectively (Adams, 1849; Sunderland, 1991; Belen et al., 2009).   
Recognition of the significance of nerve injury and discussion of nerve repair techniques 
have been credited to the Persian physicians Rahzes and Avicenna and to Galen in the 1
st
 
and 2
nd
 Century‟s CE (Terzis et al., 1997; Battiston et al., 2009), nerve suturing was 
described by Paul von Aegina in the 7th Century (Streppel et al., 2000) and refined by 
Gabriele Ferrara (1543-1627) working from Milan (Artico et al., 1996).   More recently, 
peripheral nerve surgery has been revolutionised by development of the operating 
microscope (Smith 1966; Terzis et al., 1997).   During the 2
nd
 World War, Sir Herbert 
Seddon reported cases of primary and secondary nerve repair as well as describing nerve 
grafting, and subsequently Sir Sidney Sunderland examined the internal fascicular 
architecture of peripheral nerves, classifying nerve injury in order to rationalise surgical 
intervention strategies (Sunderland, 1984). 
 
Despite these clinical advances, which have also been accompanied by exponential 
increase in the scientific understanding of the cellular and molecular basis of nerve 
response to injury and regeneration (cf. 1.2.2.2 - 1.2.2.4), sensory recovery after peripheral 
nerve injury is still far from satisfactory (Lundborg, 2000; Kline et al., 2000); in fact “no 
adult with a major nerve transection has ever attained normal sensibility” (de Mendinaceli 
& Seaber, 1989)    The ætiology of such disappointing outcomes is multifactorial, 
reflecting the neurobiological hurdles of nerve regeneration (Gordon et al., 2003), 
peripheral target organ atrophy (Liss et al., 1994; Zelena, 1982) and CNS somatotopic re-
modelling (Lundborg, 2003).   Of primary importance is the apoptotic death of primary 
sensory neurons in the dorsal root ganglia (DRG), which occurs over a two month period 
post nerve transection (McKay Hart et al., 2002a), and accounts for loss of up to 50% of 
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neurons (Arvidsson et al., 1986; Cheema et al., 1994a & b; Degn et al., 1999; Ekstrom, 
1995; Groves et al., 1997; Himes & Tessler, 1989; Liss et al., 1994; Liss et al., 1996; 
Ljungberg et al., 1999; McKay Hart et al., 2002a; Ranson, 1909; Rich et al., 1987; Rich et 
al., 1989; Tandrup et al., 2000; Ygge 1989).   As only surviving cells can regenerate, these 
neurons are lost from the regenerative pool (Fu & Gordon, 1997) and such cellular attrition 
will contribute to the reduced „innervation density‟ of the skin after nerve trauma (Weiberg 
et al. 2003).    
 
Two neuroprotective agents ALCAR and NAC have been identified which prevent post-
axotomy neuronal apoptosis in murine models (McKay Hart et al. 2002b; Hart et al. 
2004a.)   These agents have a range of metabolic, antioxidant, signalling and translational 
activities, and the mechanism by which they exert their neuroprotective role remains under 
investigation (cf. 1.2.4).   Translation of the potential clinical benefit of adjuvant 
ALCAR/NAC therapy into the clinic remains an obvious objective, and the studies 
reported here were designed to facilitate this process.   The overarching aims of this thesis 
were to further study the activity and utility of these agents, and to investigate objective, 
non-invasive imaging techniques, MRI and HFUS which could be used to act as an index 
of neuronal population change or nerve regeneration, and would be applicable to human 
patients. 
 
Key questions in establishing a clinical trial of the neuroprotective agents relate to the 
logistical considerations of therapy.   Optimal doses for both agents have been identified 
(Wilson et al., 2003; West et al., 2007a), it has been shown that a short delay in 
commencing ALCAR or NAC therapy does not confer a detrimental effect on neuron 
survival (Zhang et al., 2005; Wilson et al., 2007).   The NAC treatment duration study 
described in Chapter 2 addressed the issue of how long therapy should continue post 
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injury, and the results allow two main conclusions to be drawn.   Firstly, all groups treated 
for less that the full duration of the experiment did show a degree of neuronal loss.   
However, the amount of apoptosis which occurred after cessation of treatment was notably 
less that occurring over the same time period in untreated animals as described in previous 
experiments.   At one month after sciatic axotomy with no treatment there is loss of ≈22% 
of DRG neurons (McKay Hart et al., 2002a), but after one month of NAC administration 
followed by a month of no treatment, there was only ≈5% neuronal death.   The 
implication is that apoptosis does not resume at the normal rate after cessation of NAC 
therapy, and that approximately 17% of neurons which would have undergone apoptosis 
were saved by NAC treatment. 
 
The second conclusion from the NAC treatment duration study is that one month treatment 
seems to preserve all but ≈5% of sensory neurons, and would appear to be a reasonable, 
clinically applicable duration of therapy. 
 
Chapter three describes volumetric MRI of the L4 DRG of the animals in the NAC 
treatment duration study.   Problems with existing clinical and neurophysiological tests of 
nerve regeneration (cf. 1.3.1) would potentially hamper monitoring and assessment of a 
clinical trial of ALCAR/NAC treatment; MRI measurement of changes in the DRG volume 
has been proposed as a non-invasive, objective test which may translate to a clinical 
outcome measure of neuronal population change (West et al., 2007b).   Previous work had 
suggested that DRG volume reduces in proportion with neuron loss (McKay Hart et al., 
2002a; Wilson et al., 2003); and that in a pilot study, MRI assessment of L4 volume 
correlated with both histological DRG volume assessment and neuron loss (West et al., 
2007b).   The results of this study verify that volumetric MRI has the ability to detect 
significant reduction in DRG volume under experimental conditions, and that these 
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correlate to neuronal loss.   MRI measurement of DRG volume loss was shown however to 
have sensitivity restrictions, not being as precise as stereological neuronal counting and 
failing to detect small changes in volume.   If cognisance of these limitations is applied to 
future experiments, volumetric MRI is proposed as a highly useful and time efficient 
assessment modality, potentially able to replace histological analysis in the murine model.   
The human DRG is much larger than that in the rat, and MRI measurement of human 
ganglion volume may present less methodological difficulties.   Pilot studies (as yet 
unpublished) have demonstrated the possibility of imaging volunteer human brachial 
plexus DRG in cross section to facilitate volume measurement. 
 
Other proposed applications of MRI were explored in Chapter three.   Firstly, scanning of a 
live animal was performed, verifying that maintaining safe anæsthesia within the scanner 
was possible and identifying the particular challenges of in vivo imaging, such as 
movement of respiratory excursion and the and cardiac cycle.   Various strategies to 
address these issues are discussed, such as use of respiratory gating or navigator echoes, 
which are predicted to enhance the resolving power of live scanning allowing multiple 
sequential imaging of animals, tracking DRG volume change over time. 
 
Significant time was spent attempting to reproduce the findings of other groups studying 
human or rat nerve injury which suggest that detectable MRI signal changes occur in 
degenerating nerve, and that these changes resolve during axonal regrowth (Britz et al., 
1995; Britz et al., 1996; Aagaard et al., 2003; Bendszus et al., 2004; Bher et al., 2009).   
Disappointingly, despite systematic application of a wide variety of hardware and MRI 
sequence combinations, including intraneural injection of contrast media (cf. 4.2.2.2), the 
rat sciatic nerve could not be reliably identified on high resolution T1 or diffusion weighted 
scans, nor could signal change corresponding to site of axotomy be detected on T2 
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weighted images.   The explanation for being unable to replicate the results of other groups 
is uncertain, but probably reflects differences in the hardware and sequence libraries 
available between researchers. 
 
In contrast, a pilot study investigating the application of HFUS to peripheral nerve injury 
was highly successful.   The rat sciatic nerve could easily be identified throughout its full 
extra-pelvic course, and even its three terminal branches were followed for some way 
distally.   Ultrasound imaging at two time points after nerve transection demonstrated that 
HFUS was able to detect a physical breach in nerve continuity; neurotmetic grade injury in 
Sunderland‟s classification (Sunderland, 1951).   After a period of healing, HFUS could 
still identify anatomical derangement in what has reviled to be a continuous nerve structure 
on direct observation, such epineural continuity is a feature of axonotmetic grade injury.   
As imaging of the human digital nerves was also demonstrated to be relatively easy, HFUS 
is proposed as being of potential diagnostic benefit in patients with finger lacerations 
threatening the digital neurovascular bundle, although clearly further verification studies 
are required. 
 
Chapter 5 discusses establishment of an experimental protocol to investigate the effects of 
ALCAR and NAC administration in a cell culture system of primary sensory neurons.   
Acknowledging that the cellular dose response to many neuritogenic substances is non-
linear (Calabresi, 2008), the first phase of this work was to select doses of the 
neuroprotective agents as used in previous in vitro experiments to take forward into future 
work.   Representative high, medium and low doses for each agent were identified which 
did not have any detrimental effect on neuronal survival and laminin adherence compared 
to control conditions.   NGF is the prototype neurotrophic factor (Green & Kaplan, 1995; 
Kaplan & Miller, 1994, 1997; Kaplan & Stephens, 1994; Miller & Kaplan, 2000, 2001a, 
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2001b, 2003, 2007; Gould & Gordon Weeks, 2005); the hypothesis that ALCAR or NAC 
exert their neuroprotective and pro-regenerative effects by substituting for NGF was tested.   
In isolation none of the tested neuroprotectant doses enhanced cell survival or neurite 
outgrowth after 24h in culture.   So far, only these early and relatively simple 
investigations have been performed, and the scope for culture based systems to investigate 
the neuroprotective effects of ALCAR and NAC documented in vivo remains to be further 
explored. 
 
6.2 PROPOSED FURTHER WORK 
Future research efforts concerning the neuroprotective potential of ALCAR and NAC are 
likely to proceed along two parallel tracts.   Firstly are those experiments designed to 
investigate the mechanisms by which the agents exert their effects, this would be 
anticipated to involve further in vitro work, such as examining whether NAC and ALCAR 
modify neuronal behavior in the presence of NGF or in co-culture with Schwann cells. 
 
Recent work investigating neuronal apoptotic gene expression post axotomy using laser 
microdissection and quantitative real-time polymerase chain reaction has identified that 
NAC administration alters transcription of Bax, Bcl-2 and caspase-3 genes to promote 
mitochondrial stabilisation and hence survival rather than apoptosis in some DRG neuronal 
subpopulations (Reid et al., 2009).   This technique clearly offers much scope for 
investigation of signalling cascade modifications that follow axotomy and ALCAR/NAC 
neuroprotection. 
 
The second group of experiments are those designed to facilitate clinical translation of 
ALCAR/NAC neuroprotection and investigate the logistics of such therapy, such as the 
NAC treatment duration study presented above.   No murine study has yet investigated the 
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effectiveness of oral administration of either agent, which is anticipated to need large doses 
to overcome first pass hepatic metabolism (Olsson et al., 1988).   While there are two 
published experiments demonstrating that ALCAR increases peripheral nerve regeneration 
rate (McKay Hart et al., 2002c; Wilson et al., 2010) this has not to date been carried out 
for NAC treatment.   Most patients with nerve injury do undergo nerve repair or grafting, 
such reconnection with neurotrophic factors in the distal stump confers an incomplete 
neuroprotective benefit (McKay Hart et al., 2002a), an experiment designed to investigate 
duration of therapy needed to provide complete neuroprotection after sciatic nerve 
transection and repair may provide further information guiding clinical therapy. 
 
Volumetric MRI scanning of the rat DRG has been shown to act as a proxy measure of 
neuronal population under experimental conditions, and the possibility of in vivo imaging 
has been established.   Further refinements to the technique, such as use of respiratory or 
ECG gaiting may increase the resolution of live scanning sufficiently to allow repeated 
analyses of animals over time.   Pilot MRI studies of human standardised DRG imaging 
facilitating volume measurement, controlled with cadaveric DRG stereological neuron 
counting are underway.    
 
The potential to visualise the rat sciatic nerve response to transection, regeneration and 
neuroprotectant treatment with MRI remains unfulfilled.   One potential avenue for 
exploration would be to more closely emulate the experimental protocols of other groups, 
which used human clinical scanners, with propriety surface coils and access to a large 
range of commercial pulse sequences (Aagaard et al., 2003; Bendszus et al., 2004).   The 
HFUS pilot reported here was necessarily limited by only having a brief period of access to 
the unit.   The next step in evaluation would by a blinded trial; with a group of animals 
undergoing sham, crush or transection operations with the researcher scanning the animals 
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(potentially in vivo) unaware of the operation each had received, to test the diagnostic 
sensitivity of the system. 
 
In summary, the research described above brings a clinical trial of NAC/ALCAR sensory 
neuroprotection a step closer, suggesting that one month therapy post injury is likely to 
provide substantial clinical benefit and, for the first time demonstrates that NAC has the 
potential to save neurons after axotomy, rather than simply delay onset of apoptosis.   MRI 
volumetry of the rat DRG has been verified to act as a sensitive proxy measure of neuron 
loss, and the potential for in vivo scanning explored.   This technique will be applicable to 
future murine studies, as well as justifying establishment of a human volumetric MRI DRG 
imaging protocol.   HFUS has been demonstrated to hold significant potential for further 
peripheral nerve imaging in animals and potential translation to investigating injury to 
small calibre superficial human nerves.    
 
Establishment of an experimental protocol to further investigate the neurobiological effects 
of ALCAR and NAC in vitro will hopefully further elucidate the mechanisms by which 
these agents eliminate sensory neuronal apoptosis after peripheral nerve injury. 
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APPENDIX 1: Miscellaneous Laboratory Materials & 
Equipment 
 
1.1. REAGENTS ETC. 
 
MATERIAL MANUFACTURER 
PRODUCT 
CODE 
Cryostat 
Leica Microsystems, Nussloch, D-
69226, Germany 
CM30505 
DAKO Pen for 
Immunohistochemistry 
DAKO, Glostrup, Denmark, DK-2600 S2002 
DPX Mounting Medium 
BDH Laboratory Supplies, Poole, 
BH15 1TD, England 
- 
Glass Coverslips (22x55mm) 
Scientific Laboratory Supplies Ltd. 
www.scientific-labs.com 
- 
Paraformaldehyde 
Sigma®, Sigma-Aldrich Co Ltd, 
www.sigma-aldrich.com 
P6148 
Potassium Phosphate 
Sigma®, Sigma-Aldrich Co Ltd, 
www.sigma-aldrich.com 
P-5379 
Sodium Azide 
Sigma®, Sigma-Aldrich Co Ltd, 
www.sigma-aldrich.com 
S-2002 
 
Sodium Chloride 
AnalaR®, BDH Laboratory Supplies, 
Poole, BH15 1TD, England 
10241AP 
Sodium Phosphate 
Sigma®, Sigma-Aldrich Co Ltd, 
www.sigma-aldrich.com 
S-7907 
Sucrose 
AnalaR®, BDH Laboratory Supplies, 
Poole, BH15 1TD, England 
 
102747E 
Tissue-Tek® OCT Compound Sakura Finetek 4583 
Triton X-100 
(t-ctylphenoxypolyethoxyethanol) 
BDH Laboratory Supplies, Poole, 
BH15 1TD, England 
306324N 
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Vectabond
 TM 
Reagent 
Vector Laboratories, Inc. 30 Ingold 
Rd, California, USA. 
www.vectorlabs.com 
SP-1800 
Vectashield®
 
Mounting Medium 
with DAPI 
Vector Laboratories, Inc. 30 Ingold 
Rd, California, USA. 
www.vectorlabs.com 
H-1000 
Manganese Chloride (anhydrous)  
Sigma®, Sigma-Aldrich Co Ltd, 
www.sigma-aldrich.com 
244589 
 
 
1.2. PREPARATION OF SOLUTIONS 
 
1.2.1. Phosphate Buffered Saline 
For 10L: add 87.9g Sodium Chloride, 2.72g Potassium Phosphate and 113.5g of Sodium 
Phosphate to 7L distilled water.   Magnetic stir for 3h, make up to 10L and adjust pH. 
 
1.2.2. Paraformaldehyde (4%)    
For 1L: (in fume hood) add 40g anhydrous Paraformaldehyde to 800ml PBS, heat until 
solution clears (max 60°C).   Make solution up to 1L, store at 4°C, use within 24h. 
 
1.2.3. PBS-Sucrose Solution (15%) 
Add 150g sucrose and 1g sodium azide in 1L PBS, store at 4°C. 
 
1.2.4. Antibody Diluent Solution (0.03% Triton X-100, 0.1% BSA, 0.1% Sodium 
Azide) 
For 1L: dissolve 0.3ml Triton X-100, 1g Bovine Serum Albumin and 1g sodium azide in 
1L PBS, store at 4°C. 
 
1.2.5. Triton X-100 Permeabilisation Solution 
For 1L: dissolve 20ml Triton X-100 in 9980ml PBS 
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APPENDIX 2: Surgical Materials 
 
MATERIAL MANUFACTURER 
PRODUCT 
CODE 
#15 & #23 Surgical Blade 
Swan-Morton, Sheffield, 
England 
0205 & 0210 
Biogel sterile gloves 
Williams Medical Supplies 
Ltd, UK 
406A8 
Buprenorphine Hydrochloride Alstoe Animal Health, UK 00063/4000 
Isoflourane BP 100% v/v 
Rhodia Organique Fine Ltd, 
Avonmouth, Bristol, BS11 
9YF 
ISO-9001 
Johnson‟s Cotton Buds x100 
Johnson & Johnson Medical, 
UK 
J3762856 
Silicone Tubing (High grade, 1mm 
internal diameter) 
Philip Harris International, 
Linchfield, Staffordshire, UK 
T88-5420 
10 μL Hamilton Syringe 
Hamilton, Bonaduz, 
Switzerland 
80357 
3/0 Polypropyline suture (Prolene
TM
) 
Ethicon
TM
, Johnson & Johnson 
Intl. www.ethicon.com 
W8770 
4/0 Vicryl TM 
Ethicon
TM
, Johnson & Johnson 
Intl.  
W9825 
6/0 Polypropyline suture (Prolene
TM
) 
Ethicon
TM
, Johnson & Johnson 
Intl.  
W8718 
9/0 & 6/0 Ethilon 
Ethicon
TM
, Johnson & Johnson 
Intl 
W2898 
Chlorhexidine Gluconate 0.5% w/v 
Preston Pharmaceuticals, UK 
 
ML13460/01 
Surgical Loupe Telescopes (x3.8) 
Surgical Acuity, 3225 Deming 
Way Suite 190, Middleton, WI 
53562 
Custom 
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APPENDIX 3: N-acetylcysteine Treatment 
 
 
MATERIAL MANUFACTURER 
PRODUCT 
CODE 
0.9% w/v Sodium Chloride 
Intravenous Injection BP 
 
Baxter Healthcare Ltd, UK 
 
FKB1313G 
1 ml syringe with needle (28 guage) 
Kendall Monoject ™, Tyco 
 
Healthcare UK Ltd, Gosport, 
PO1 
3AS, UK. 
 
1100-601630 
N-acetylcysteine 200mg/ml 
(Parvolex ®) 
Parvolex, UCB Pharma Ltd, 
Slough, Berkshire, SL1 3WE. 
UK 
PL 00039/0410 
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APPENDIX 4: Hoechst H33342 & Propidium Iodide 
Fluorescent Staining 
 
 
4.1. MATERIALS AND REAGENTS 
 
MATERIAL 
WORKING 
DILUTION 
MANUFACTURER 
PRODUCT 
CODE 
Bisbenzimide 
Hoechst 33342 
 
1μg/ml 
Fluka, Sigma®, Sigma-Aldrich Co 
Ltd, 
www.sigma-aldrich.com 
14533 
Propidium Iodide 1μg/ml 
Fluka, Sigma®, Sigma-Aldrich Co 
Ltd, 
www.sigma-aldrich.com 
81845 
 
  
4.2. STAINING PROTOCOL 
 
1. Section: Cut entire ganglion into serial 50µm sections onto Vectabond® coated 
slides. 
2. DAKO pen around edges. 
3. Permeabilise: 0.1% Triton X in PBS 15 minutes 
4. Wash: PBS 5min × 2 
5. Stain: Apply 1µg/ml Propidium iodide with 1µg/ml Hoechst 33342 in PBS (300µl) 
onto slide and incubate 10 min room temp. 
6. Wash: PBS 5min × 2 
7. Mount: Vectashield for fluorescence with glass cover slip  
8. Seal: with DPX 
9. Store: Light exclusion slide box at 4°C. 
 
 
  Appendices 
Alex. E. Hamilton: MD Thesis, 2011. 184 
 
APPENDIX 5: Fluorescence Microscopy and Optical Dissection 
 
 
 
  
 
 
MATERIAL MANUFACTURER 
PRODUCT 
CODE 
Optical Microscope Olympus Optical Co. Ltd, Japan BX60 
Optical Microscope Olympus Co. Ltd, Japan BX61 
Digital Camera (Cooled, 
Monochrome 12-bit) 
Media Cybernetics, Inc. 8484 
Georgia Ave, Silverspring, MD, 
USA. 
Evolution QEi 
32-0074A-101 
Digital Camera (Colour) Olympus Optical Co. Ltd, Japan 
U-SPT 
Optitronics 
Fluorescent Lamp Burner Unit Olympus Optical Co. Ltd, Japan U-RFL-T 
Motorised XY Microscope Stage 
(BioPrecision 3x2 Upright Stage) 
Ludl Electronic Products Ltd 
(LEP) 
99S000 
Stage Controller 
Ludl Electronic Products Ltd 
(LEP) 
MAC 5000 
Z-Focus Microcator Control Box Olympus Optical Co. Ltd, Japan BX-UCB 
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APPENDIX 6: MRI Scanning Hardware 
 
 
MATERIAL MANUFACTURER 
PRODUCT 
CODE 
7T actively shielded 15cm 
horizontal bore MRI scanner  
Magnex UK Ltd, Abingdon - 
SMIS console software  
Magnetic Resonance Research 
Systems, Guildford UK 
- 
2cm Surface Coil 
Department of Imaging Science, 
University of Manchester, UK. 
Custom 
8cm Volume Coil 
Department of Imaging Science, 
University of Manchester, UK. 
Custom 
Magnet Probes 
Department of Imaging Science, 
University of Manchester, UK. 
Custom 
Tektronix 475 Oscilloscope 
Tektronix, Inc.  
14150 SW Karl Braun Drive, 
Beaverton, United States 
- 
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APPENDIX 7: MRI SEQUENCE PARAMETERS 
 
7.1 DRG Volumetry Protocol 
 
7.1.1. Scout Images 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.1.2. Sagittal Gradient Echo Sequence 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.1.3. Low Resolution Coronal Gradient Echo Sequence 
 
TR 102ms 
TE 6ms 
Number of Averages 4 
Number of Samples 128 
Number of Views 64 
Flip Angle 30° 
Field of View 30x30mm 
Matrix 128x64 
Block Size 64 
Number of Slices 6 
Slice Thickness/Separation 0.5/0.5mm 
Scan Time 3min 
 
TR (Time to repeat) 50ms 
TE (Time to echo) 5ms 
Number of Averages 4 
Number of Samples 128 
Number of Views 65 
Flip Angle 30° 
Field of View 100x100mm 
Matrix 128x64 
Block Size 64 
Number of Slices 3 
Slice Thickness/Separation 1mm/1mm 
Scan Time 3 min 
TR 140ms 
TE 5ms 
Number of Averages 4 
Number of Samples 128 
Number of Views 64 
Flip Angle 30° 
Field of View 30x30mm 
Matrix 128x64 
Block Size 64 
Number of Slices 8 
Slice Thickness/Separation 1/1 
Scan Time 3 min 
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7.1.4. High Resolution Coronal Gradient Echo Sequence 
 
TR 102ms 
TE 6ms 
Number of Averages 64 
Number of Samples 256 
Number of Views 128 
Flip Angle 30° 
Field of View 30x30mm 
Matrix 256x128 
Block Size 64 
Number of Slices 6 
Slice Thickness/Separation 0.5/0.5mm 
Scan Time 14.88min 
 
 
7.1.5. 3D Gradient Echo Sequence (Axial) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TR 17ms 
TE 6ms 
Number of Averages 32 
Number of Samples 256 
Number of Views 232 
Flip Angle Optimised (15-30°) 
Field of View 30(w)x8(h)mm 
Matrix 256x128 
Block Size 64 
Number of Slices 32 
Slice Thickness/Separation 0.25mm 
Scan Time 45min 
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7.2. Sciatic Nerve Imaging 
 
7.2.1. Low Resolution Axial Gradient Echo Sequence (T1 weighted) 
 
TR 500ms 
TE 6ms 
Number of Averages 4 
Number of Samples 128 
Number of Views 64 
Flip Angle 90° 
Field of View 50x50mm 
Matrix 128x64 
Block Size 64 
Number of Slices 30-50 
Slice Thickness/Separation 0.5/0.5mm 
 
 
7.2.2. Medium Resolution Axial Gradient Echo Sequence (T1 weighted) 
 
TR 800ms 
TE 6ms 
Number of Averages 4 
Number of Samples 128 
Number of Views 64 
Flip Angle 60° 
Field of View 30x30mm 
Matrix 128x64 
Block Size 64 
Number of Slices 44 
Slice Thickness/Separation 0.5/0.5mm 
 
 
7.2.3. High Resolution Oblique Gradient Echo Sequence (T1 weighted) 
 
TR 500ms 
TE 6ms 
Number of Averages 32 
Number of Samples 128 
Number of Views 256 
Flip Angle 90° 
Field of View 50x50mm 
Matrix 256x128 
Block Size 64 
Number of Slices 11 
Slice Thickness/Separation 0.5/0.5mm 
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7.2.4. Axial Gradient Echo Sequence (diffusion weighted) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
7.2.5. Medium Resolution Axial Fast Spin Echo Sequence (T2 weighed) 
 
TR 1000ms 
TE 60ms 
Number of Averages 4 
Number of Samples 128 
Number of Views 64 
Flip Angle N/A 
Field of View 50x50mm 
Matrix 256x128 
Block Size 64 
Number of Slices 8 
Slice Thickness/Separation 1/1mm 
 
 
7.2.6. Medium Resolution Coronal Fast Spin Echo Sequence (T2 weighted) 
 
TR 2000ms 
TE 32ms 
Number of Averages 4 
Number of Samples 256 
Number of Views 128 
Flip Angle N/A 
Field of View 24x24mm 
Matrix 128x64 
Block Size 64 
Number of Slices 8 
Slice Thickness/Separation 0.5/0.5mm 
 
 
 
 
TR 1000ms 
TE 60ms 
Number of Averages 4 
Number of Samples 128 
Number of Views 64 
Flip Angle N/A 
Field of View 050x50mm 
Matrix 128x64 
Block Size 64 
Number of Slices 10 
Slice Thickness/Separation 1/2mm 
Diffusion Gradient 8ms 
Diffusion Time 24ms 
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APPENDIX 8: High Frequency Ultrasound Scanning 
 
 
 
MATERIAL MANUFACTURER 
PRODUCT 
CODE 
Vevo 660 High frequency 
ultrasound scanner 
VisualSonics Inc. 
3080 Yonge Street Suite 6100, Box 66 
Toronto, Ontario, Canada 
660 
40MHz RMV Ultrasound scan 
head 
VisualSonics Inc. 
3080 Yonge Street Suite 6100, Box 66 
Toronto, Ontario, Canada 
RMV-40A 
Veet® Hair removal cream.  
Reckitt Benckiser plc, Turner House  
103-105 Bath Road, Slough, 
Berkshire, UK 
- 
Aquasonic® 100 Ultrasound 
Transmission Gel 
Parker Laboratories Inc, New Jersey. 01-02 
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APPENDIX 9: Cell Culture Materials 
 
 
MATERIAL MANUFACTURER 
PRODUCT 
CODE 
Acetyl-L-carnitine 
Sigma®, Sigma-Aldrich Co Ltd, 
www.sigma-aldrich.com 
A6706 
Bovine Serum Albumin 
Invitrogen Ltd, 3 Fountain Drive 
Inchinnan Business Park, Paisley, 
Scotland. 
15561020 
Collagenase, Type IV. 
Worthington Biochemical Corp.  
730 Vassar Ave 
Lakewood, NJ, USA. 
LS004186 
Cytosine arabinoside 
Sigma®, Sigma-Aldrich Co Ltd, 
www.sigma-aldrich.com 
C1768 
F-12 Nutrient Mixture (Ham), 
liquid 
Invitrogen Ltd, 3 Fountain Drive 
Inchinnan Business Park, Paisley, 
Scotland. 
21765037 
Foetal Bovine Serum (Gamma-
Irradiated) 
Invitrogen Ltd, 3 Fountain Drive 
Inchinnan Business Park, Paisley, 
Scotland. 
10109155 
Insulin 
Sigma®, Sigma-Aldrich Co Ltd, 
www.sigma-aldrich.com 
I6634 
Lab-Tek™ II 
8 Chambered Coverglass 
Nunc GmbH & Co. KG   
Robert-Bosch-Straße 1 
D-63505 Langenselbold, Germany. 
155409 
LaminiN-1 
Sigma®, Sigma-Aldrich Co Ltd, 
www.sigma-aldrich.com 
L2020 
Millex Syringe-driven filter unit 
(0.22μ mesh) 
Millipore Corporate Headquarters:  
290 Concord Road, Billerica, MA 
01821, USA. 
SLLGH04NL 
N-acetylcysteine(cell culture 
tested, BioReagent) 
Sigma®, Sigma-Aldrich Co Ltd, 
www.sigma-aldrich.com 
A9165 
Nerve Growth Factor-2.5S from 
murine submaxillary gland 
Sigma®, Sigma-Aldrich Co Ltd, 
www.sigma-aldrich.com 
N6009 
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Penicillin-Streptomycin, liquid 
(10,000 units penicillin;10,00µg 
streptomycin) 
Invitrogen Ltd, 3 Fountain Drive 
Inchinnan Business Park, Paisley, 
Scotland. 
15140163 
Progesterone 
Sigma®, Sigma-Aldrich Co Ltd, 
www.sigma-aldrich.com 
P0130 
Putrescine 
Sigma®, Sigma-Aldrich Co Ltd, 
www.sigma-aldrich.com 
P5780 
Sodium selenite 
Sigma®, Sigma-Aldrich Co Ltd, 
www.sigma-aldrich.com 
S5261 
Transferrin 
Sigma®, Sigma-Aldrich Co Ltd, 
www.sigma-aldrich.com 
T1408 
Trypsin 
Worthington Biochemical Corp. 
730 Vassar Ave 
Lakewood, NJ, USA. 
LS02120 
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APPENDIX 10: Immunofluorescent Staining 
 
10.1 REAGENTS 
 
MATERIAL 
WORKING 
DILUTION 
MANUFACTURER 
PRODUCT 
CODE 
1° Antibody 
Anti-ßIII-tubulin 
(mouse monoclonal) 
1:1000 
Sigma®, Sigma-Aldrich Co Ltd, 
www.sigma-aldrich.com 
T8600 
2° Antibody 
FITC-Conjugated 
Horse-anti-mouse. 
(IgG, H&L) 
1:100 
Vector Laboratories, Inc. 30 
Ingold Rd, California, USA. 
www.vectorlabs.com 
 
FI-2100  
Blocking Serum 
Normal Horse Serum 
(2.5%)  
1:100 
Vector Laboratories, Inc. 30 
Ingold Rd, California, USA. 
www.vectorlabs.com 
 
S-2012 
 
 
10.2. STAINING PROTOCOL 
 
1. Aspirate cells growth medium 
2. Wash:  PBS - 5 min. RT 
3. Fix: PFA 4% - 20 min. RT 
4. Wash: PBS - 5 min. RT 
5. Permeabilise: Triton X-100 - 30 min. RT 
6. Wash: PBS - 5 min. RT 
7. Blocking: NHS (1:100 - 5.4mg PBS + 60μl NHS) - 60 min. RT 
8. Primary Antibody: Anti-ßIII-tubulin (1:1000: 1.2ml AbD + 12μl Ab) 16h 4°C 
9. Wash: PBS - 5 min. RT 
10. Secondary antibody: FITC Horse anti mouse (1:100: 5.4ml AbD + 60μl Ab) 2 
hours. RT 
11. Wash: PBS - 5 min. X 2 Times 
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12. Mount: Vectashield mounting medium with DAPI. 
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